" / " 05/2009 ISRAEL STATE RECORDS ' " December 24, 2009 PATENTS AND DESIGNS JOURNAL PATENTS Page 3 Applications filed 310 Applications accepted 496 Patents granted 497 Patents renewed 499 Patents not in force 500 Patents renewed for 20 years 501 Extension orders renewed 502 Notices 507 Corrigenda 508 Country codes i Indices of applications accepted DESIGNS 510 Designs registered 517 Designs renewed 518 Designs void
אל' וכו, מסמכים, מכתבים :בענייני פטנטים ומדגמים יש לשלוח ירושלים, מלחה,5בנין, ירושלים, גנים טכנולוגיים, רשם הפטנטים והמדגמים
פתוחה ירושלים והיא, מלחה,5בנין, לשכת הפטנטים נמצאת בגנים טכנולוגיים ירושלים.12:30-ו 8:30לציבור בימי חול שאינם ערבי שבת או מועד בין השעות
כל 2.50לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של שקלים בעד.עמוד או חלק ממנו
' אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מסג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה יש להצי. 0-24145-2
.שולמה
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:The Commissioner of Patents and Designs, Jerusalem Technology Park, Building 5, Malcha,Jerusalem
The Patent Office is located at Jerusalem Technology Park, Building 5, Malcha, Jerusalem andis open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of theOffice, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office togetherwith the application for the action for which the fee has been paid.
זכות היוצרים בתקצירים אלה שמורהמת, למדינת ישראל אין להעתיק
קצירים.אלה אלא ברשות לשכת הפטנטים
Copyright by the State of Israel. NoExtracts may be published except with thepermission of the Patent Office.
מ(לכל חוברת בודדת: מחיר Price.96₪.)מ.ע.כולל per single issue (incl. VAT) : NIS 96.
טכנולוגיה תהליכית להחזרת פולימריםסטירנים שעברו ברומינציה מתערובות
ו או להפיכת/הריאקציות בהם נוצרו גרגרונים או טבליות, התערובות לגלולות
PROCESS TECHNOLOGY FORRECOVERING BROMINATEDSTYRENIC POLYMERS FROMREACTION MIXTURES IN WHICHTHEY ARE FORMED AND/ORCONVERTING SUCH MIXTURESINTO PELLETS OR INTO GRANULESOR PASTILLESALBEMARLE CORPORATION
20/07/200660/832184US28/11/200660/867548US
PCT/US/2007/073805WO/2008/011477
)2009.01 (F41H19645612/01/2009
UDERBELLY גחון לרכב משורין OF ARMORD VEHICLEPLASANמ"פלסן סאסא בע SASA LTD.
)2009.01 (H01L19645910/07/2007
שיטה והתקן לבקרה על מהירות סיבובו של רוטור של מנוע פיאזואלקטרי
METHOD AND CONTROL DEVICEFOR THE SPEED OF ROTATION OF APIEZOELECTRIC MOTOR ROTORSAGEM DEFENSE SECURITE
A METHOD FOR MEASURING THERADIAL VELOCITY OF A TARGETWITH A DOPPLER RADARTHALES NEDERLAND B.V.
22/02/20081035066NL
)2009.01 (A61B19705516/02/2009
AN מכשיר לגילוי שתל דנטאלי APPARATUS FOR DETECTING ADENTAL IMPLANT
.DRר רמי פטררו"ד REMI PETRARU
)2009.01 (H01H19706416/02/2009
FLOATING צלחת מרחפת PLATEYITZHAK יצחק מרק MARK
December–ע"התש בכסלו'ז 24, 2009 16
)2009.01 (H01H19706516/02/2009
אמצעים להחדרת צורת ביטוי של השגחהעליונה לתוך אורגניזם חי ולחפצים
תהליך לייצורם והשימוש בהם, דוממיםלטיפול ומניעה של הפרעות פתולוגיות
ת –כונות כימוופסיכולוגיות ולשיפור פיזיקליות
MEANS FOR INSERTION OFEXPRESSION OF HIGHERSUPERVISION INTO LIVINGORGANISM AND INANIMATEOBJECTS, A PROCESS FOR THEMANUFACTURE THEREOF ANDTHEIR USE IN THE TREATMENT ANDPROPHYLAXIS OF PATHOLOGICALAND PSYCHOLOGICAL DISORDERSAND IMPROVEMENT OF CHEMO-PHYICAL PROPERTIES
ADI עדי לויט LAVIT
)2009.01 (E02B19706616/02/2009
SYSTEM מערכת ושיטה למחזור מים AND METHOD FORRECYCLING WATER
YUVAL יובל ים YAM
)2009.01 (B62J19707717/02/2009
עגלה עבור שער תומכה שניתן להחלקה עבור יצורהותהליך
TROLLEY FOR A SLIDABLECANTILEVER GATE AND PROCESSFOR ITS MANUFACTUREFRATELLI COMUNELLO S.P.A.
12/06/200808425418.4EP
)2009.01 (B32B19708117/02/2009
, ציפוי סופג קרינה באופן בררני שפופרת סופגת ותהליך להכנתם
RADIATION-SELECTIVE ABSORBERCOATING, ABSORBER TUBE ANDPROCESS FOR PRODUCTION THEREOFSCHOTT AG
20/02/2008102008010199.0DE
December–ע"התש בכסלו'ז 24, 200917
)2009.01 (H01H19708617/02/2009
אפוי וממולא בעל תכולת, חטיף פריך לחות גבוהה
FILLED BAKED CRISPY SNACKHAVING A HIGH MOISTURECONTENTKRAFT FOODS GLOBAL BRANDSLLC
29/02/200812/040428US
)2009.01 (G06F19709223/08/2007
שיטות ומערכות לניהול מערכות מידעMETHODS AND APPARATUS FORINFORMATION MANAGEMENTSYSTEMSRAYTHEON COMPANY
24/08/200660/823439US22/08/200711/843266US
PCT/US/2007/076621WO/2008/024900
)2009.01 (H04Q19713420/08/2007
תזמון וסימון עבור, הקצאת משאב דינמיב LTE–קצב שירות מידע משתנה
DYNAMIC RESOURCE ALLOCATION,SCHEDULING AND SIGNALING FORVARIABLE DATA RATE SERVICE INLTEINTERDIGITAL TECHNOLOGYCORPORATION
שיטות לטיפול בסרטן הכוללות מתןוהרכבים, וחומר תרופתי נוסףDויטמין
המכילים אותם
METHODS FOR TREATING CANCERCOMPRISING THE ADMINISTRATIONOF A VITAMIN D COMPOUND ANDAN ADDITIONAL THERAPEUTICAGENT, AND COMPOSITIONSCONTAINING THE SAMECOUGAR BIOTECHNOLOGY, INC.
]D–4,5[תיאזולו)3,1(תולדות חדשות שלדו–)H3(2–פירימידינ מותמרות–אמין ושימושן בטיפול7–ו5באמצות
NOVEL 5,7-DISUBSTITUTED(1,3)THIAZOLO [4,5-D]PYRIMIDIN-2(3H)-AMINE DERIVATIVES ANDTHEIR USE IN THERAPYASTRAZENECA AB
29/09/200660/827442US04/10/200660/828122US
PCT/SE/2007/000858WO/2008/039139
)2009.01 (C07K19729904/10/2007
PTHשעברו פגילציה כמאפננים שלל ושימושםPTH–רצפטור
PEGYLATED PTH AS PTH RECEPTORMODULATORS AND USES THEREOF
ELI LILLY & CO.13/10/200660/829383US
PCT/US/2007/080367WO/2008/048784
)2009.01 (C07K19730012/09/2007
נוגדנים וחלקי נוגדן הומניים כנגד רצפטורפולאט לטיפול רדיואימוני–אלפא לאנטי
בקרצינומה של השחלה
HUMAN ANTI-FOLATE RECEPTORALPHA ANTIBODIES ANDANTIBODY FRAGMENTS FOR THERADIOIMMUNOTHERAPY OFOVARIAN CARCINOMAISTITUTO NAZIONALE PER LOSTUDIO E LA CURA DEI TUMORI
מערכת ושיטה להנעה תוך שימוש בתא שריפה הפולט מסה מרוכזת
PROPULSION SYSTEM AND METHODUSING A COMBUSTION CHAMBERDISCHARGING A CONCENTRATEDMASS
TECHNIONמ"מוסד הטכניון למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT FOUNDATION LTD.
December–ע"התש בכסלו'ז 24, 2009 74
)2009.01 (G08B19738803/03/2009
שיטה המשתמשת ברדאר לגילוי מטרהבלתי ידועה העשויה להיות ממוקמת
ליד מטרות אחרות, בגובה נתון בקירוב הממוקמות באותו גובה בקירוב
METHOD USING RADAR TO DETECTA KNOWN TARGET LIKELY TO BEPOSITIONED AT APPROXIMATELY AGIVEN HEIGHT, NEAR OTHERTARGETS POSTIONED ATAPPAOXIMATELY THE SAMEHEIGHTTHALES
01/04/20080801787FR
)2009.01 (C07K19738904/10/2007
חומר פרופילקטי או תרפואטי לסרטן
PROPHYLACTIC OR THERAPEUTICAGENT FOR CANCERTAKEDA PHARMACEUTICAL COMPANYLIMITED
SPRזיהוי שיירים על ידיDETECTION OF ANALYTES BYSURFACE PLASMON RESONANCESPECTROSCOPY
יישום חברה לפיתוח המחקר של רסיטה העברית בירושליםהאוניב
YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM
)2009.01 (G06F19742501/11/2007
HEALTH המשלבת בריאותAPIתוכנית INTEGRATION PLATFORMAPIMICROSOFT CORPORATION
01/11/200660/863897US08/05/200711/745902US
PCT/US/2007/083395WO/2008/057973
December–ע"התש בכסלו'ז 24, 200983
)2009.01 (A61K19742611/09/2007
מעכבי היסטון דאצטילאז עם פעילותIמשולבת על היסטון דאצטילאזים מסוג
בשילוב עם מעכבי פרוטיאזוםIIBומסוג
HISTONE DEACETYLASEINHIBITORS WITH COMBINEDACTIVITY ON CLASS-I AND CLASS-IIB HISTONE DEACETYLASES INCOMBINATION WITH PROTEASOMEINHIBITORSJANSSEN PHARMACEUTICA, N.V.
15/09/200606120726.2EP03/05/200760/915895US
PCT/EP/2007/059518WO/2008/031817
)2009.01 (B26B19742706/09/2007
וח רטוב המכילה סייע גילוח מערכת לגיל המצופה בשמן מינרלי
WET SHAVING SYSTEM INCLUDINGA MINERAL OIL COATED SHAVINGAIDTHE GILLETTE COMPANY
NEW IMIDAZOLONE DERIVATIVES,PREPARATION THEREOF AS DRUGS,PHARMACEUTICAL COMPOSITIONS,AND USE THEREOF AS PROTEINKINASE INHIBITORS, INPARTICULAR CDC7SANOFI-AVENTIS
]5,4–B[אילאמין אשר בו אטומי–5–פירידיןותכשיריBOCהחנקן מוגנים בקבוצות רוקחות המכילים אותם
5-AMINO-7-(1H-INDOL-2-YL)-1,3-DIHYDRO-IMIDAZOL[4,5-b]PYRIDIN-2-ONE AND ITS N- BOC PROTECTED-7-(1H-INDOL-2-YL)-2-METHYL-3H-IMIDAZO[4,5-b]PYRIDIN-5-YLAMINEAND PHARMACEUTICALCOMPOSITIONS COMPRISING THEM
שיטה בלתי פולשנית ומכשיר לניבויעתידיים ומחלות הפלה או לידה מוקדמת
אחרות אצל נש ים אסימפטומטיות וחיות משק בגילאים שונים
A NON INVASIVE METHOD ANDDEVICE FOR PREDICTION OFFUTURE ABORTION OR PRETERMDELIVERY AND OTHER MEDICALDISORDERS IN ASYMPTOMATICWOMEN AND DOMESTIC ANIMALSOF VARIOUS AGES
ABRAHAM אברהם קסלר KESSLER
December–ע"התש בכסלו'ז 24, 2009111
)2009.01 (A61M19752611/09/2007
התקן להגנה מפני תסחיף דם ושיטה לשימוש
EMBOLIC PROTECTION DEVICE ANDMETHOD OF USEEMBRELLA CARDIOVASCULAR ,INC.
MATCHINGם לצרכניםהתאמת מידת בגדי THE FIT OF GARMENTSTO CONSUMERSMYSHAPE, INC.
PCT/US/2006/035965WO/2008/033138
)2009.01 (A61K19758204/03/2003
תכשירים המכילים צורה קריסטלינית שלחומצה הידרוקסמית של סברואילאניליד
)SAHA(ושיטות להכנתSAHA
COMPOSITIONS COMPRISING ACRYSTALLINE FORM OFSUBEROYLANILIDE HYDROXAMICACID (SAHA) AND METHODS FORSAHA PREPARATIONSLOAN-KETTERING INSTITUTE FORCANCER RESEARCH
METHOD שיטה ומתקן עבור אימות הדדי AND APPARATUS FORMUTUAL AUTHENTICATIONQUALCOMM INCORPORATED
10/10/200660/850882US03/10/200711/866946US
PCT/US/2007/080525WO/2008/045773
)2009.01 (H01H19759115/03/2009
טבעת להחזקת מפתחות עם אמצעיםהמאפשרים הכנסה קלה והוצאה קלה של
המפתחות מהטבות
KEYS RING WITH MEANS, THETALLOW EASY INSERTION ANDTAKING OUT OF THE KEYS IN ANDFROM THE RING RESPECTIVELY
.DR עמרם בן שמחוןר חיים"ד HAIM AMRAM BEN-SIMHON
December–ע"התש בכסלו'ז 24, 2009127
)2009.01 (F41H19759215/03/2009
,ש או רכב"נגמ, שריון ריאקטיבי לטנקאו(כנגד פגזים או טילים בעלי מטען חלול
)חודר שריון
REACTIVE ARMOR FOR A TANK,APC(ARMOURED PERSONNELCARRIER) OR A VEHICLE, AGAINSTSHELLS OR MISSILES WITHHOLLOW EXPLOSIVE CHARGE(ARMOR PENETRATINGAMUNITION).
.DRר חיים עמרם בן שמחון"ד HAIM AMRAM BEN-SIMHON
)2009.01 (G06F19759317/09/2007
מערכת ושיטה לאוטומציה של העברת נתונים מממשק אינטרנטי לממשק אחר
SYSTEM AND METHOD FORAUTOMATING THE TRANSFER OFDATA FROM A WEB INTERFACE TOANOTHERJOBDIVA, INCORPORATED
15/09/200660/844646US17/09/200711/856586US
PCT/US/2007/078677WO/2008/034139
)2009.01 (C07K19759417/09/2007
תכשירים המכילים חלבונים המטופליםת להכנתםבלחץ גבוה ושיטו
COMPOSITIONS COMPRISING HIGHPRESSURE-TREATED PROTEINS ANDMETHODS OF PREPARING THESAMEBAROFOLD, INC.
CMOS LINEAR IMAGE SENSOROPERATING BY CHARGE TRANSFER
E2V SEMICONDUCTORS19/09/20060608188FR
PCT/EP/2007/058549WO/2008/034677
December–ע"התש בכסלו'ז 24, 2009 130
)2009.01 (C12N19760118/09/2007
פחמימנים וחומצות שומן של אצות באורך שרשרת בינוני
ALGAL MEDIUM CHAIN LENGTHFATTY ACIDS ANDHYDROCARBONSTHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY
, לייעול, לתזמון, שיטות ומערכות לקביעהולאתחול של תקשורת אישית ולקבוע
קי תקשורת סדר עדיפויות עבור אפי ומתקני תקשורת
METHODS AND SYSTEMS FORSETTING, SCHEDULING,OPTIMIZING, AND INITIATINGPERSONAL COMMUNICATION ANDPRIORITIZING COMMUNICATIONCHANNELS AND DEVICESNEATCALL LTD.
אינסולין ארוך טווח להורדת התחלואההקרדיוווסקולרית והתמותה בחולים קדם
2סכרתיים ובחולים עם סכרת מסוג
LONG ACTING INSULIN FORREDUCING CARDIOVASCULARMORBIDITY AND MORTALITY INPREDIABETIC PATIENTS ANDPATIENTSWITH TYPE 2 DIABETESAVENTIS PHARMACEUTICALS INC.
RECOMBINANT וירוס הצרפי–וקטורים של רינו RHINOVIRUSVECTORSSANOFI PASTEUR BIOLOGICS CO.
29/09/200660/848308US15/01/200760/880664US
PCT/US/2007/021102WO/2008/100290
December–ע"התש בכסלו'ז 24, 2009 172
)2009.01 (G10L19775729/08/2007
מערך, מערכת של מערך מסננים לניתוחמערבל,מפענח, מקדד, מסננים לסינתזה וניהול ועידות
ANALYSIS FILTERBANK, SYNTHESISFILTERBANK, ENCODER, DECODER,MIXER AND CONFERENCINGSYSTEMFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.
18/10/200660/862032US04/05/200711/744641US
PCT/EP/2007/007553WO/2008/046468
)2009.01 (C07D19775802/10/2007
תכשיר, נגזרות חדשות מסוג בנזופורןאו הכולל את האמור לצורך טיפול
ושימוש, מניעת תפקוד קוגניטיבי לקוי באלה
NOVEL BENZOFURAN TYPEDERIVATIVES, A COMPOSITIONCOMPRISING THE SAME FORTREATING OR PREVENTINGCOGNITIVE DYSFUNCTION AND THEUSE THEREOFDIGITAL BIOTECH CO. LTD
, בנזאמיד)מתיל)ילידן–4–פיפרידינ)ילמתיל, תהליך לייצורו ושימושו לטיפול בכאב
חרדה ודיכאון
N-(2-HYDROXYETHYL)-N-METHYL-4-(QUINOLIN-8-YL(1-(THIAZOL-4-YLMETHYL)PIPERIDIN-4-YLIDENE)METHYL)BENZAMIDE,THE PROCESS OF MAKING IT ASWELL AS ITS USE FOR THETREATMENT OF PAIN, ANXIETYAND DEPRESSIONASTRAZENECA AB
–מודולטורים מסוג ביפניל סולפוניל ופניל3Hהטרואריל סולפוניל של רצפטור
להיסטמין השימושיים לטיפול במחלות בקשורות אליו
BIPHENYL SULFONYL AND PHENYL-HETEROARYL SULFONYLMODULATORS OF THE HISTAMINEH3-RECEPTOR USEFUL FOR THETREATMENT OF DISORDERSRELATED THERETOARENA PHARMACEUTICALS, INC.
17/10/200660/852610US11/06/200760/934358US
PCT/US/2007/022086WO/2008/048609
December–ע"התש בכסלו'ז 24, 2009 208
)2009.01 (C07J19789324/10/2007
הרכבים ושיטות לעיכוב של שגשוג באנדומטריום
COMPOSITIONS AND METHODS FORSUPPRESSING ENDOMETRIALPROLIFERATIONREPROS THERAPEUTICS INC.
24/10/200660/862632US17/01/200760/885348US
PCT/US/2007/082432WO/2008/067086
)2009.01 (A01N19789402/10/2007
מכשור ושיטות לשימוש בתרכובות סמיוכימיות לשם הדברת חרקים
APPARATUS AND SYSTEMS FORUSING SEMIOCHEMICALCOMPOSITIONS FOR INSECT PESTCONTROLSUTERRA LLC
HYDRATES OF 2-CHLORO-5-[3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUORO-METHYL)-1-(2H)-PYRIMIDINYL]-4-FLUORO-N-[[METHYL-(1-METHYLETHYL)-AMINO]SULPHONY]BENZAMIDEBASF SE
–התקן ושיטה ליצירת ערכי שמע תתפסיים והתקן ושיטה ליצירת דוגמיות שמע
הזמן–במתחם
APPARATUS AND METHOD FORGENERATING AUDIO SUBBANDVALUES, AND APPARATUS ANDMETHOD FOR GENERATING TIME-DOMAIN AUDIO SAMPLESFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.
עם–Lחומצה ,18Fגלוטמית המסומנת L–, נגזרותיהם,18Fגלוטאמין המסומן עם
השימוש בהם ותהליכים להכנתם
[F-18]-LABELED L-GLUTAMIC ACID,[F-18]-LABELED-L-GLUTAMINEDERIVATIVES THEREOF AND USETHEREOF AND PROCESSES FORTHEIR PREPARATIONINSTITUTE OF THE HUMAN BRAINRUSSIAN ACADEMY OF SCIENCE(IHB RAS)OF
01/11/20062006138584RU18/11/200606090211.1EP
PCT/EP/2007/009518WO/2008/052788
)2009.01 (D21F19802314/08/2007
מלמלית מעוצבות על ידי לחץ בתנאיMOLDED רטיבות WET-PRESSED TISSUE
שיטה לייצור נשא זיהוי או מפתחאלקטרוני עבור מנעולים עבור מנעולים
המופעלים אלקטרונית
METHOD FOR THE PRODUCTION OFAN IDENTIFICATION CARRIER ORELECTRONIC KEY FORELECTRONICALLY ACTUATEDLOCKSEVVA-WERK SPEZIALERZEUGUNGVON ZYLINDER-UNDSICHERHEITSSCHLOSSERNGESELLSCHAFT M.B.H. & CO. KG
CRYSTALLINE FORM OF 2-CHLORO-5-[3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUOROMETHYL)-1-(2H)-PYRIMIDINYL]-4-FLUORO-N-[[METHYL-(1-METHYL)ETHYL)AMINO]SULPHONYL]BENZAMIDE
BASF SE13/10/200606122265.9EP
PCT/EP/2007/060879WO/2008/043835
)2009.01 (H04L19809329/10/2007
CDM–FDMשיטה ומתקן עבור מבנההיברידי עבור ערוצי בקרה מבוססי נושא
יחיד
METHOD AND APPARATUS FORHYBRID FDM-CDM STRUCTURE FORSINGLE CARRIER BASED CONTROLCHANNELSQUALCOMM INCORPORATED
FLUID מערכת שסתומית לבקרת נוזל ושיטות CONTROL VALVA SYSTEMAND METHODSTYCO FIRE PRODUCTS LP
20/10/200660/862305US29/01/200760/887040US
PCT/US/2007/082006WO/2008/051871
)2009.01 (A61P19817518/10/2007
שיטה ותכשיר רוקחות לטיפול בתת פוריות בזכרים
METHOD AND PHARAMCOLOGICALCOMPOSITION FOR THE DIAGNOSISAND TREATMENT OF MALE SUB-FERTILITY
PERINESSמ"פרינס בע LTD18/10/200660/852402US
PCT/IL/2007/001250WO/2008/047364
)2009.01 (H04Q19817610/10/2007
שיטה ומערכת לשליחת משוב עבור שרותמשותף מהלווין לארץ המשודר למספר
ל קליטה/שידוררב של יחידות אלחוטיות
METHOD AND APPARATUS FORSENDING FEEDBACK FOR ADOWNLINK SHARED SERVICETRANSMITTED TO A PLURALITY OFWIRELESS TRANSMIT/RECEIVEUNITSINTERDIGITAL TECHNOLOGYCORPORATION
10/10/200660/828881US05/01/200760/883594US
PCT/US/2007/021642WO/2008/045471
December–ע"התש בכסלו'ז 24, 2009281
)2009.01 (B67D19817710/10/2007
שיטה והתקן לניפוק מנתי של נוזל מוגז לאחר השוואת לחצים
METHOD AND APPARATUS FORDOSED DISPENSING OF GASIFIEDLIQUID AFTER PRESSUREEQUALISATIONDISPENSING TECHNOLOGIES B.V.
P-TOLUENE SULFONIC ACID SALTOF 5-AMINO-3-(2'-O-ACETYL-3'-DEOXY-?-D-RIBOFURANOSYL-3H-THIAZOLE[4,5-D]PYRIMIDINE-2-ONEAND METHODS FOR PREPARATIONANADYS PHARMACEUTICALS, INC.
זרם צדדי וזרם מבעד לנבדק אורגניזמי חישיטות, המבוסס על תבנית מדיה נקבובית
להכנה ושיטות לשימוש
LATERAL FLOW AND FLOW-THROUGH BIOASSAY BASED ONPATTERNED POROUS MEDIA,METHODS OF MAKING SAME, ANDMETHODS OF USING SAMEPRESIDENT AND FELLOWS OFHARVARD COLLEGE
התקן ושיטה לעיבוד נוסף של ערכיםספקטריים ומקדד ופענח עבור אותות
אודיו
DEVICE AND METHOD FORPOSTPROCESSING SPECTRAL VALUESAND ENCODER AND DECODER FORAUDIO SIGNALSFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.
CHASSIS שסי לעגלה או לרכב FOR CART OF VEHICLEYARON לאוניד מינוטין LEVY
December–ע"התש בכסלו'ז 24, 2009 286
)2009.01 (B23K19819417/11/2001
שיטה ומערכת לניתור ובקרה בזמן אמתגובה משקע בשימוש בטכנולוגיית צילום
דמות ועיבוד דמות בצפוי בלייזר ובתהליך ייצור מתכת ישיר בסיוע לייזר
METHOD AND SYSTEM FOR REAL-TIME MONITORING ANDCONTROLLING HEIGHT OF DEPOSITBY USING IMAGE PHOTOGRAPHINGAND IMAGE PROCESSINGTECHNOLOGY IN LASER CLADDINGAND LASER AIDED DIRECT METALMANUFACTURING PROCESSINSSTEK INC
PCT/KR/2001/001970WO/2003/042895
)2009.01 (C03C19819519/10/2007
ל הכנתםחומרים מורכבים ושיטותCOMPOSITE MATERIALS ANDPROCESSES FOR PRODUCING THESAMEMILLENIUM RESEARCH PTY LTD.
–?17שימוש באסטראדיאול וולראט אוסט לטיפול'אסטראדיאול יחד עם דיאנוג
ו או הגברת אביונה/רפואי פומי לשמירה נשית
USE OF ESTRADIOL VALERATE OR17?-ESTRADIOL IN COMBINATIONWITH DIENOGEST FOR ORALTHERAPY FOR MAINTAININGAND/OR INCREASING THE FEMALELIBIDOBAYER SCHERING PHARMA AG
SYSTEM AND METHOD FORGROWING PHOTOSYNTHETIC CELLSTHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY
MODIFIED ציאנובקטריה מותאמת CYANOBACTERIATHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY
SOLID FORMS COMPRISING 4-[9-(TETRAHYDRO-FURAN-3-YL)-8-(2,4,6-TRIFLUORO-PHENYLAMINO)-9H-PURIN-2-YLAMINO]-CYCLOHEXAN-1-OL, COMPOSITIONSTHEREOF, AND USE THEREWITHSIGNAL PHARMACEUTICALS, LLC
ו –פירימידיניל–2–פיפרידיניל–8–און און–6–פירימידין]A–1,2[פירימידו
SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO [1,2-A]PYRIMIDIN -6- ONE AND 8-PIPERIDINYL-2- PYRIMIDINYL [1,2-A] PYRIMIDIN -6- ONE DERIVATIVESSANOFI-AVENTIS
שיטה והתקן לייצור אנליטים של גזו או שלילית עבור אנליזת/מיונן חיובית
גז
METHOD AND DEVICE FORPRODUCING POSITIVELY AND/ORNEGATIVELY IONIZED GAS ANALYTESFOR GAS ANALYSISGESELLSCHAFT ZUR FORDERUNG DERANALYTISCHEN WISSENSCHAFTENE.V.
The applications, particulars of which are setout below, have been accepted pursuant toSection 17 of the Patents Law. Any personwishing to oppose the grant of a patent on anyof the applications published here, may,within three months from the date of thisjournal, give to the Commissioner of Patentsnotice under Section 30 of the Patents Law, inthe manner prescribed in regulations 57 et seqof the Patents Regulations, 5728-1968
פרטי הבקשות במידה ויישימים מובאים לפיזהס :דר
Particulars of the applications, whereapplicable, are given in the following order:
[11] מספר הבקשה [21] Number of application[54] שם האמצאה Title of invention
[22] תאריך הבקשה Application dateמדינת–מספר ותאריך של בקשות החוץ
האגוד[31] [32] [33] Number and date of foreignapplication – convention country.
[51]* מהדורה שביעית–סיווג בינלאומי* Int.Cl.[61] בקשה לפטנט מוסף Application for patent of addition
[62] בקשת חלוקה Divisional application[71] המבקש Applicant[72] הממציא Inventor
[87] פרסום של בקשה הבינלאומית' מס International Publication Number[74] מען למסירת מסמכים Address for service
[57])בשפה בה ערוך הפירוט(תקציר האמצאה Abridgement of invention (in thelanguage in which the specification is drawnup)
מסהחל מיומ: הערה* 'ן הפטנטים והמדגמיםניתן ציון לבקשות פטנטים הסיווג לפי 1/06
המהדורה השמינית של הסיווג הבינלאומי )2006משנה(של פטנטים
*Note: As from Patents and Designs JournalNo.1/06, patent applications are classifiedaccording to the Eighth Edition of theInternational Patent Classification (2006)
December–ע"התש בכסלו'ז 24, 2009311
124636]21][11[
וקטורים נגזרים מנגיף ששכפולם מותנה ושימושם
CONDITIONALLY REPLICATINGVIRAL VECTORS AND THEIRUSE
The present invention provides a conditionally replicating viral vector, methods ofmaking, modifying, propagating and selectively packaging, and using such a vector,isolated molecules of specified nucleotide and amino acid sequences relevant to suchvectors, a pharmaceutical composition and a host cell comprising such a vector, theuse of such a host cell to screen drugs. The methods include the prophylactic andtherapeutic treatment of viral infection, in particular HIV infection, and, thus, are alsodirected to viral vaccines and the treatment of cancer, in particular cancer of viraletiology. Other methods include the use of such conditionally replicating viral vectors ingene therapy and other applications.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 312
126626]21][11[
פפטידים חדשים המעכבים גדילת כליפולינוקליאוטידים המקדדים אותם, דם
ושיטות לעיכוב גדילת כלי דם
NOVEL ANTIANGIOGENICPEPTIDES, POLYNUCLEOTIDESENCODING SAME ANDMETHODS FOR INHIBITINGANGIOGENESIS
תל אביב, 11490.ד.ת, 124אבן גבירולDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
Mammalian kringle (5) fragments of plasminogen and kringle (5) fusion proteins aredisclosed as compounds for treating angiogenic diseases. Methods and compositionsfor inhibiting angiogenic diseases are also disclosed.
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
195827,The applications for divisionfrom this application havenot yet been published
__________
December–ע"התש בכסלו'ז 24, 2009313
126728]21][11[
נגזרות אתילן ותכשירים אגרוכימייםהמכילים את הנגזרות האמורות כמרכיב
פעיל
ETHYLENE DERIVATIVES ANDAGROCHEMICALCOMPOSITIONS CONTAININGSAID DERIVATIVES AS ANACTIVE INGREDIENT
Ethylene derivatives of general formula (I) and pesticides or aquatics adhesioninhibitors characterized by containing at least one of the derivatives, wherein Q isoptionally substituted phenyl or a hetero-cyclic group (particularly, 4-thiazolyl, 1- or 3-pyrazolyl, 1,3-oxazol-4-yl, phenyl or pyridyl); E is cyano or the like; A is 4-pyrrazolyl,thiazolyl or the like; and B is alkylcarbonyl or the like.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 314
129966]21][11[
גופיפים עובריים שמקורם בתאי מקור עובריים של אדם
ISOLATED HUMAN EMBRYOIDBODIES (HEB) DERIVED FROMHUMAN EMBRYONIC STEMCELLS
Apparatus configured for entering the spine of a body of a live human patient throughseparate first and second incisions, made in the patient adjacent to different vertebraein the spine, to remove material from the spine, the apparatus comprising: a handle(210), first (208) and second (200) elongate extensions, attached to said handle, long
]57[
December–ע"התש בכסלו'ז 24, 2009315
enough to extend, simultaneously, from the handle respectively through the first andsecond incisions to separate first and second locations along the length of the spine;and a flexible rasp (202) configured to pass along the first extension into the bodythrough the first incision and up to the first location on the spine, through a spinalchannel from the first location to the second location, and from the second locationalong the second extension out of the body through the second incision.
__________
132251]21][11[
בעלי החלפותNGFוריאנטים שלל trkC–חומצות אמינו המקנות קשור
NGF VARIANTS HAVING AMINOACID SUBSTITUTIONS THATIMPART TRKC BINDING
NGF variants which have trkC-binding activity and trkC-signal inducing activity areprovided. The variants optionally have trkA or trkB binding and signal induction activity.The NGF variants of the present invention are useful in the treatment of neuronaldisorders. Nucleic acids and expression vectors encoding the NGF variantneurotrophins are also provided.
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
In some embodiments, network traffic information is captured at network informationsources. These sources provide detailed information about the networkcommunications transactions at a network device. Importantly, different types ofsources can provide different types of information. Gatherer devices gather the detailedinformation from the various information source devices and convert the informationinto standardized information. The gatherer devices can correlate the gatheredinformation with account information for network transaction accounting. Managerdevices manage the gatherer devices and store the gathered standardized information.The manager devices eliminate duplicate network information that may exist in thestandardized information. The manager devices also consolidate the information.Importantly, the information stored by the manager devices represents theconsolidated, account correlated, network transaction information that can be used forbilling or network accounting. The system thereby provides a distributed networkaccounting and billing system.
טירת הכרמל 5/2האלה' רחOREN ALOUCE,6/2 ELLA ST. TIRAT HACARMEL
]74[
של,ן בחלון או בקדמת מאווררלוח המיועד לקירור של חללים המותק]57[ כאשר הלוח בעל מספר רבכל, חורים היוצרים בעובי הלוח צינורות שהקוטר שלהם הולך וקטן מפתח הצינור ליציאת הצינור כאשר
צינור מורכב ממספר שרוולים המחוברים בניהם כך שהאוויר הזורם בתוכם משנה את מסלולו בזוית של על מנת לגרום לקירור האוויר היוצא מהשרוול בעל הקוטר, ושרוול מעלות במעבר שבין כל שרוול 90
.הקטן ביותר
December–ע"התש בכסלו'ז 24, 2009317
לתקנות35פירוט זה נבח) בהתא� לתקנה 1968–ח"תשכ, הפטנטי�
This specification was examined inaccordance with regulation 35 of the PatentRegulations, 5728 - 1968
__________
138380]21][11[
מבער במחזור ברייטון היברידי בעל נצילות גבוהה וזיהום סביבתי נמוך
HIGH EFFICIENCY LOWPOLLUTION HYBRID BRAYTONCYCLE COMBUSTOR
]54[
10.03.1999]22[US]33[13.03.1998]32[09/042231]31[
Int. Cl.(2008.04) F01K 21/04, F02C 3/30]51[VAST POWER PORTFOLIO, LLC,U.S.A.
]71[
WO/1999/046484]87[',דניאל פריימן ושות
תל אביב,10בית כלל קומה5דרויאנובDANIEL FREIMANN & CO.,5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
]74[
A power generating system is described which operates at high pressure and utilizes aworking fluid consisting of a mixture of compressed non-flammable air components,fuel combustion products and steam. The working fluid exiting the power generatingsystem is substantially free of NOx and CO. Working fluid is provided at constantpressure and temperature. Combustion air is supplied by one or more stages ofcompression. Fuel is injected at pressure as needed. Substantially all of the oxygen inthe compressed air is consumed when the fuel is burned. Inert liquid is injected at highpressure to produce an inert mass of high specific heat diluent vapor for use for internalcooling of the combustion chamber. The use of non-flammable liquid injection inhibitsthe formation of pollutants, increases the efficiency and available horsepower from thesystem, and reduces specific fuel consumption. Control systems allow the independentcontrol of the quantity, temperature and pressure of the air, fuel and non-flammableliquid introduced in the combustion chamber allowing control of the maximumtemperature and average temperature within the combustion chamber as well as thetemperature of the exhaust from the combustion chamber. Substantially all of thetemperature control of the system is provided by the latent heat of vaporization of theinert liquid, which is preferably water, the latent heat of vaporization counteracting theheat generated by combustion of the fuel. If the injected water contains inorganic ororganic contaminants, they are collected as a molten or solid residue or, if flammable,ignited by the flame.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 318
138716]21][11[
GENES גנים המקודדים עבור סינתזה של פלוון CODING FOR FLAVONESYNTHASES
A DNA encoding an enzyme capable of converting flavanone directly into flavone whichis obtained from, for example, antirrhinum and torenia, and utilization thereof. Theamino acid sequences of this DNA and the enzyme encoded thereby are representedby, for example, SEQ ID NOS: 1, 2, 3 and 4. Transfer of this gene into a plant makes itpossible to, for example, change the flower color of the plant.
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
195809,195808,The applications for divisionfrom this application havenot yet been published
__________
December–ע"התש בכסלו'ז 24, 2009319
139674]21][11[
הארכת טווח שדות המיחשוב של מספריםשלמים ורוחב ואופרנדים ההזנה הסדרתית
עבדים משניים לחשבון מודולרי של בממפתח ציבורי קריפטוגרפי המתוכננים
אי–אס–אר–לחישוב מסוג עיקול אליפטיו )RSA(
EXTENDING THE RANGE OFCOMPUTATIONAL FIELDS OFINTEGERS AND WIDTH OFSERIAL INPUT OPERANDS INMODULAR ARITHMETICPUBLIC KEY CRYPTOGRAPHICCO-PROCESSORS DESIGNEDFOR ELLIPTIC CURVE AND RSATYPE COMPUTATIONS
A public key encryption system comprising: a processor for performing a modulararithmetic multiplication, A-B (mod N), of an integer multiplier, denoted A, with aninteger multiplicand, denoted B, modulo an integer modulus, denoted N, using base rinteger arithmetic and without performing an integer division operation, wherein at leastone of A, B and N is a large integer, comprising: memory registers storingrepresentations of each of A, B and N in base r as a sequence of at least one segment,wherein a segment is a k-character integer, and wherein a character is an integerbetween 0 and r-1, and wherein k is a pre-selected segment length; a multipliermultiplying two k-character integers in base r; an accumulator summing two k-characterintegers in base r; and a logical unit adjusting a k-character base r integer so as toforce its least significant character to be zero.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 320
140492]21][11[
POLYMORPH פולימורף של חומר רוקחי OF APHARMACEUTICAL
שב, 5352.ד.ת, עומר, גן תעשייה עבארLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention relates to peptides and proteins which may be used to inhibitinfection or cell proliferation. It is based, at least in part, on the discovery of peptidesand proteins isolated from embryonic tissue which have been found to exhibit anantiproliferative effect on a variety of cancer cells and/or to act as broad-spectrumantiviral agents.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009321
140793]21][11[
מערכת גלובלית לארוח מסמכיםמשת בשרתים משוכפלים מבוזרים המשת
בעלי תכולה משובצת
GLOBAL DOCUMENT HOSTINGSYSTEM UTILIZING EMBEDDEDCONTENT DISTRIBUTED GHOSTSERVERS
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A network architecture or framework that supports hosting and content distribution on atruly global scale. The framework allows a Content Provider to replicate and serve itsmost popular content at an unlimited number of points throughout the world. Theframework comprises a set of servers operating in a distributed manner. The actualcontent to be served is preferably supported on a set of hosting servers (36),sometimes referred to as ghost servers. This content comprises HTML page objectsthat, conventionally, are served from a Content Provider site. In accordance with theinvention, however, a base HTML document portion of a web page is served from theContent Provider's site (1), while one or more embedded objects for the page areserved from the hosting servers (3, 4), preferably those hosting servers (5) near theclient machine. By serving the base HTML document from the Content Provider's site,the Content Provider maintains control over the content.
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
198508,The applications for divisionfrom this application havenot yet been published
__________
December–ע"התש בכסלו'ז 24, 2009 322
141061]21][11[
חלבון לשימוש כסמן לסרטן ושיטהלאבחון סרטן הערמונית או סרטן
ל"שלפוחית השתן בשימוש בחלבון הנ
PROTEIN USEFUL AS A MARKERFOR CANCER AND METHOD FORDIAGNOSING PROSTATE ORBLADDER CANCER USING SAIDPROTEIN
Described is a novel gene and its encoded secreted tumor antigen, termed BPC-1, andto diagnostic and therapeutic methods and compositions useful in the management ofvarious cancers which express BPC-1, particularly including prostate cancer andbladder cancer. In human normal tissues, BPC-1 is only expressed in certain tissues ofthe brain. However, BPC-1 is expressed at high levels in prostate cancer cells and isalso expressed in bladder cancer cells. The structure of BPC-1 includes a signalsequence and a CUB domain. BPC-1 protein is secreted. Preliminary experimentalevidence suggests that BPC-1 is directly involved in oncogenesis or maintenance ofthe transformed phenotype of cancer cells expressing BPC-1. BPC-1 also appears tobind specifically to a cellular protein expressed in prostate cancer cells and other cells.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009323
142025]21][11[
חלבונים/פפטידים) פולי(שיטות להצגתג דרך קשרים'על חלקיקי באקטריופא
דיסולפידיים
METHODS FOR DISPLAYING(POLY) PEPTIDES/PROTEINS ONBACTERIOPHAGE PARTICLESVIA DISULFIDE BONDS
The present invention relates to methods for displaying (poly)peptides/proteins on thesurface of bacteriophage particles by attaching the (poly)peptide/proteins via disulfidebonds.
Variants of hedgehog protein that contain N-terminal modifications are described thatcan block hedgehog function; thus allowing these variants to serve as functionalantagonists. These peptides have a primary amino acid sequence lacking the ability toelicit a hedgehog-dependent response in C3H 10T1/2 cells but having the ability to bindto the hedgehog receptor, patched-1. Methods for producing such functionalantagonists and methods of using the � unctional antagonists are also described.
A computer-implemented method for organizing a sequence of video frames,comprising: generating a first portion of a segment of the sequence by: for each framebeginning from an initial frame in the sequence, computing a multi-dimensional vectorof parameters indicative of a characteristic of the frame; determining vector distancesbetween the frames in the sequence responsively to differences in the multi-dimensional vector of parameters among the frames; and finding, responsively to thedistances, a bounding subset comprising at least three of the frames in the sequence,chosen so as to maximize a sum of the distances between all of the at least threeframes in the subset, while each of the distances is no greater than a predeterminedmaximum, such that the first portion comprises the frames in the sequence that arebounded by the at least three of the frames in the bounding subset; selecting one of theframes in the first portion to be a representative frame for the segment; and generatinga second portion of the segment by adding to the segment further frames in thesequence subsequent to the first portion while determining that the respectivedistances between the added further frames and the representative frame are within apredefined bound.
]57[
__________
143351]21][11[
ור אנושי לביטוי תא מארח היברידי ממק גנים של יונקים
HUMAN HYBRID HOST CELLFOR MAMMALIAN GENEEXPRESSION
Human/human hybrid cells were made via fusion of human embryonic kidney cells(293S) and modified Burkitt's lymphoma cells (2B8). The fusion cells are useful as hostcells for the recombinant expression of mammalian genes. The advantages of usingthese hybrid clones of human kidney- and B-cells, called HKBs, for mammalian geneexpression, include (i) the cells are negative for immunoglobulin expression, (ii) thecells grow easily in plasma protein-free medium (with or without the addition ofrecombinant insulin) as suspension cultures in a shake flask or in a fermenter (iii) thecells are very susceptible for transfection of DNA, and (iv) the cells secrete high levelsof heterologous recombinant proteins, such as recombinant monoclonal antibodies,soluble ICAM-1, rIL-4, and rFVIII.
]57[
__________
144043]21][11[
שימוש בריאווירוס להכנת תכשיר רפואי לטיפול בהפרעות התרבות תאית
USE OF REOVIRUS FOR THEPREPARATION OF APHARMACEUTICALCOMPOSITION FOR THETREATMENT OF CELLULARPROLIFERATIVE DISORDERS
WO/2000/050051]87[,ושותפיו ריינהולד כהן רמת החייל',א26רחוב הברזל
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that itultimately directly contacts ras-mediated proliferating cells. Proliferative disordersinclude but are not limited to neoplasms. Human reovirus, non-human mammalianreovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, serotype1 (e.g., strain Lang), serotype 2 (e.g., strain Jones), serotype 3 (e.g., strain Dearing orstrain Abney), as well as other serotypes or strains of reovirus can be used.Combinations of more than one type and/or strain of reovirus can be used, as canreovirus from different species of animal. Either solid neoplasms or hematopoieticneoplasms can be treated.
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
197903,The applications for divisionfrom this application havenot yet been published
__________
December–ע"התש בכסלו'ז 24, 2009 326
145145]21][11[
צנתרים המיועדים להחלפה על ידי מפעיל יחיד ושיטות לשימוש בהם
SINGLE OPERATOR EXCHANGECATHETERS AND METHODS OFUSE
תל אביב, 11490.ד.ת, 124אבן גבירולDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
A single operator exchange biliary catheter having a tubular member extendingproximally from the proximal guidewire port. The tubular member defines a guidewirelumen extension adapted to permit the guidewire to be retracted from guidewire lumenand re-inserted therein. By retracting the guidewire from the guidewire lumen and intothe guidewire lumen extension, fluid may be readily injected via the guidewire lumenwithout encountering resistance to fluid flow from the guidewire. The guidewire lumenextension also maintains guidewire lumen access such that the guidewire may beeasily re-inserted into the guidewire lumen.
]57[
__________
145381]21][11[
תכשירים רפואיים לטיפול במחסורAגלקטוסידאז מסוג–באלפא
MEDICAL PREPARATIONS FORTHE TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
December–ע"התש בכסלו'ז 24, 2009327
The invention provides highly purified $g(a)-Gal A, and various methods for purifying it;$g(a)-Gal A preparations with altered charge and methods for making thosepreparations; $g(a)-Gal A preparations that have an extended circulating half-life in amammalian host, and methods for making same; and methods and dosages foradministering an $g(a)-Gal A preparation to a subject.
A coating system for application to solid pharmaceutical dosage units, said systemcomprising:(a) a subcoat comprising (i) a water soluble cellulosic material and (ii) a sugarcomponent; and(b) a polish coat comprising polyethylene glycol, wherein the weight ratio of cellulosicmaterial to sugar component within the subcoat ranges from about 40:60 to about85:15 percent by weight.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 328
145759]21][11[
תולדות אמין ותכשירי רוקחות המכילים אותן
AMINE DERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Amine derivatives represented by general formula (I) or pharmacologically acceptablesalts thereof, which are useful as therapeutic and/or preventive agents for diabetes,hyperlipemia, arteriosclerosis, cancers, and so on: wherein R¿1? is optionallysubstituted carbamoyl or the like; R¿2? is hydrogen or the like; R¿3? is C¿1?-C¿10?alkyl or the like; W¿1?, W¿2? and W¿3? are each independently a single bond orC¿1?-C¿8? alkylene; X, Y and Q are each sulfur or the like; Z is =CH- or the like; Ar isa benzene ring or the like; and L is hydrogen or the like.
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
December–ע"התש בכסלו'ז 24, 2009329
The present invention relates to adjuvant compositions which are suitable to be used invaccines. In particular, the adjuvant compositions of the present invention comprises asaponin and an immunostimulatory oligonucleotide, optionally with a carrier. Alsoprovided by the present invention are vaccines comprising the adjuvants of the presentinvention and an antigen. Further provided are methods of manufacture of theadjuvants and vaccines of the present invention and their use as medicaments.Methods of treating an individual susceptible to or suffering from a disease by theadministration of the vaccines of the present invention are also provided.
]57[
זו בקשות חלוקה מבקשה.שטר� פורסמו
189736,The applications for divisionfrom this application havenot yet been published
__________
146679]21][11[
SIGNATURE לכידת חתימה באמצעות שטח ממשק CAPTURE VIAINTERFACE SURFACE
A method of enabling user interaction with computer software running in a computersystem via an interface surface and a sensing device. The interface surface containsinformation relating to the computer software and coded data indicative of a signaturefield relating to the computer software. When the sensing device is placed in anoperative position relative to the interface surface, it senses indicating data indicative ofthe signature field. The sensing device also generates movement data indicative of thesensing device's movement. The indicating data and the movement data are receivedfrom the sensing device, and the signature field is identified. Once the signature hasbeen identified, the computer software is operated in reliance on the movement data,and in accordance with instructions associated with the signature field.
]57[
December–ע"התש בכסלו'ז 24, 2009 330
__________
146887]21][11[
פרוסתזה סקלרלית לטיפול בפרסביופיה ומחלות אחרות של העין
IMPROVED SCLERALPROSTHESIS FOR TREATMENTOF PRESBYOPIA AND OTHEREYE DISORDERS
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Presbyopia and other eye disorders are treated by implanting within a plurality ofelongated pockets formed in the tissue of the sclera of the eye transverse to a meridianof the eye, a prosthesis having an elongated base member having an inward surfaceadapted to be placed against the inward wall of the pocket and having a ridge on theinward surface of the base extending along at least a major portion of the majordimension of the base. The combined effect of the implanted prostheses is to exert aradially outward traction of the sclera in the region overlying the ciliary body whichexpands the sclera in the affected region together with the underlying ciliary body. Theexpansion of the ciliary body restores the effective working distance of the ciliarymuscle in the presbyopic eye and thereby increases the amplitude of accommodation.Introduced is an improved scleral prosthesis for the treatment of presbyopia and othereye disorders. An exemplary prosthesis is adapted for contact with the sclera of aneyeball, and comprises a body having a first end and a second end wherein the bodyhas (i) a planform adapted to expand the contacted sclera to increase the effectiveworking distance of the ciliary muscle of the eyeball, and (ii) means for stabilizing theprosthesis within the surgically formed pocket within the sclera of the eyeball.
]57[
December–ע"התש בכסלו'ז 24, 2009331
__________
147214]21][11[
מתיל קרבאפינם ותכשירי–1תולדות ות המכילים אותןרוקח
1-METHYLCARBAPENEMDERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
]54[
06.07.2000]22[JP]33[06.07.1999]32[11/191368]31[
Int. Cl.(2008.04) A61K 314/07, C07D 477/20]51[DAIICHI SANKYO COMPANYLIMITED, JAPAN
]71[
WO/2001/002401]87[,ברגמן וגולר, וולף
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Crystals of compound (I) or pharmacologically acceptable salts thereof, which exhibitan excellent antimicrobial activity and are so excellent in storage stability andhandleability as to be put into practical use as antimicrobial agents. Crystals ofcompound (I) or pharmacologically acceptable salts thereof, which exhibit an excellentantimicrobial activity and are so excellent in storage stability and handleability as to beput into practical use as antimicrobial agents.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 332
147963]21][11[
מערכת שתל רפואית עם שידור אנרגיה אלחוטי
MEDICAL IMPLANT APPARATUSWITH WIRELESS ENERGYTRANSMISSION
A medical implant apparatus include or use an energy transmission means for wirelesstransmission of energy of a first form from outside a patient's body. An implantedmedical device is operable in response to energy of a second form different than theenergy of the first form. An implanted energy transforming means transforms energy ofthe first form wirelessly transmitted by the energy transmission means into energy ofthe second form for use in the control and operation of the medical device.
]57[
__________
148505]21][11[
PROGRESSIVE עדשות המתווספות באופן הדרגתי ADDITIONLENSES
]54[
25.08.2000]22[US]33[05.09.1999]32[391095]31[
Int. Cl.(2009.01) G02C 07//00, 07//06]51[ESSILOR INTERNATIONAL(COMPAGNIE GENERALED'OPTIQUE), FRANCE
]71[
WO/2001/018591]87[The present provides progressive addition lens designs and lenses in which unwantedlens astigmatism is reduced as compared to conventional progressive addition lenses.
OXABISPIDINE COMPOUNDS,PROCESS FOR THEIRPREPARATION,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USE THEREOF INTHE PREPARATION OF AMEDICAMENT FOR THETREATMENT OF ARRHYTHMIA
]54[
13.10.2000]22[SE]33[18.10.1999]32[9903759-0 ]31[
Int. Cl.(2008.04) A61K 315/383, A61P 9/06, C07D 265/30, 303/36, 498/08]51[ASTRAZENECA AB, SWEDEN]71[PEDER SVENSSON, ANNIKABJORE, MAGNUS BJORSNE, DAVIDCALDINGBOEL, KURT-JURGENHOFFMAN, JOHN PAVEY, FRITIOFPONTEN, GERT STRANDLUND,COLIN THOMSON, JOHANMICHAEL WILSTERMANN
]72[
WO/2001/028992]87[,לוצאטו את לוצאטו
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
There is provided compounds of formula (I), wherein R?1¿, R?2¿, R?3¿, R?4¿,R?41¿ to R?46¿, A, B and G have meanings given in the description, which are usefulin the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventriculararrhythmias.
]57[
December–ע"התש בכסלו'ז 24, 2009 334
בקשות חלוקה מבקשה זו.שטר� פורסמו
183854,183853,183852,The applications for divisionfrom this application havenot yet been published
A domain name system includes a native language domain name registrar (105), whichreceives a native language domain name, containing at least one non-alphanumericcharacter, registration request and converts the native language domain name into analphanumeric domain name. The alphanumeric domain name is used in the domainname/IP address entry in the domain name server (DMS) (103).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009335
149325]21][11[
גנים פוליפפטידים הומניים סינתטיים ושימושם לטיפול במחלות אוטואימוניות
SYNTHETIC HUMAN GENES ANDPOLYPEPTIDES AND THEIR USEIN THE TREATMENT OFAUTOIMMUNE DISEASES
Synthetic human target autoantigen genes comprising sequences coding for at leasttwo immunogenic epitopic clusters (hereinafter IEC) of autoantigen(s) related to aspecific autoimmune disease, wherein said at least two IECs may be derived from asole autoantigen or from at least two different autoantigens related to said autoimmunedisease, and polypeptides encoded thereby, can be used for the treatment and thediagnosis of autoimmune diseases such as multiple sclerosis (MS), insulin-dependentdiabetes mellitus (IDDM), rheumatoid arthritis (RA), myasthenia gravis (MG) anduveitis.
]57[
__________
149496]21][11[
רוקחיים ושימושם לטיפול הרכבים במערכת העיכול
PHARMACEUTICALCOMBINATIONS AND THEIR USEIN TREATINGGASTROINTESTINALDISORDERS
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention relates to a combination of a first agent including either a 5-HT¿4? receptor agonist or antagonist or a 5-HT¿3? receptor antagonist and a co-agentand pharmaceutical compositions and formulations containing the combination. The
]57[
December–ע"התש בכסלו'ז 24, 2009 336
pharmaceutical combination may be employed for the treatment of alteredgastrointestinal motility, sensitivity, secretion or abdominal disorders. The dosage ispreferably oral. The preferred first agent is tegaserod.
The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acidsequence of human G-CSF in at least one specified introduced and/or removed aminoacid residue comprising an attachment group for a non-polypeptide moiety, and havingat least one non-polypeptide moiety attached to an attachment group of thepolypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid orglutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g.be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate hasone or more improved properties such as increased biological half-life and reducedside effects.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009337
150636]21][11[
שיטה והתקן לייצור אריגים מרוכביםידי תפירה–מסיבים לא רקומים על
דינמית–הידרו
METHOD AND DEVICE FORPRODUCTION OF COMPOSITENON-WOVEN FIBRE FABRICS BYMEANS OF HYDRODYNAMICNEEDLING
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A conventional method for the production of a composite non-woven fibre fromat least one spun non-woven fibre and subsequent application of a wood pulplayer to the above for production of a hygiene product is known. Accordingly,the spunbonded non-woven fibre is hydrodynamically needled, before theapplication of the pulp layer, in order to increase the fluid dispersionproperties. Consequently, the pulp layer can no longer be needled, as the pulpwould be washed out through the non-woven fibre. Due to the requiredabrasion resistance a bonding of the non-woven fibre is, however, necessary.According to the invention, the above problem is resolved, whereby a non-woven fibre is compressed or calendered with compressed air, as a pre-bonding treatment, before coating with the super-absorbent material, then thewoodpulp layer is applied and both are bonded with a hydrodynamic waterneedling, followed by drying. A further calandering can be added. A furtherpre-bonded, in other words, calendered spunbonded, or card non-woven fibrecan be applied to the spunbonded non-woven fibre as support layer, or thereverse.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 338
150972]21][11[
מי ים–שיטה והתקן לפיקוח על חדירתלאקוויפרים של מים מתוקים הסמוכים
לערי חוף
METHOD AND APPARATUS FORMONITORING THE ADVANCE OFSEAWATER INTO FRESH WATERAQUIFERS NEAR COASTALCITIES
Sensors are permanently placed in the ground near observation and injection wells inorder to passively and continuously monitor the status of seawater advance towardfresh water aquifers near coastal cities as well as the status of fresh water injected intothe injection wells. Such sensor devices are installed in the ground and electricallyconnected to surface acquisition equipment that would, without human intervention,transmit acquired data to a centralized facility for processing and interpretation. Varioustypes of sensors can be used: the sensors used for general reservoir monitoring and/orthe sensors used for leak detection, soil heating, and temperature mapping.Alternatively, a special type of sensor can be designed and provided for the purpose ofmonitoring the status of seawater advance toward fresh water aquifers.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009339
151139]21][11[
זרז, תהליך לפירוק תחמוצת חנקנית קתועבורו ותהליך להפ
PROCESS FOR DECOMPOSINGN2O, CATALYST THEREFOR ANDPROCESS FOR ITS PRODUCTION
The invention relates to a method for decomposing N¿2?O during theproduction of nitric acid by bringing the waste gas, which containsN¿2?O and which is exiting the absorption column, into contact with acatalyst containing at least one oxidic cobalt compound and at least oneoxidic magnesium compound. The waste gas is brought into contactwith the catalyst under conditions that permit N¿2?O to be convertedinto gaseous nitrogen and oxygen. The content of oxidic cobaltcompounds ranges from 0.1 to 50 wt. %, and the content of oxidicmagnesium compounds range from 50 to 99.9 wt. % each with regard tothe total mass of the catalyst. At least 30 % of the cobalt atoms in thecatalyst are provided in a trivalent state. The production of the catalystincludes a dry mixing of the oxidic cobalt compounds and the oxidicmagnesium compounds or corresponding precursors, which aretransformed into oxidic compounds by annealing, and involves acompacting of the mixture while eliminating water until the resultingcatalyst has the desired bulk density.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 340
151216]21][11[
פלורפלבינים ונגזרות שלהם תהליך להכנתם והשמוש בהם
PLURAFLAVINS ANDDERIVATIVES THEREOF,PROCESS FOR THEIRPREPARATION AND USETHEREOF
The invention relates to a compound of formula (I) wherein R¿1? is a sugar; R¿2? is -CH¿2?-O-(R¿7?)m, R¿7? representing a sugar, or R¿2? is -COOH; R¿3? is anepoxide-comprising group, C¿1?-C¿6?-alkyl or C¿2?-C¿6?-alkenyl, unsubstituted orsubstituted by at least one OH; R¿5? is H, C¿1?-C¿6?-alkyl, C¿2?-C¿6?-alkenyl orC¿2?-C¿6?-alkynyl; R¿4?, R¿6?, R¿8? and R¿10? independently of one another areH,C¿1?-C¿6?-alkyl, C¿2?-C¿6?-alkenyl, C¿2?-C¿6?-Alkynyl, -X¿2?H, or -X¿2?R¿12?, or R¿4? and R¿6? together and/or R¿8? and R¿10? together are =X¿2?;X¿2? is O, NH, N-C¿1?-C¿6?-alkyl, N-C¿2?-C¿6?-alkenyl, N-C¿2?-C¿6?-alkynyl or S;R¿12? is C¿1?-C¿6?-Alkenyl, C¿2?-C¿6?-alkynyl, C¿2?-C¿6?-alkynyl, aryl or acyl;and m and n are 1 or 2; and its physiologically acceptable salts. The compounds areobtainable from a culture of the microorganism Actinomycetales species HAG 003959,DSM 12931, by fermentation. Accordingly, the invention relates to a process for theirpreparation and to the use of the compounds as pharmaceuticals, for example as anti-tumor agents.
A polypropylene fibre including at least 80 % by weight of a first isotactic polypropyleneproduced by a metallocene catalyst, and from 5 to 20 by weight of a second isotacticpolypropylene produced by a Ziegler-Natta catalyst.
]57[
__________
151372]21][11[
תולדות פירולידין עם ציקלופרופיל מותך ותכשירי רוקחות המכילים אותן
CYCLOPROPYL-FUSEDPYRROLIDINE DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula (I)where x is 0 or 1 and y is 0 or 1 (provided that x = 1 when y = 0 and x = 0 when y = 1);n is 0 or 1; X is H or CN; and wherein R?1¿, R?2¿, R?3¿ and R?4¿ are as describedherein. A method is also provided for treating diabetes and related diseases, especiallyType II diabetes, and other diseases as set out herein, employing such DP 4 inhibitoror a combination of such DP 4 inhibitor and one or more of another antidiabetic agentsuch as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulinand/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or othertherapeutic agent.
]57[
December–ע"התש בכסלו'ז 24, 2009 342
בקשות חלוקה מבקשה זו.שטר� פורסמו
177019,177018,The applications for divisionfrom this application havenot yet been published
__________
151705]21][11[
יטה והתקן לבקרת שידורים במערכתש תקשורת
METHOD AND APPARATUS FORCONTROLLING TRANSMISSIONSOF A COMMUNICATIONSSYSTEM
In some aspects, each cell in the communications system can bedesigned to operate in accordance with a set of back-off factors thatidentify the reductions in peak transmit power levels for the channelsassociated with the back-off factors. The back-off factors are defined toprovide the required power to a large percentage of the users whilereducing the amount of interference. In some other aspects, the cellsoperate using an adaptive reuse scheme that allows the cells toefficiently allocate and reallocate the system resources to reflectchanges in the system. A reuse scheme is initially defined and resourcesare allocated to the cells. During operation, changes in the operatingconditions of the system are detected and the reuse scheme is redefinedas necessary based on the detected changes. For example, the loadingconditions of the cells can be detected, and the resources can be
]57[
December–ע"התש בכסלו'ז 24, 2009343
reallocated and/or the reuse scheme can be redefined. In yet otheraspects, techniques are provided to efficiency schedule datatransmissions and to assign channels to users. Data transmissions can bescheduled based on user priorities, some fairness criteria, systemrequirements, and other factors. Users are assigned to available channelsbased on a number of channel assignment schemes. Channel metrics arealso provided, which can be used to prioritize users and for channelassignments.
בקשות חלוקה מבקשה זו.שטר� פורסמו
197980,The applications for divisionfrom this application havenot yet been published
__________
151772]21][11[
קפסולרי סוכר–תהליכים להכנת רב פנומוקוקלי
METHODS FOR PRODUCINGPNEUMOCOCCAL CAPSULARPOLYSACCHARIDE
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The invention relates to methods of modulating capsular polysaccharide production inpneumococci such as Streptococcus pneumoniae. The invention further relates tomethods of alleviating pneumococcal infections in animals, and to methods ofidentifying both agents capable of modulating pneumococcal infections in animals.Figure (1) comprising figures 1Ai-1Avi and 1Bi-1Bvi is a series of images indicating theeffect of environmental oxygen and carbon dioxide concentration on colony morphologyand capsule size, as assessed using the Quellung reaction.
]57[
December–ע"התש בכסלו'ז 24, 2009 344
בקשות חלוקה מבקשה זו.שטר� פורסמו
191962,The applications for divisionfrom this application havenot yet been published
__________
151858]21][11[
מתקן ושיטה לטיפול באי שליטה במתן שתן בנקבות
DEVICE AND METHOD FORTREATING URINARYINCONTINENCE IN FEMALES
תל אביב, 11490.ד.ת, 124אבן גבירולDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
Provided herein is a novel and useful device and method for locallydelivering and controllably releasing oxybutynin in the cervical regionof a female. A device of the invention comprises a ring comprisingtrifluoropropylmethyl/dimethyl siloxane elastomer. A pharmaceuticalcomposition comprising oxybutynin and an excipient is placed within abore located in the ring, wherein the bore runs from the surface of thering into the ring. The ring has a sufficient size such that it can beinserted into the vaginal canal of a female. A cap comprising is placedover the bore at the surface of the ring in order to contain thepharmaceutical composition within the bore. When the ring is insertedinto the vaginal canal, the trifluoropropylmethyl/dimethyl siloxaneelastomer controllably releases and locally delivers a therapeuticallyeffective amount of oxybutynin to the detrusor muscle to treat thefemale's urinary incontinence.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009345
152328]21][11[
של תכשירים המכילים שילובי ותר פקטורים דפיברוטיד ואחד או
המטופואטיים ושימושם
FORMULATIONS CONTAINING ACOMBINATION OFDEFIBROTIDE AND ONE ORMORE HAEMATOPOIETICFACTORS AND USES THEREOF
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A description is given of a method of increasing the amount of stem cells andprogenitor cells in the peripheral blood of a mammal; the method is characterised bythe administration of defibrotide in combination or in temporal proximity with at leastone haematopoietic factor, (preferably G-CSF) having the capacity to mobilisehaematopoietic progenitors.
]57[
__________
152372]21][11[
גוף חימום חשמלי טבול ודוד מים המשמש בו
ELECTRIC IMMERSIONELEMENT AND WATERHEATER USING SAME
]54[
20.10.2002]22[Int. Cl.(2008.04) F24H 1/20]51[
HAIM ירוחם, חיים חזן HAZAN]71[,ברגמן וגולר, וולף
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
December–ע"התש בכסלו'ז 24, 2009 346
152528]21][11[
,3אגוניסטים אדרנרגיים של בטא תכשירי רוקחות והכנתם
BETA3 ADRENERGIC AGONISTS,PHARMACEUTICALCOMPOSITIONS AND THEIRPREPARATION
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention relates to a $g(b)¿3? adrenergic receptor agonist of formula (I)or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energyexpenditure in cells and, therefore, is useful for treating Type II diabetes and/or obesity.The compound can also be used to lower triglyceride levels and cholesterol levels orraise high density lipoprotein levels or to decrease gut motility. In addition, thecompound can be used to reduced neurogenic inflammation or as an antidepressantagent. Compositions and methods for the use of the compounds in the treatment ofdiabetes and obesity and for lowering triglyceride levels and cholesterol levels orraising high density lipoprotein levels or for decreasing gut motility are also disclosed.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009347
152561]21][11[
DISPOSABLE התקן קבוע חיצוני חד פעמי EXTERNALFIXATION DEVICE
]54[
02.03.2001]22[EP]33[26.05.2000]32[00830380.2]31[
Int. Cl.(2008.04) A61B 17/64]51[ORTHOFIX S.R.L., ITALY]71[DANIELE VENTURINI, SANDORBERKI, ANTAL INSPERGER
]72[
WO/2001/091655]87[,פרל כהן צדק לצר
, 12704.ד.ת,5שנקר'רח,1ים-מרכז גב הרצליה
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to a novel disposable axial external fixation device for reducingbone fractures, of the type comprising an extendible rod-like middle body (2) andoppositely located bone screw clamps (5, 6) which are articulated to the respectiveends (3, 4) of the rod-like middle body (2) by means of ball joints. Advantageously, aball-and-socket joint (16) is mounted to each clamp (5, 6), within a main body (20) withwhich means (25, 26, 21, 22, 23) for clamping bone screws clamping is associated orco-operates. It is also provided an ancillary member (30) adapted for releasableassociation with one end of each clamp (5, 6) to better adapt each clamp for use indifferent conditions of installation of the fixation device.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 348
152625]21][11[
לא פפטידים אימונגניים סינתטיים אךbאמיליודוגניים שווי ערך לאמיליואיד
לשם יצירת תגובה חיסונית לאמיליואידbולמשקעים אמיליואידיים
SYNTHETIC IMMUNOGENIC BUTNON-AMYLOIDOGENICPEPTIDES HOMOLOGOUS TOAMYLOID B FOR INDUCTION OFAN IMMUNE RESPONSE TOAMYLOID B AND AMYLOIDDEPOSITS
The present invention relates to synthetic immunogenic but non-amyloidogenicpeptides homologous to amyloid $g(b) which can be used alone or conjugated to animmunostimulatory molecule in an immunizing composition for inducing an immuneresponse to amyloid $g(b) peptides and amyloid deposits.
]57[
__________
152645]21][11[
METHOD שיטה עבור ההכנה של ציטהלופראם FOR THEPREPARATION OF CITALOPRAM
',ר שלמה כהן ושות"ד תל אביב, 11490.ד.ת, 124אבן גבירול
DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
December–ע"התש בכסלו'ז 24, 2009349
A method for the preparation of citalopram comprising reaction of acompound of formula 5-aminomethyl-1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran with an oxidising agent toprepare citalopram.
]57[
__________
152770]21][11[
שימוש באנלוגים של גאבאפנטין להכנת תכשירים לטיפול בהפרעות שינה
GABAPENTIN ANALOGUES FORUSE IN THE PREPARATION OFCOMPOSITIONS FOR TREATINGSLEEP DISORDERS
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The invention provides a new use of compounds for formula (1) or (1A) or apharmaceutically acceptable salt thereof. The compounds are useful in the treatment ofinsomnia and related disorders.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 350
152786]21][11[
תחבושת עורית להקלה על הסימפטומים צינון וגודש באף, של שיעול
SKIN PATCH FOR THE RELIEFOF THE SYMPTOMS OF COUGH,COLD AND NASALCONGESTION
A vaporizable decongestant is supported and stabilized on a flexible foraminous carriercomposed typically of open-cell plastic foam, cloth or other fibrous material such asnonwoven fabric. The term 'foraminous' herein is intended to refer to a substance ormedium containing minute openings or perforated by many minute apertures. Thedecongestant is placed on the surfaces within the interstices and minute apertures oron fibers from which the foraminous carrier is formed. Vaporization of the inhalabledecongestant is facilitated by providing the potential for greatly increasing its exposedsurface area. Distributing the decongestant composition over the large, expandedsurface within the foraminous carrier is beneficial in enhancing both the volatilizationand evaporation of the decongestant agent. It also prolongs the useful life of theproduct. Once vaporized, the aromatic decongestant is available for natural inhalationthrough the nose or mouth to help relieve one or more of the symptoms of cough,colds, nasal or chest congestion and related symptoms. The foraminous carrier ispreferably provided in the form of a patch or sheet that is bonded to the skin to serveas a supporting base for the active decongestant agent. The patch defining the carrieris typically adhesively bonded to the upper part of the body, e.g. on the face, neck orchest, in a location where the decongestant is liberated into the air and can be inhaledthrough the mouth or nose.
A particulate metal oxide having the mean length of the primaryparticles in the range from 50 to 90 nm, the mean width of the primaryparticles in the range from 5 to 20 nm, and the median volume particlediameter of the secondary particles is less than 45 nm. The metal oxidecan be used in a sunscreen product that exhibits both effective UVprotection and improved transparency.
A method and apparatus for implementing ink data communication between multipleparties using computing and/or communication devices on a network is disclosed. Anelectronic chat system comprising a hardware interface layer for receiving raw ink datafrom an input device, an ink management layer for processing the raw ink data into aform usable by a chat interface layer, and a network interface layer for transferring theprocessed ink data across a network to a chat interface layer on a remote computer.
]57[
December–ע"התש בכסלו'ז 24, 2009 352
__________
153719]21][11[
מכשיר ושיטה לטיפול תוך נרתיקי או, חוץ נרתיקי בדלקות פיטריתיות
ויראליות או טפיליות, חיידקיות
DEVICE AND METHOD FORINTRAVAGINAL ORTRANSVAGINAL TREATMENTOF FUNGAL,BACTERIAL, VIRAL ORPARASITIC INFECTIONS
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
Devices, methods, and compositions for treating vaginal fungal,bacterial, viral and parasitic infections by intravaginal or transvaginaladministration of therapeutic and/or palliative antifungal, antibacterial,antiviral or parasiticidal drugs to the vagina or to the uterus.
Disclosed are compounds of the Formula (I), and pharmaceutically acceptable saltsand prodrugs thereof, wherein A, B, R?1¿, R?2¿, R?3¿, R?4¿ and R?5¿ are asdefined in the specification. Such compounds are tyrosine phosphatase inhibitors anduseful in the treatment or prevention of Type II Diabetes Mellitus. Also encompassed bythe invention are formulations comprising the noted compounds, processes forpreparing such compounds, a method for treating or preventing Type II DiabetesMellitus.
An iso-truss structure (10) includes at least two helical components (30, 32) and atleast one reverse helical component (34) attached thereto with opposing angularorientations. Each helical and reverse helical component preferably includes at leastfour elongate, straight segments (22) rigidly connected end to end in a helicalconfiguration forming a single, substantially complete rotation about a common axis(14) forming a first square cross section. The structure may further include at least tworotated helical components (80, 92) and at least one rotated reverse helical component(98) which are rotated with respect to the helical and reverse helical componentsforming a second square cross section, rotated with respect to the first. The structuremay be straight, curved, flexible, or form angles.
]57[
__________
154334]21][11[
מערכת לתקשורת בין מדור פנימי למדור חיצוני
SYSTEM FOR PROVIDINGCOMMUNICATION BETWEENTHE INTERIOR AND THEEXTERIOR OF ACOMPARTMENT
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A system for making a connection between the interior and exterior of a compartment,comprising a door opening through the compartment wall, a connector body which canengage with the wall, and having a connection port through it, and a removable coveron the connector body. The body is engaged with the door opening, and an inner doorwithin the compartment engages and removes the cover. A preferred constructioncreates a single line of confidence seal. The system is particularly suited for sterilecompartments.
]57[
December–ע"התש בכסלו'ז 24, 2009355
__________
154495]21][11[
ErbB4שימוש בנוגד ספציפי לרצפטור טבעי ליצור תרופה לטיפול בסטנוזיס
USE OF AN ANTAGONISTSPECIFIC FOR A NATIVE ERBB4RECEPTOR IN THEMANUFACTURE OF AMEDICAMENT FOR THETREATMENT OF STENOSIS
The present invention concerns methods and means for controlling excessiveproliferation and/or migration of smooth muscle cells, and in particular for treatingstenosis, by using antagonists of a native ErbB4 receptor. The invention furtherconcerns a method for the identification of ErbB4 agonists and antagonists capable ofinhibiting or enhancing the proliferation or migration of smooth muscle cells.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 356
154538]21][11[
ריאקצית הפחמן השחור עם מלחיתוצרי הפחמן השחור הנוצרים, דיאזוניום
מכך
REACTION OF CARBON BLACKWITH DIAZONIUM SALTS,RESULTANT CARBON BLACKPRODUCTS AND THEIR USES
DIVISION FROM 116377]62[CABOT CORPORATION, U.S.A.]71[
',ריאלי ושותזליגסון גב תל אביב, 1426.ד.ת,31יבנה' רח
SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,
P.O.B. 1426,TEL AVIV 61013
]74[
A carbon black product having attached to the carbon black either an aliphatic group ora cyclic group selected from alicyclic hydrocarbon groups and heterocyclic hydrocarbongroups, said groups being substituted by a functional group selected from the consisting of OR, COR, COOR, OCOR, halogen, NR2, SO3H, sulfonate salts, OSO3H, OSO3 saltsNR(COR), CONR2, NO2 PO3H2, phosphonate salts, phosphate salts, NR3
+X-, PR3+X-,
SkR, SS03H, SS03 salts, S02NRR', S02SR, SNRR', SNQ, S02NQ, C02NQ, S-(1,4-piperazinediyl)-SR, 2-(1,3-dithianyl), 2(1,3-dithiolanyl), SOR, and S02R; when theattached group is an aliphatic group it may also be substituted by a functional groupselected COOLi, COONa, COO+NR4
+, and when the attached group is a cyclic group itmay also be substituted by a functional group selected from R, CN, N=NR or acarboxylate salt, wherein R and R' nay be the same or different, branched orunbranced C1-C20 unsubstituted or substituted alkyl, alkenyl or alkynyl; unsubstituted orsubstituted aryl; unsubstituted or substituted heteroaryl; unsubstituted or substitutedalkylaryl; or unsubstituted or substituted arylalkyl groups, and when the � roup attachedto the carbon black is a cyclic group R and R' may also be hydrogen, k is an integerfrom 1 to 8; X-is a halide or an anion derived from a mineral or organic acid; and Q is(CH2)w, (CH2)xO(CH2)z, (CH2)xNR(CH2)z or (CH2)xS(CH2)z where x is 1 to 6, z is 1 to 6,and w is 2 to 6.
]57[
__________
154581]21][11[
JOINT מפרק לחיבור שני שלבים של מוט FOR CONNECTING TWOADJACENT SECTIONS OF AROD
]54[
23.02.2003]22[Int. Cl.(2009.01) F16B 07//00]51[
REFAEL מושב בני עטרות, רפאל פלד PELED]71[,רפאל פלד
מושב בני עטרות,REFAEL PELED,MOSHAV BENE ATAROT
]74[
December–ע"התש בכסלו'ז 24, 2009357
:המפרק מכיל,)10(מפרק לחיבור שני שלבי� סמוכי� של מוט]57[;של המוט)1(המקובע לשלב ראשו), בעל מבנה מרחבי קוני זכרי, נבוב)3(, פרק ראשו)
של)5(ובע לשלב שני המק, בעל מבנה מרחבי קוני זכרי ונבוב)4(, פרק שני הסמו1 לשלב הראשו)מבנהו המרחבי של הפרק בעל המבנה הקוני הזכרי מתאי� למבנהו המרחבי של הפרק בעל, המוט
משיכה גמיש העובר במרכז הפרקי� ומחובר מצידו האחד לשלב)6(ומנגנו); המבנה הקוני הנקביל, הראשו) ומצידו השני לשלב השני .זהלצור1 הצמדת השלבי� זה
__________
154663]21][11[
שיטה לקביעת דרגת המתילציה של–3'ציטוזינים מוגדרים בדנא גנומי ברצף
CPG – '5
METHOD FOR DETERMININGTHE DEGREE OFMETHYLATION OF DEFINEDCYTOSINES IN GENOMIC DNA INTHE SEQUENCE CONTEXT 5'-CPG-3'
The invention relates to a method for detecting the degree ofmethylation of a defined cytosine in the sequence context 5′-CpG-3′ of agenomic DNA sample. The first stage involves chemically treating thegenomic DNA in such a way that the cytosine bases, but not the 5-methylcytosine bases, are converted into uracil. Parts of the genomicDNA containing the defined cytosine are then amplified. The amplifiedparts are given a detectable mark and the extent of the hybridisation ofthe amplified parts on the two classes of oligonucleotides is thendetermined by detecting the mark of the amplified parts. The degree ofmethylation of the defined cytosine in the genomic DNA sample can bededuced on the basis of the relationship between the marks detected onthe two classes of oligonucleotides following the hybridisation.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 358
154897]21][11[
HIGH סגסוגת מגנזיום חזקה מאד ושיטת הכנתה STRENGTH MAGNESIUMALLOY AND ITS PREPARATIONMETHOD
]54[
26.09.2000]22[Int. Cl.(2008.04) C22C 23/04]51[KWANG SEON SHIN, REPUBLICOF KOREA
The present invention provides high strength magnesium alloys consisting essentiallyof 3 $m(k) 10 wt.% Zn, 0.25 $m(k) 3.0 wt.% Mn, and the balance of Mg and inevitableimpurities, the high strength magnesium alloy further containing 1 $m(k) 6 wt.% Al, 0.1$m(k) 4.0 wt.% Si, and 0.1 $m(k) 2.0 wt.% Ca, in order to provide a high strengthmagnesium alloy having an improved hardness and strength, and an excellentelongation at an ambient temperature. In addition, the present invention provides amethod for preparing the high strength magnesium alloy characterized in that a Zn-Mnmother alloy is added to a magnesium melt by a fluxless melting method, and processconditions for working and heat-treating an obtained cast material.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009359
155183]21][11[
, קסיליותחומצות קרבו–3–אוקסאפנםתכשירי רוקחות המכילים אותה ושימוש
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
An oxapenem compound which is, or is capable of forming, a zwitterionof formula Ia or Ib: (Ia), (Ib) wherein R is a C¿1?-C¿8? branched orstraight chain alkyl group which includes a protonated basic substituent.The compounds find particular use as high bioavailability $g(b)-lactamase inhibitors.
WO/2002/034050]87[עורכי דין ועורכי, קבוצת איתן מהולל
,פטנטים הרצליה, 2081.ד.ת,10שדרות אבא אבן
EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,
P.O. B. 2081,HERZLIYA 46120
]74[
A pesticidal composition comprisinig a pesticidally effective amount of at least one of apyridic compound of the formula (I) or it salt and at least one of otherpesticides:wherein Y is a haloalkyl group, m is 0 or 1, and Q is or a substituted orunsubstituted heterocyclic group, (wherein X is an oxygen atom or a sulfur atom, R?1¿and R?2¿ are respectively independently a hydrogen atom, a substituted orunsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or
]57[
December–ע"התש בכסלו'ז 24, 2009 360
unsubstituted alkynyl group, a substituted or unsubstituted cycloalkyl group, and thelike.
__________
155545]21][11[
SOLVATE צורת סולבאט של קברגולין FORM OFCABERGOLINE
,פרל כהן צדק לצר, 12704.ד.ת,5שנקר'רח,1ים-מרכז גב הרצליה
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
Amorphous physical form of cabergoline substantially free of other physical forms,which is characterized by a halo x-ray powder diffraction pattern having a range ofsignals from between about 15 to about 23 degrees 2-theta.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009361
155801]21][11[
רצף חומצת גרעין המקודד קינזים ספציפים לאשך אנושי
NUCLEIC ACID SEQUENCEENCODING HUMAN TESTISSPECIFIC KINASES
UNIVERSITY OF VIRGINIAPATENT FOUNDATION, U.S.A.GREGORY S. KOPF, U.S.A.
]71[
WO/2002/038732]87[,ברגמן וגולר, וולף
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The present invention relates to a family of testis specific kinases (thetssk family), nucleic acid sequences encoding those kinases andantibodies against the kinases. The invention is further directed to theuse of thise kinases as targets for isolating specific inhibitors oranagonists of tssk kinase activity. Such inhibitors are anticipated to haveuse as contraceptive agents.
]57[
__________
155901]21][11[
–תהליך הפרדה סופח לקבלת פארא קסילן
ADSORPTIVE SEPARATIONPROCESS FOR RECOVERY OFPARA-XYLENE
The performance of an adsorptive separation process recovering para-xylene from a C¿8? aromatic hydrocarbon feed mixture is improved byoperating the process at higher desorbent purity. The improved
]57[
December–ע"התש בכסלו'ז 24, 2009 362
performance allows for tradeoffs in other operating parameters and ratesor improved product rates. The process preferably employs a bariumand potassium exchanged zeolitic molecular sieve as the adsorbent andtoluene as the desorbent.
__________
156049]21][11[
TAPPING ברז ROD]54[
21.11.2001]22[NL]33[23.11.2000]32[1016687]31[
Int. Cl.(2008.04) B67D 1/08]51[HEINEKEN TECHNICAL SERVICESB.V, THE NETHERLANDS
A tapping rod (2) with a beverage valve (16), a gas valve (14) cooperating therewith,and a collar (24), while in or on the collar a connecting device (26) is fitted, whichconnecting device comprises a pressure body (30) for opening the beverage valve (16)and the gas valve (14), wherein: the pressure body (30) comprise or defines at leastone first beverage channel (50) for bringing, with the beverage valve in open position,the inner space of a keg, in particular a riser of the taping rod, into fluid communicationwith a beverage dispensing line; the pressure body comprises or defines at least onegas channel (48) for bringing, with the gas valve in open position, the inner space of thekeg into fluid communication with a gas supply line.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009363
156115]21][11[
דם STENT מערכת למיקום תומך לכלי POSITIONING SYSTEM]54[
HADASIT MEDICAL RESEARCHSERVICES & DEVELOPMENTLTD.
]71[
, יס ורשיצקיבור, נחום בוריבקר, חיים לוטן מוריס מוסרי
HAIM LOTAN, NACHUMBORIVKER, BORIS VARSHITSKY,MORRIS MOSSERI
]72[
,ברגמן וגולר, וולף ירושלים, 1352.ד.ת,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A stent positioning system, comprising: a guide catheter 912); an inflatable balloon (22)connected to said catheter for expanding a stent, said balloon, in its collapsed state,fitting into and being adapted to carry said stent in its pre-expanded condition;characterized by a stent locator means (14) slidably coupled to said guide catheter andadapted to change its shape from a contracted shape extending along said guidecatheter to an expanded shape extending laterally from said guide catheter, andmechanical means for changing the shape of said stent locator means; wherein thechange of shape enables said locator means to about an interior wall surface of amajor blood vessel in the ostial region of a smaller blood vessel branching off from saidmajor blood vessel, therby ensuring correct position between the stent and an ostium ofsaid smaller blood vessel.
]57[
__________
156227]21][11[
MULTILAYER רצועה דקה רב שכבתית של גטר מימן THIN FILMHYDROGEN GETTER
A thin film hydrogen getter is provided for protecting GaAs circuitry sealed in anhermetic package. The thin film getter which comprises a multilayer metal film which isdeposited by vacuum evaporation techniques onto a surface of the packaging. Themultilayer film comprises (1) a titanium film and (2) palladium film which is depositedonto the titanium film. Both the titanium and the palladium are deposited during thesame coating process run, thereby preventing the titanium from being oxidized. Thepalladium continues to prevent the titanium from being oxidized once the getter isexposed to the atmosphere. However, hydrogen is easily able to diffuse through thepalladium into the titanium where it is chemically bound up, since palladium is highlypermeable to hydrogen. If EMI shielding is desired, a conductive metal, such asaluminum or copper, can first be formed between the packaging and the titanium layer.
A testing device (100) for testing an analyte in a sample of bodily fluid, comprising:memory storing data, said data being analyte data related to analyte measurementscarried out by the testing device and lifestyle data, and the analyte data includes apointer to a bodily location from which an analyte sample was taken by an individualusing the testing device, wherein the testing device utilizes a plurality of data pointers,each of said data pointers indicating a separate bodily location; initiation means (102)for initiating immediate entry of data related to a specific category of lifestyle data;navigation means (104) for entry and navigation of said data; and transfer means fortransferring said data to said memory.
]57[
December–ע"התש בכסלו'ז 24, 2009365
__________
156277]21][11[
תרופות המכילות, נגזרות קווינאזוליןשימוש בהן ושיטה, תרכובות אלו
להכנתן
QUINAZOLINE DERIVATIVES,MEDICAMENTS CONTAININGSAID COMPOUNDS, THEIRUTILIZATION AND METHODFOR THE PRODUCTIONTHEREOF
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to quinazoline derivatives of general formula (I),wherein R¿a?, R¿b? and R¿c? have the meaning defined in claim 1, totheir tautomers, their stereoisomers and their salts, especially theirphysiologically acceptable salts with inorganic or organic acids. Saidcompounds have valuable pharmacological properties, especially aninhibiting effect upon signal transduction caused by tyrosine kinase.The invention further relates to their utilization in the treatment ofdiseases, especially of tumoral diseases, diseases of the lung and therespiratory tract and to the production of said compounds.
]57[
December–ע"התש בכסלו'ז 24, 2009 366
__________
156330]21][11[
ARTICLE מערכת להעברת פרטים TRANSFER SYSTEM]54[
05.06.2003]22[Int. Cl.(2008.04) G05G 11/00]51[
NOVA רחובות,מ"נובה מכשירי מדידה בע MEASURINGINSTRUMENTS LTD.
]71[
ו ,שותפיוריינהולד כהן רמת החייל',א26רחוב הברזל
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A system (100) for controlling a movement of an article, the system comprising: asupport stage assembly (112); a spring suspension arrangement (110) mounted onsaid support stage assembly and comprising first and second assemblies (114A, 114B)arranged in a coaxial relationship with respect to the axis of the article movement, andone inside the other, the first assembly being attached to said support stage assemblyand the second assembly serving for supporting an article-carrying member (118) andbeing driven for a movement along said axis of the article movement with respect to thefirst assembly, the outer one of the first and second assemblies being configured todefine two spaced-apart parallel planes perpendicular to said axis of the articlemovement, said first and second assemblies being attached to each other by first andsecond membrane members (M1 M2) arranged in a spaced-apart parallel relationshipalong said axis of the article movement; and a motor operable for rotating said supportstage assembly around said axis, said motor being located inside the inner one of saidfirst and second assemblies.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009367
156579]21][11[
INJECTION תקן הזרקהה DEVICE]54[
30.07.1998]22[GB]33[31.07.1997]32[9716065.9]31[
Int. Cl.(2009.01) A61M 05//178]51[DIVISION FROM 134284]62[ARES-TRADING S.A.,SWITZERLAND
]71[
WO/1999/006100]87[,ברגמן וגולר, וולף
ושליםיר, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
An injection device has a barrel (1) for housing and guiding a syringe (13) as it is urgedforward to project its needle (14), while the dose is ejected, and as a return spring (22)retracts it. A firing mechanism (6) is connectable to the rear end of the barrel and is re-usable, whereas the barrel (1) with its spent syringe (13) is disposable. The connection(4) has limited freedom of axial movement so that, once made, forward pressure on thefiring mechanism (6) moves the syringe (13) up to a ready position. A number of barrels(1) with syringes (13) can be housed in a common box (31) with a single firingmechanism (6), the forward end of each barrel (1) being screwed to a locator (32) onthe base of the box. The engagement of the firing mechanism (16) with the rear end ofeach barrel (1) is also screw-threaded, but of opposite hand, so that screwing the firingmechanism (6) on and continuing to turn releases the complete device; andcorrespondingly the barrel (1) can be returned and located in the box (31) while thefiring mechanism (6) is separated from it.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 368
156626]21][11[
SYSTEM מערכת להריסת תאים סלקטיבית FOR SELECTIVE CELLDESTRUCTION
]54[
24.06.2003]22[Int. Cl.(2009.01) G01N 21//00]51[
YEDA רחובות,מ"ידע חברה למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT CO. LTD.
]71[
YARON דן אורון, דביר ילין, ירון זילברברג SILBERBERG, DVIRYELIN, DAN ORON
]72[
,מ"בע) 1995(ארליך.אי.י'ג,11מנחם בגין רחוב,15קומה, מגדל אילון
A system (10) for destroying living cells (12), the cells being characterized by anionization threshold, the system comprising: an optical device (14) for providing at leastone optical pulse having an optical field power which is smaller than the ionizationthreshold of the cells; and a mechanism (16) for locally increasing said optical fieldpower per unit area beyond the ionization threshold of the cells, thereby destroying thecells via ionization.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009369
156764]21][11[
שיטה והתקן לביצוע מסירה קשיחה מסוייעת ניידות בין מערכות תקשורת
METHOD AND APPARATUS FORPERFORMING MOBILEASSISTED HARD HANDOFFBETWEEN COMMUNICATIONSYSTEMS
]54[
19.12.1997]22[US]33[15.01.1997]32[08/784280]31[
Int. Cl.(2008.04) H04Q 7/38]51[DIVISION FROM 130734]62[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/1998/032262]87[ט ',קולב ושות. סנפורד
, 2273.ד.ת, מרמורק,4שער הגיא רחובות
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
In a wireless communication system wherein a mobile station (M1, M2, M3) is movingfrom the coverage area of an origination system (51) operating at a first frequency intothe coverage area of a destination system (52) operating at a second frequency, amethod for providing handoff from said origination system to said destination system,the method comprising: predicting at least one PN offset associated with thedestination system; transmitting, at the first frequency, from said origination system tosaid mobile station a set of search parameter data associated with the at least one PNoffset; determining at said mobile station the availability of said destination system inaccordance with said set of search parameter data; transmitting from said mobilestation to said origination system a message indicative of the received strength ofsignals associated with the at least one PN offset measured at the mobile station;generating at said origination system a set of acquisition parameters in accordancewith said message from said mobile station; and attempting at said mobile station toacquire said destination system in accordance with said set of acquisition parameters.
]57[
קה מבקשה זו בקשות חלו.שטר� פורסמו
198051,The applications for divisionfrom this application havenot yet been published
__________
December–ע"התש בכסלו'ז 24, 2009 370
156858]21][11[
של הקצאת קבוצות של אלמנטיםבמערכת) הסרת וויסות(דימודולאציה
טווח נרחב
ASSIGNING CLUSTERS OFDEMODULATION ELEMENTS INA SPREAD SPECTRUM SYSTEM
An apparatus, such as a subscriber unit or a base station within a spread spectrumcommunication system, may add one or more additional 'virtual' paths to a list ofcandidate paths when assigning demodulation elements. These 'virtual' paths areadded as candidate paths even though a corresponding peak was not necessarilydetected within a received spread spectrum system. The list of paths may include a firstpath having a time offset approximately equal to a time offset for one of thedemodulation elements, and the virtual path having a short time separation from thefirst path. The time separation between the paths may be, for example, less than 2chips.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009371
156871]21][11[
על מנחה אור לאמצעי תצוגה המורכב הראש או על החלק העלי של הראש
LIGHT GUIDE FOR DISPLAYDEVICES OF THE HEAD-MOUNTEDOR HEAD-UP TYPE
A light guide for display devices of the head-mounted or head-up type, comprising: abody of the light guide (22) at least in part transparent to visible light; a coupling device(24) associated to the body of the light guide and designed to couple the body to anoptical system designed to generate an image, the coupling device being obtained insuch a way the light beams coming from said optical system enter the ody of the lightguide and propagate in the body by total internal reflection; and an image-exteractiongrating (28) designed to extract the light beams which propagate in the body of the lightguide so as to enable an observer to visualize the extracted image on a backgroundvisible in transparency through the body of the light guide; wherein said extractiongrating is set in the proximity of one of the outer surfaces (22) of the guide; saidextraction grating has a saw-tooth profile; said extraction grating is coated with apartially reflecting coating deposited prevalently on the surfaces of the teeth (28) thatare least inclined with respect to the surfaces of the guide; and said coating is in turncoated with a layer of material having a refractive index that is substantially the sameas that of the body of the light guide and having a surface facing the extraction grating,which follows the saw-tooth profile, and another plane surface which is substantiallyparallel to the outer surface of the guide in an area corresponding to which the gratingis made.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 372
156999]21][11[
WEIGHT דלת בעלת משקל מופחתת SAVING DOOR]54[
17.07.2003]22[Int. Cl.(2008.04) E06B 3/70]51[
RAV יבנה,מ"רב בריח מוצרי בטחון בע BARIACH SECURITYPRODUCTS LTD.
]71[
EYAL אלפרד גולדובר, אייל ארציאלי ARTSIELY, ALFREDGOLDOVER
]72[
,ד עורכי פטנטים"עו, אפלפלד זר פישרב2יון בן גור גן-רמת,16קומה.ר.ס.מגדל
APPELFELD ZER FISHER,B.S.R TOWER 1, FLOOR 16
2 BEN GURION ST.RAMAT GAN 52573
]74[
A door (10) comprising: a pair of first (12) and second (14) sheets which form front andrear faces of the door; and at least one filling element (20) placed between said firstand second sheets, wherein said at least one filling element has a non-straight shapecomprising at least one first surface (22) that abuts an inner surface of said first sheet,at least one second (24) surface that abuts an inner surface of said second sheet, andat least one intermediate portion (26) between and extending from said first and secondsurfaces, wherein said intermediate portion does not touch inner surfaces of said firstand second sheets.
]57[
__________
157015]21][11[
ABLATION צנתר להסרת רקמה בעל מערך מעצב CATHETER HAVINGSTABILIZING ARRAY
כ"ד ',הן ושותר שלמה תל אביב, 11490.ד.ת, 124אבן גבירול
DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
A circumferential ablation catheter comprising: an elongated tubular catheter body (12)having an outer wall, proximal and distal ends, and at least one lumen extendingtherethrough; an ablation assembly (14) mounted at the distal end of the catheter body,the ablation assembly comprising a circumferential ablation element mounted on thedistal end of the catheter body; and an inflatable balloon (26) provided in surrounding
]57[
December–ע"התש בכסלו'ז 24, 2009373
relation to the circumferential ablation element that is adjustable between a radiallycollapsed position and a radially expanded position; and a stabilization assembly (17)mounted on the catheter distal to the ablation assembly, the stabilization assemblybeing capable of contacting a plurality of points about an inner circurnference of agenerally tubular region of or near the heart.
__________
157048]21][11[
שיטה ומערכת לקבלת אימות במערכת תקשורת
METHOD AND APPARATUS FORPROVIDING AUTHENTICATIONIN A COMMUNICATION SYSTEM
A method includes receiving an authentication request from a mobile station (401) anddetermining whether to forward the request to an authentication agent. When it isdetermined to forward the request, the request is forwarded to the authentication agent(107). A random number and a random seed are received from the authenticationagent (107). The random number and the random seed are forwarded to the mobilestation (401). A response to the random number and the random seed from the mobilestation (401) is received and forwarded to the authentication agent (107). Theauthentication agent (107) compares the response with an expected response. Whenthe authentication agent (107) authenticates the mobile station (401), a derived cipherkey is received from the authentication agent (107).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 374
157097]21][11[
תרומבין, תרחיף המכיל פיברינוגןשיטה לציפוי, שיטות להכנתו, ואלכוהול
כ שיטה ליבוש,זהנשא עם תרחיף הציפוי של הנשא וספוג קולגן מצופה
SUSPENSION COMPRISINGFIBRINOGEN,THROMBIN ANDALCOHOL, METHOD FORPREPARING SUCH ASUSPENSION, METHOD FORCOATING A CARRIER WITHSUCH A SUSPENSION, METHODOF DRYING A COATING OF ACARRIER AND COATEDCOLLAGEN SPONGE
A suspension of fibrinogen, thrombin, alcohol and optionally aprotinin is obtained bymixing fibrinogen in alcohol with thrombin in alcohol. The suspension containsfibrinogen and thrombin particles with a Folk Ward mean diameter of 25 – 100 µm. Thethrombin may be human, bovine or recombinant. The fibrinogen may be human orrecombinant. A method for coating a carrier, such as a collagen sponge, with thesuspension, and a method for drying the coating is disclosed. The coated collagencarrier may be used as a ready-to-use absorbable composition for tissue gluing, tissuesealing and haemostasis wherein the carrier is coated with solidly fixed components offibrin glue, i.e. fibrinogen and thrombin.
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
Monoesters, diesters and polyesters are provided wherein both the acid-derived moiety and the alcohol-derived moiety of the esters arecarotenoid compounds. The synthetic ester linkage between two ormore carotenoids provides new compounds in which the similar andcomplementary properties of the individual carotenoids are combined.The new all-carotenoid esters may be useful as antioxidants, therapeuticagents, pigmenting ingredients in poultry feed or as coloring agents forfats. The polyesters have the potential to act as molecular wires withunique electrical conductance characteristics. The all-carotenoid estersmay be prepared from the esterification of at least one hydroxycarotenoid with at least one carboxylic carotenoid, or via the reaction ofthe acid chloride of a carboxylic carotenoid with a hydroxy carotenoid.Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin,violaxanthin, carotene diol, hydroxy carotene, hydroxylcopene,alloxanthin and dehydrocryptoxanthin. Preferred caroxylic carotenoidsinclude bixin, norbixin, $g(b)-apo-8-carotenoic acid, crocetin,diapocarotenoic acid, carboxylcarotene and azafrin.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 376
157117]21][11[
DEVICE התקן למניעת דליפת שתן בנשים FOR THE PREVENTIONOF URINARY INCONTINENCEIN FEMALES
A disposable device (100) for minimizing involuntary urination in females adapted forbeing inserted into the vagina, comprising:(a) an internal support structure comprising:(i) a pressure providing member (101) capable of transition between a first collapsibleposition and a second expandable position, adapted for providing pressure, through thevaginal wall, on the mid-urethral region following insertion of the device into the vagina;(ii) an anchoring member (102), said anchoring member adapted for anchoring theinternal support structure following insertion of the device into the vagina, so as toprevent movement of the device into the apex of the vagina; the pressure providingmember and the anchoring member being spaced apart;(b) pulling means (107) for removal of the device from the vagina, so that when saidpressure providing member is in the collapsible position the internal device may beinserted or removed from the vagina; and when said pressure providing member is inthe second expanded position, the device is positioned in the vagina in such a mannerso at to provide pressure through the vaginal wall on the mid-urethra minimizinginvoluntary urination.
The invention relates to pharmaceutical salts comprised of apharmaceutical active substance, particularly N,N-dimethylaminopropylphenol compounds or tradamol, and of at least onesugar substitute such as saccharin, cyclamate or acesulfame, tomedicaments containing these salts, and to the use of these salts forproducing medicaments.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 378
157534]21][11[
, צורה רוקחית של סידן אטורבסטטיןתרכובת שלו ופורמולציה רוקחית
המכילה סידן אטורבסטטין
ATORVASTATIN CALCIUM IN APHARMACEUTICAL FORM,COMPOSITION THEREOF ANDPHARMACEUTICALFORMULATION COMPRISINGATORVASTATIN CALCIUM
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Atorvastatin calcium can exist in an amorphous form or in one of the atleast four known crystalline forms (Form I, Form II, Form III and FormIV). Atorvastatin calcium is the substance which is sparingly soluble inwater, with pKa 4,5, and it has been found that the crystalline forms areless soluble than the amorphous form, which may cause problems inbioavailability of atorvastatin in the body. The present invention solvesthe problem of providing therapeutic equivalence of atorvastatinpharmaceutical formulation regardless the form (crystalline, amorphous,mixture of both) of atorvastatin calcium used for its preparation.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009379
157588]21][11[
תרכובות קרבמט לשימוש במניעה ובטיפול בהפרעות פסיכותיות
CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATING PSYCHOTICDISORDERS
תל אביב, 11490.ד.ת, 124אבן גבירולDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
This invention is directed to a method for preventing or treating psychotic disorderscomprising administering to a subject in need thereof a therapeutically effective amountof a compound selected from the group consisting of formula (I) and formula (II)wherein phenyl is substituted at X with one to five halogen atoms selected from thegroup consisting of fluorine, chlorine, bromine and iodine; and, R¿1?, R¿2?, R¿3?,R¿4?, R¿5? and R¿6? are independently selected from the group consisting ofhydrogen and C¿1?-C¿4? alkyl; wherein C¿1?-C¿4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, C¿1?-C¿4? alkyl, C¿1?-C¿4? alkoxy,amino, nitro and cyano).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 380
157591]21][11[
תרכובות קרבמט לשימוש במניעה ובטיפול בהפרעות נוירודגנראטיביים
CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATINGNEURODEGENERATIVEDISORDERS
תל אביב, 11490.ד.ת, 124אבן גבירולDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
This invention is directed to a method for preventing or treating neurodegenerativedisorders comprising administering to a subject in need thereof a therapeuticallyeffective amount of a compound selected from the group consisting of Formula (I) andFormula (II), wherein phenyl is substituted at X with one to five halogen atoms selectedfrom the group consisting of fluorine, chlorine, bromine and iodine; and, R¿1?, R¿2?,R¿3?, R¿4?, R¿5? and R¿6? are independently selected from the group consisting ofhydrogen and C¿1?-C¿4? alkyl; wherein C¿1?-C¿4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, C¿1?-C¿4? alkyl, C¿1?-C¿4? alkoxy,amino, nitro and cyano).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009381
157592]21][11[
תרכובות קרבמט לשימוש במניעההובטיפול של הפרעות בתנוע
CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATING MOVEMENTDISORDERS
תל אביב, 11490.ד.ת, 124אבן גבירולDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
This invention is directed to a method for preventing or treating movement disorderscomprising administering to a subject in need thereof a therapeutically effective amountof a compound selected from the group consisting of Formula (I) and Formula (II):wherein phenyl is substituted at X with one to five halogen atoms selected from thegroup consisting of fluorine, chlorine, bromine and iodine; and, R¿1?, R¿2? R¿3?,R¿4?, R¿5? and R¿6? are independently selected from the group consisting ofhydrogen and C¿1?-C¿4? alkyl; wherein C¿1?-C¿4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, C¿1?-C¿4? alkyl, C¿1?-C¿4? alkoxy,amino, nitro and cyano).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 382
157678]21][11[
תבניות בעלות מערכת ושיטה לגילוי רעש
SYSTEM AND METHOD FORDISCOVERING PATTERNS WITHNOISE
,מחלקת קנין רוחנימעבדות יבמ חיפה, אוניברסיטת חיפה הר הכרמל
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
A system and method for determining patterns in a data sequence (Fig. 1) constructs acompatibility matrix (100) which provides a probability between an actual occurrence ofan item and an observed occurrence of that or another item between each item in thedata sequence. Candidate patterns are generated (201). The candidate patternsinclude items in the data sequence. The candidate patterns are checked against thedata sequence to determine a match value (203) based on the compatibility matrix, andsignificant matches are determined based on candidate patterns having the matchvalue above a threshold (204).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009383
157721]21][11[
התקן ושיטה לעיבוד ובחינה של דגימה ביולוגית
APPARATUS AND METHOD FORPROCESSING AND TESTING ABIOLOGICAL SPECIMEN
]54[
06.03.2002]22[US]33[06.03.2001]32[799355]31[
Int. Cl.(2008.04) G01N 21/13]51[א, דוד ורון 'כפר בילו
תלרמות ליד אוניב בע-רסיטת ,מ"אביב אביב-תל
DAVID VARONRAMOT AT TEL-AVIVUNIVERSITY LTD.
]71[
WO/2002/071037]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
An apparatus for analyzing liquid specimens, the device comprising at least onespecimen handling station for obtaining preparation on a specimen carrying device, andan imaging station fitted with an optical image capturing device for analyzing thepreparation. A carriage with a specimen carrying device receptacle rotatably retains thespecimen carrying device and is displaceable between a loading station and anunloading station with respective positions at the stations. An incremental displacementmechanism for displacing at least one of the specimen carrying device and an imagingdevice so as to obtain at least one consecutive image of the preparation.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 384
157818]21][11[
שיטה לניטור תנועות של אדם בתוך חדרים וכדומה, ומסביב לבניינים
METHOD FOR MONITORINGTHE MOVEMENTS OFINDIVIDUALS IN AND AROUNDBUILDINGS, ROOMS AND THELIKE
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention relates to a method of monitoring the movements of an individualin and around buildings, rooms and other spaces, wherein each individual carries apassive transponder which has an individual-unique identity and which is intended forco-action with an active antenna that is connected, either directly or indirectly, to amonitoring centre (13) for transmitting signals received from transponders, and whereina plurality of antennas (12) are placed in and around the buildings, rooms or otherspaces to be monitored. The signals transmitted to the exercise centre (13) are used toshow movements of the individual in the form of a three-dimensional animated pictureon a picture screen.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009385
157878]21][11[
שיטה להכנת תרחיפים יציבים ואבקות של ננוטובות העשויות מפחמן
METHOD FOR THEPREPARATION OF STABLESUSPENSIONS AND POWDERSOF SINGLE CARBONNANOTUBES
]54[
25.03.2002]22[IL]33[26.03.2001]32[142254]31[
Int. Cl.(2009.01) B01J 13//00, C01B 31//02]51[הרשות, גוריון בנגב-אוניברסיטת בן באר שבע, למחקר ופיתוח
BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
]71[
WO/2002/076888]87[,לוצאטו את לוצאטו
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A method is provided for exfoliation of carbon nanotubes and for thepreparation of a stable aqueous suspension thereof containing dispersed,essentially single tubes, using a water-soluble polymeric material. Apowder of carbon nanotubes is further provided, that can be re-dispersedto form a stable suspension. Said nanotubes can be used in electronics,printing, coatings, thin layers, molecular machines, and for theproduction of composite materials.
The invention relates to substituted pyrazolopyrimidines andthiazolopyrimidines with the general structures (I A), (I B) and (II), to amethod for their production, to substance libraries containing the same,to medicaments containing said compounds, to the use of saidcompounds in the production of medicaments for treating pain,epilepsy, schizophrenia, neurodegenerative diseases, in particularAlzheimer's disease, Huntington's disease and Parkinson's disease, fortreating cerebral ischaemia and infarcts, psychosis caused by increasedamino acid levels, cerebral oedema, conditions caused by an under-supply of the central nervous system, in particular in hypoxia, especiallynewborn hypoxia and anoxia, for treating AIDS-related dementia,encephalomyelitis, Tourette's syndrome, perinatal asphyxia, tinnitus,neuropathic pain, diseases of the respiratory tract, cancer, cardiacarrythmia, immune disorders and diseases, inflammatory conditions anddiseases, renal shutdown, dyssomnia, strokes, thromboses, urinaryincontinence, diabetes, psoriasis, septicaemic shock, cerebral traumas,glaucoma and/or congestive heart failure. The invention further relatesto pharmaceutical compositions containing said compounds.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009387
157902]21][11[
על אמצעי זיהוי הנקרא על ידי מכונההמכילה קפה טחון, גבי אריזת מנה
למכונות אספרסו
MACHINE-READABLEIDENTIFIER ON A PORTIONPACKAGE WHICH CONTAINSGROUND COFFEE FORESPRESSO MACHINES
A machine-readable identifier on a portion package, which containsground coffee, for espresso machines is provided in a rotationallysymmetrical manner, whereby permitting it to be easily and reliablyread, on an essentially flat surface of the portion package. The portionpackage is preferably a portion capsule (1) with an essentially roundbottom (2) to which the identifier is coaxially applied.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 388
158060]21][11[
לשימוש במניעה25CDמולקולות קישוראו טיפול במחלות אצל מטופלים עם
תנגודת לסטרואידים
CD25 BINDING MOLECULES FORUSE IN THE PREVENTION ORTREATMENT OF DISEASES INSTEROID-RESISTANT PATIENTS
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A method for the treatment of a disease selected from the groupconsisting of autoimmune hepatitis, eczema, vasculitis, temporalarteritis, sarcoid and Crohn's disease, in a steroid-resistant or steroid-sensitive patient, comprising administering to the patient an effectiveamount of a CD25 binding molecule.
]57[
בקשות חלוקה מבקשה זו.� פורסמושטר
198757,The applications for divisionfrom this application havenot yet been published
__________
158127]21][11[
זיהוי קולי המבוסס על האינטרנט עםפ קודות לביצוע ואובייקטים סדרת סמנטיים
WEB-BASED SPEECHRECOGNITION WITHSCRIPTING AND SEMANTICOBJECTS
',זליגסון גבריאלי ושות תל אביב, 1426.ד.ת,31יבנה' רח
SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,
P.O.B. 1426,TEL AVIV 61013
]74[
December–ע"התש בכסלו'ז 24, 2009389
The present invention is a system and method for creating and implementingtransactional speech applications (SAs) using Web technologies, without reliance onserver-side standard or custom services. A transactional speech application may beany application that requires interpretation of speech in conjunction with a speechrecognition (SR) system (210), such as, for example, consumer survey systems. Aspeech application in accordance with the present invention is represented within aWeb page (220, 220'), as an application script (222, 222') that interprets semanticobjects (230) according to a context. Any commonly known scripting language can beused to write the application script, such as JavaScript (or ECMAScript), PerlScript, andVbscript. The present invention is 'Web-based' to the extent that it implements Webtechnologies, but it need not include or access the World Wide Web.
]57[
__________
158155]21][11[
שימוש באריתרופויטין להכנת תרופהת הנובעת מכימותרפיהלהפחתת רעילו
USE OF ERYTHROPOIETIN FORTHE PREPARATION OF AMEDICAMENT TO AMELIORATECHEMOTHERAPY-INDUCEDTOXICITY
תל אביב, 6451.ד.ת, 279רחוב הירקוןDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
A method of reducing organ toxicity in a subject being administered acytotoxic agent comprising concurrently administering with thecytotoxic agent erythropoietin (EPO), the EPO being administered in anamount effective to reduce pulmonary toxicity caused by the cytotoxicagent.
]57[
December–ע"התש בכסלו'ז 24, 2009 390
בקשות חלוקה מבקשה זו.שטר� פורסמו
198783,The applications for divisionfrom this application havenot yet been published
__________
158161]21][11[
שיטה והתקן לשירושי שידור במערכת תקשורת אלחוטית
METHOD AND APPARATUS FORBROADCAST SERVICES IN AWIRELESS COMMUNICATIONSYSTEM
Method and apparatus for providing a broadcast system parameter message in awireless communication system supporting a broadcast service. In one embodiment,the message identifies a service option number corresponding to a set of broadcastparameters. In an alternate embodiment, the message identifies a block of bytescorresponding to broadcast parameters. The message may be transmitted on achannel for transmitting overhead information. For a system supporting a broadcastservice, the message identifies a protocol stack for processing broadcast service, themessage identifies a protocol stack for processing broadcast content.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009391
158162]21][11[
בקרת כח לשירותי נקודה למספר נקודות המסופקים במערכת תקשורת
POWER CONTROL FOR POINT-TO-MULTIPOINT SERVICESPROVIDED IN COMMUNICATIONSYSTEMS
To enable point-to-multipoint communication services in an existing cellularcommunication system infrastructure, each member subscriber station (102), i.e., asubscriber station participating in such a service, is receiving a forward link sharedchannel (106), and in certain embodiments additionally a forward link dedicatedchannel. Because transmission on the forward link channels from neighboring sectorspresents interference to the transmission from the sector serving the subscriber station,it is desirable to control the forward link channel transmission power to the minimumacceptable power. Additionally, a transmission from each member subscriber station ona reverse link channel (108) presents interference to other subscriber stations.Therefore, it is desirable to control the reverse link channel transmission to theminimum signal level. Consequently, a method and apparatus for a power control thatenables point-to-multipoint services in an existing infrastructure of a wireless cellulartelephone system is disclosed.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 392
158228]21][11[
שימוש באסטרים של חומצות שומניותבעלות שרשרת ארוכה להכנת תרופות
לטיפול במחלות אוטואימוניות
USE OF ESTERS OF LONG-CHAINFATTY ACIDS FOR THEPREPARATION OFMEDICAMENTS FOR THETREATMENT OF AUTOIMMUNEDISEASES
Agents selected from: (i) a C¿1? - C¿24? alkyl ester of a saturated orcis-unsaturated C¿10? - C¿24? fatty acid; (ii) a monoester or polyesterof a polyol having at least four hydroxy groups with a saturated or cis-unsaturated C¿10? - C¿24? fatty acid or an anhydro derivative thereof;(iii) a monoester or polyester of a mono-, di- or poly-saccharide with asaturated or cis-unsaturated C¿10? - C¿24? fatty acid; (iv) an amide of asaturated or cis-unsaturated C¿10? - C¿24? fatty acid with an aliphaticor aromatic amine or with an amino acid, peptide, protein oraminosaccharide; and (v) combinations of any of (i) to (iv), can be usedfor treatment of autoimmune diseases and other immune-associatedinflammatory disorders. Preferred agents are ethyl oleate and mannidemonooleate or a combination thereof.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009393
158285]21][11[
פפטידים להכנת תכשירים לטיפול חיסוניבטרשת עורקים ופיתוח בוחן המבוסס על פפטידים לקביעת התגובה החיסונית נגד
ליפופרוטאינים מחומצנים בעלי משקל סגולי נמוך
PEPTIDES FOR PREPARINGMEDICAMENT FOR IMMUNO-THERAPY OFATHEROSCLEROSIS ANDDEVELOPMENT OF PEPTIDE-BASE ASSAY FORDETERMINATION OF IMMUNERESPONSES AGAINST OXIDIZEDLOW DENSITY LIPOPROTEIN
CEDARS-SINAI MEDICAL CENTER,U.S.A.FORSKARPATENT I SYD AB,SWEDEN
]71[
WO/2002/080954]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention relates to fragments of apolipoprotein B, inparticular defined peptides thereof, for immunization or therapeutictreatment of mammals, including humans, against ischemiccardiovascular diseases, as well as diagnosing the presence or absenceof antibodies related to increased or decreased risk of developingischemic cardiovascular diseases, using one or more of said peptides inan ELISA (Enzyme Linked Immuno Sorbent Assay).
]57[
ת חלוקה מבקשה זו בקשו.שטר� פורסמו
195356,188286,The applications for divisionfrom this application havenot yet been published
__________
December–ע"התש בכסלו'ז 24, 2009 394
158634]21][11[
תהליך עבור הכנת תולדותפרוסטאגלאנידין החומר הכנה
סטריוספציפיים עבורו
PROCESS FOR PREPARINGPROSTAGLANDIN DERIVATIVESAND STEREOSPECIFICSTARTING MATERIALTHEREFOR
]54[
07.05.2002]22[KR]33[08.05.2001]32[2001/25011]31[
Int. Cl.(2009.01) C07C 40/5/00, 41//02, 43//02, 43//17, 43//174, C07F 07//00]51[YONSUNG FINE CHEMICAL CO.,REPUBLIC OF KOREA
]71[
WO/2002/090324]87[,ר יצחק הס ושותפיו"ד
תל אביב, 6451.ד.ת, 279רחוב הירקוןDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
The present invention relates to a process for effectively preparingprostaglandin derivatives and to a stereospecific alkyl halide containing 15S-alcohol group as a starting material.
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a method for producing biperiden which ischaracterised in that an exo/endo mixture of 1-(bicyclo[2.2.1]hept-5-en-2-yl)-3-piperidino-l-propanone is reacted with an isomer ratio of the exo form to theendo form of at least 2.5:1 with diphenyl magnesium, an isomer mixturecontaining biperiden is obtained therefrom and biperiden is producedtherefrom.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009395
158933]21][11[
METHOD שיטה להכין ביפרידן FOR THEPRODUCTION OF BIPERIDEN
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a method for the production of biperiden byreacting an exo/endo mixture of 1-(bicyclo[2.2.1.]hept-5-en-2-yl) 3-piperidino-1-propanone with a phenyl magnesium compound, whereinthe exo/endo ratio of 1-(bicyclo[2.2.1.]hept-5-en-2-yl)-3-piperidino-1-propanone is at least 4.5: 1.
]57[
__________
158935]21][11[
ציריים המתפרקים באופן–קרומים דו טבעי בעלי התנגדות מבוקרת לקריעה
BIODEGRADABLE BIAXIALLYDRAWN FILM WITHCONTROLLED TEARRESISTANCE
The invention relates to a film with controllable tear resistant properties,comprising at least one basic layer which contains at least one polymer Ifrom at least one hydroxycarboxylic acid, and >0.1 wt. %, in relation tothe weight of the layer, of a thermoplastic polymer II which is differentfrom polymer I, and/or inorganic additives.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 396
158968]21][11[
SOLAR מחמם מים סולארי WATER HEATER]54[
20.11.2003]22[Int. Cl.(2008.04) F24J 2/04]51[
OFER עפר דגן DAGAN]71[,עפר דגן
שער העמקיםOFER DAGAN,SHA'AR HA'AMAKIM
]74[
An integral storage-collector solar water-heating system comprising: a tank (11) havingin inlet (13) for city water inlet – located in the lower side of said tank, a first outlet (14a)for supplying hot water – located in the upper side of said tank – and a second outlet(20) for feeding water to a fin – tube absorber (15) – located in the lower side of saidtank: a thermally insulated layer (12), which is attached to the inside walls of said tank;and an upper solar tank-absorber (16) and said lower solar fin-tube absorber, each forthe purpose of enabling a flow of water there-through to which solar heat collected bythe absorbers can be transferred, wherein: said upper solar tank-absorber is built insidethe exposed wall of said tank, by a water-flow-grid made of tunnels (25) that aregrooved in said thermally insulated layer, having an inlet (17) and an outlet into saidtank; and said lower solar fin-tube absorber has an inlet and an outlet, wherein saidinlet is connected to said second outlet of said tank and said fin-tube absorber's outletis connected to said inlet of said upper solar tank-absorber.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009397
159017]21][11[
מנהל נתונים להתקני תקשורת אלחוטית ושיטה לניהול נתונים בהתקן אלחוטי
DATA MANAGER FOR WIRELESSCOMMUNICATION DEVICESAND METHOD OF MANAGINGDATA IN A WIRELESS DEVICE
A data manager, and a method of managing data, for a wireless device. The datamanager includes a data receiver that receives voice data over the internet protocolconnection, a data sender that sends other voice data over the internet protocolconnection, a data recognizer that differentiates the voice data and the other voice datafrom non-voice data and non-data, and a controller that broadcasts the voice data andthe other voice data in an internet voice protocol format. The method includes the stepsof receiving voice data over the internet protocol connection at the wireless device,sending other voice data over the internet protocol connection from the wireless device,differentiating the voice data from non-voice data and non-data, differentiating the othervoice data from other non-voice data and non-data, and controlling the broadcast of thevoice data, and the other voice data.
This invention relates to benzopyran derivatives of the formula (1) or the formula (2)wherein R?1¿ and R?2¿ represent independently of each other hydrogen atom or C¿1-6?alkyl group, R?3¿ represents hydroxyl group or C¿1-6? alkylcarbonyloxy group,R?4¿ represents hydrogen atom or C¿1-6? alkyl group, R?5¿ represents C¿1-6? alkylgroup substituted with C¿6-14? aryl group or heteroaryl group, R?6¿ represents C¿1-6? alkyl group, C¿1-6? alkoxy group, halogen atom, nitro group, C(O)NH¿2?,C(O)NHR?8¿ or C(O)NR?8¿R?9¿, or pharmaceutically acceptable salts thereof. Thesecompounds are useful as an antiarrhythmic agent.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009399
159534]21][11[
שיטה להכנת קורולים המותמרים באופן סלקטיבי וקורולים מותמרים חדשים
METHOD FOR THEPREPARATION OFSELECTIVELY-SUBSTITUTEDCORROLES AND NEWSUBSTITUTED CORROLES
]54[
01.07.2002]22[US]33[02.07.2001]32[60/301851]31[
Int. Cl.(2008.04) A61K 31/40, 31/55, C07D 487/22]51[TECHNION חיפה,מ"מוסד הטכניון למחקר ופיתוח בע RESEARCH AND
wherein:Ar is aryl or heteroaryl;M is absent or is metal selected from the group consisting of Al, Ga, Co, Mn, Fe, Ru,Sn, Cr and Rh; E2, E3 and E17, the same or different, each is H, SO2Cl, SO3H,SO2NR1R2, CO2H, CO2R, COCl, CONR1R2, CHO or NO2 R is alkyl or aryl, and R1 andR2, the same or different, each is H, alkyl, aryl or together with the N atom to which theyare attached form a staturated 5-6 membered ring optionally containing a furtherheteroatom selected from the group consisting of O, S and N; and E18 is H or CHO; orE3 and E18 each is H and E2 and E17 each is SO2, both SO2 groups being linked by abridge R3N(R4)-phenyl-(R4)NR3, wherein R3 is H, alkyl, phenyl or aralkyl, and R4 isalkylene; and provided that at least one of E2, E3, E17 and E18 is not H.
This invention pertains to methods for protecting a propagule or a plant grown therefrom from invertebrate pests comprising contacting the propagule or the locus of the propagule with a biologically effective amount of a compound of Formula I: its N-oxide or an agriculturally suitable salt thereof wherein A and B and R?1? through R?8? are as defined in
]57[
December–ע"התש בכסלו'ז 24, 2009401
the disclosure. This invention also relates to propagules treated with a compound of Formula I and compositions comprising a Formula I compound for coating propagules.
__________
159950]21][11[
הליך להכנת אבקות ננומטריות ואבקהתבעלת מצרפים חופשיים של חלקיקים
ננומטריים
PROCESS FOR PRODUCINGNANO-POWDERS AND NANO-PARTICLE LOOSE AGGREGATESPOWDER
]54[
26.07.2002]22[CN]33[27.07.2001]32[01127978.8]31[
Int. Cl.(2009.01) B01F 03//08, B01J 19//00, C01F 03//02]51[ANSHAN UNIVERSITY OFSCIENCE AND TECHNOLOGY,CHINA
]71[
WO/2003/011761]87[,לוצאטו את לוצאטו
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention discloses a process for producing nano-powdersand powders of nano-particle loose aggregate, which comprises: (a)providing at least two reactant solutions A and B capable of rapidlyreacting to form deposits; (b) supplying the at least two solutions A andB at least at the reaction temperature into a mixing and reactionprecipitator respectively, in which mixing reaction and precipitation arecontinuously carried out in sequence, the said mixing and reactionprecipitator being selected from at least one of a tubular ejector mixingreactor, a tubular static mixing reactor and an atomizing mixing reactor;and (c) treating the deposit-containing slurry continuously dischargedfrom the mixing reaction precipitator. The process makes it possible tocontrol the size of the nano-particles, produces particles uniform in size,good in dispersibility and high in yield, while being simple and savingenergy. The process can be used to produce nano-powders of nano-particle aggregates of various kind of metals, oxides, hydroxides, salts,
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A Loctabacillus salivarius strain,AHlO2, AHlO3, AHlO5, AHlO9 or AHllO or mutants orvariants thereof are useful in the prophylaxis and/or treatment of inflammatory activityespecially undesirable gastrointestinal inflammatory activity, such as inflammatorybowel disease or irritable bowel syndrome.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009403
160053]21][11[
שיטה לבידוד ואפיון של תצמידים הקשורים לקרום והמיוחדים לליגנד
METHOD TO ISOLATE ANDCHARACTERIZE MEMBRANEBOUND LIGAND SPECIFICCOMPLEXES
A method to recover or 'deracinate' receptors from intact membranes in their nativeconfiguration without removing microenvironmental components associated with themis described. The membranes containing the receptors are first associated with ligand-coupled solid supports to achieve association of the membranes through areceptor/ligand complex which includes the microenvironmental to the solid supportand then removing the membrane from the receptor and its microenvironment by shearforces. The thus isolated receptors and their microenvironments can then be analyzedfor their role in cellular differentiation, apoptosis, transformation and the like.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 404
160330]21][11[
יישום פעולה של בקשת שידור חוזראוטומטית על שכבת פיסית עבור יחידת
מנוי
IMPLEMENTING A PHYSICALLAYER AUTOMATIC REPEATREQUEST FOR A SUBSCRIBERUNIT
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A subscriber unit implementing physical layer automatic repeat request includes atransmitter (12) and a receiver (16). The transmitter has a physical layer transmitter(12a); an acknowledge receiver (12b) for receiving the correspondingacknowledgment; and an adaptive modulation and coding controller (12c) forcollecting retransmission statistics and adjusting the particular dataencoding/modulation using the collected statistics. The receiver (16) has a physicallayer receiver (16a), and an acknowledgment generator (16c) for generating anacknowledgment for each packet if that packet has an acceptable error rate.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009405
160338]21][11[
הליך לייצור חלבון או פוליפפטיד שישבו עניין בצמח או בתאי צמח המשטמש
בחלבון איחוי המכיל פפטיד המתחבר לדופן תא
PROCESS OF PRODUCING APROTEIN OR POLYPEPTIDE OFINTEREST IN A PLANT OR INPLANT CELLS USING FUSIONPROTEIN COMPRISING CELLWALL-BINDING PEPTIDE
YURII DOROKHOV, EUGENESKURAT, VICTOR KLIMYUK, YURIGLEBA
]72[
WO/2003/020938]87[בי'ג בע, יי אמ ,מ"פקטור אנד קו
, 45087.ד.ת, הר חוצבים, רחוב המרפא ירושלים
JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,JERUSALEM 91450
]74[
A process of producing a protein or polypeptide of interest in a plant orin plant is provided, comprising: (i) transforming or transfecting a plantof plant cells with a nucleotide sequence having a coding regionencoding a fusion protein comprising the protein or polypeptide ofinterest, a signal peptide functional for targeting said fusion protein tothe apoplast, and a polypeptide capable of binding the fusion protein toa cell wall component, (ii) enriching cell wall components havingexpressed and bound fusion protein, and separating the protein orpolypeptide of interest or a protein comprising the protein orpolypeptide interest.
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The invention provides compounds of Formula I or a pharmaceutically acceptable saltor ester thereof wherein the symbols have meaning as defined, which are inhibitors ofcathepsin K and find use pharmaceutically for treatment of diseases and medicalconditions in which cathepsin K is implicated, e.g. various disorders includinginflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
198643,The applications for divisionfrom this application havenot yet been published
__________
December–ע"התש בכסלו'ז 24, 2009407
160522]21][11[
אימידזול בעלות פעילות–H1תולדות,CB1אגוניסטית מלאה או חלקית כלפי
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
AbstractThe present invention relates to a group of novel 1H−imidazole derivatives, tomethods for the preparation of these compounds, and to pharmaceutical compositionscontaining one or more of these compounds as an active component.These1H−imidazole derivatives are potent cannabinoid−CB1 receptor agonists, partialagonists or antagonists, useful for the treatment of psychiatric and neurologicaldisorders, as well as and other diseases involving cannabinoid neurotransmission.Thecompounds have the general formula (I) wherein R and R1−R4 have the meaningsgiven in the specification.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 408
160575]21][11[
ת ערוץ העברת וקבלת הודעות באמצעו תקשורת מותאם ומודל תכנות
TRANSMITTING ANDRECEIVING MESSAGESTHROUGH A CUSTOMIZABLECOMMUNICATION CHANNELAND PROGRAMMING MODEL
A computer system for implementing a messaging infrastructure which abstractsvarious processing layers within the infrastructure, wherein the infrastructure is adaptedto provide a base level of messaging functionality, and wherein the abstract processinglayers are extensible such that changes or enhancements can be made withoutnecessarily having to re-implement the base level of messaging functionality providedin other abstract processing layers, the computer system comprising: one or moremessaging layer modules adapted to provide endpoint-to-endpoint transmission of oneor more messages and to implement support for one or more message transportprotocols; one or more channel layer modules adapted to provide message exchangesemantics on top of the one or more message layer modules; and one or more servicelayer modules adapted to provide one or more programming modules on top of the oneor more channel layer modules adapted to interact with the messaging infrastructure byexposing one or more features of the messaging infrastructure to be accessed bysoftware designed to use the messaging infrastructure; wherein the one or morechannel layer modules comprise a channel manager adapted to gather and correlatemessages and present a higher-level channel abstraction to the one or more servicelayer modules.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009409
160580]21][11[
מערכת סינון זרימת צולבת ושיתה למניעת סתימות בממברנות
CROSSFLOW FILTRATIONSYSTEM AND METHOD FORMEMBRANE FOULINGPREVENTION
]54[
26.02.2004]22[Int. Cl.(2009.01) B01D 65//02]51[
BORIS חיפה, בוריס פודולסקי PODOLSKY]71[,בוריס פודולסקי
A crossflow filtration system for membrane fouling prevention, comprising:(a) a pipe-line for feeding liquid to be cleaned;(b) a pressure pump associated via a hydraulic line with the pipe-line for feeding fluid tobe cleaned;(c) a membrane module, including a membrane enclosed in a body associated via apressure line with the pump and two exits, the first whereof serves for removingcleaned fluid, and the second – for removing waste concentrate, this membranemodule serves for separating the feed into pure fluid and concentrate containingimpurities;(d) a pipe-line for cleaned fluid associated with the first exit of said membrane body;(e) a pipe-line for removing waste concentrate connected with the second exit of saidmembrane body;(f) means for applying an additional reciprocal fluid pulse to the fluid passing through(a) membrane located in a membrane module for applying an additional reciprocal fluidpulse to the fluid passing through the membrane module, whereby there are preventedmembrane fouling in said membrane module and formation thereof of a boundaryconcentrate layer.
]57[
__________
160640]21][11[
CRYSTALLINE הידרטים גבישיים של תולדות אניליד HYDRATES OFANILIDE DERIVATIVES
]54[
14.09.2002]22[DE]33[25.09.2001]32[10147034.7]31[
Int. Cl.(2008.04) A01N 43/40, C07C 233/64, C07D 213/82]51[BASF SE, GERMANY]71[WO/2003/029219]87[
,ריינהולד כהן ושותפיולרמת החיי',א26רחוב הברזל
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to crystalline hydrates of substituted nicotinic acid anilidederivatives and substituted benzoic acid anilide derivatives of formula (1), theproduction and use thereof to combat phytopathogenic fungi and undesirableinsect and accaride attacks and/or to regulate the growth of plants; wherein A
]57[
December–ע"התש בכסלו'ז 24, 2009 410
represents (A1) or (A2), R?1¿ represents phenyl substituted by halogen, R?2¿represents difluoromethyl, trifluorormethyl, chlorine, bromine or iodine andR?3¿ represents trifluoromethyl or chlorine.
__________
160660]21][11[
OPTICAL חלון אופטי למעקב אחר דגימות WINDOW FORMONITORING SAMPLES
]54[
13.09.2002]22[GB]33[20.09.2001]32[0122711.5]31[
Int. Cl.(2008.04) G01N 21/15]51[NDC INFRARED ENGINEERINGLTD., UNITED KINGDOM
]71[
WO/2003/025550]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
This invention is concerned with a material processing apparatus, e.g. a dryer such asa fluid bed dryer, for processing material, e.g. pharmaceuticals, in a compartment (12)having a wall (10). The wall has a window for transmitting radiation from an infraredspectrometer (30) into the dryer and for transmitting radiation from the material to thespectrometer. The spectrometer (30) can analyse the radiation transmitted from thematerial to measure a property of the material within the compartment, e.g. its moisturecontent. The radiation-transmitting element (28) is present in a moveable body (24),e.g. a sphere, that can be moved to bring the element (28) into a second position (31)in which the element is in contact with a duct (40) through which fluid can be passed toclean the element (28). In addition, a wiper member (34) may be provided that wipesthe element (28) as it passes over it as the moveable body (26) is moved into thesecond position.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009411
160680]21][11[
ושיטות, אנטנת פס דקדה חריץ מחודדו תצורה שלהייצור
DECADE BAND TAPERED SLOTANTENNA AND METHODS OFMAKING AND CONFIGURINGSAME
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An antenna apparatus (10) includes an antenna element (12, 412, 512) that hasconductive material with a recess therein. The recess includes a balun hole (36, 536),and a tapered slot (37, 537) communicating at its narrow end with the balun hole. Thebalun hole is approximately rectangular, has a peripheral edge defined by conductivematerial, and contains air. The tapered slot has a shape which is optimized as afunction of factors that include the balun hole design. Each slot edge follows apredetermined curve other than a first-order exponential curve.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 412
160769]21][11[
תרכובות הטרוציקליות ותכשירי רוקחות המכילים אותן
HETEROCYCLIC COMPOUNDSAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The present invention relates to compounds of the Formula (I) that are usefulantimicrobial agents and effective against a variety of multi−drug resistant bacteria.
]57[
__________
160981]21][11[
SYSTEM מערכת ושיטה לשידור אותות מידע AND METHOD FORCOMMUNICATING MEDIASIGNALS
A media streaming system for streaming media signals is provided. The mediastreaming system takes a library of separate and distinct CODECs (145) that areprovided as a searchable CODEC library and used in determining specificcharacteristics in the media signal to identify similar sections of the signal. The media
]57[
December–ע"התש בכסלו'ז 24, 2009413
streaming system uses a computer implemented intelligence system, such as anintelligence mechanism to learn and capture the unique charateristics of a signal as thesignal is being streamed (150). The media streaming system also compresses anddecompresses the media signal as the signals are streamed from a source media (100)to a destination device (130, 135, 140).
__________
161165]21][11[
מלח נתרן גבישי של טלמיסרטןוהשימוש בו באנטגוניסט לקולטן
האנגיוטנסין
CRYSTALLINE SODIUM SALT OFTELMISARTAN AND THE USE OFTHE SAME AS AN ANGIOTENSINANTAGONIST
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a crystalline sodium salt of 4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (INN: Telmisartan), to a methodfor the production thereof, and to the use of the same for producing apharmaceutical having an angiotensin II antagonistic action.
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method of treatment of sewage comprising adding at least one cell signallingchemical (CSC) to a sewage substrate, wherein the at least one CSCregulates activity of a microbial population in the sewage substrate. Inparticular, methods of reducing odour in sewage treatment systems,preventing corrosion in sewage treatment systems, enhancing microbialdigestion of sewage, managing methane gas production in a sewagetreatment system, enhancing digestion of sewage sludge, resuscitatingdormant microbes or microbes that are in a starvation or stationary phase in asewage substrate and controlling the bacteria responsible for oxidation orreduction of nitrogenous compounds in a sewage substrate, are provided.
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention describes a pouring spout device, comprising a spout fitment (4) and areclosable closure (2), said spout fitment (4) having a planar base (29) and a tubularside wall (24) defining a pouring zone therein and a flap (26) disposed at a lower end ofthe side wall (24), a cam follower (32) extending upward from said flap (26), whereinthe closure (2) retained on said fitment has an end wall (5) and a tubular side wall (3),
]57[
December–ע"התש בכסלו'ז 24, 2009415
wherein the end wall (5) has a first cam (8) depending therefrom and engageable withsaid cam follower (32), and wherein the first cam (8) contacting the cam follower (32)during rotation of the closure (2). In order to avoid breakage of the cam follower (32),when the reclosable closure (2) is replaced on the spout fitment (4), a second cam (10)is formed on the reclosable closure (2) and disposed radially outermost of the first cam(8). When the cam follower (32) reaches the end region (12), the cam follower (32) willbe able to move radially inwardly and return to the surface (11) of the first cam (8). Thecam follower (32) will then be correctly positioned for future opening operations.
__________
161559]21][11[
תולדות דיבנזיל אמין ותכשירי רוקחות המכילים אותן
DIBENZYLAMINE DERIVATIVES ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAME
A dibenzylamine compound represented by the general formula (1): (1)(wherein R1 and R2 each is optionally halogenated C1-6 alkyl, etc.; R3, R4, andR5 each is hydrogen, halogeno, etc., provided that R3 and R4 may form anoptionally substituted homocycle or heterocycle in cooperation with the carbonatoms bonded thereto; A is -N(R7)(R8), etc.; ring B is aryl or a heterocyclicresidue; R6 is hydrogen, halogeno, nitro, C1-6 alkyl, etc.; and n is an integer of 1to 3); a prodrug of the compound; or a pharmaceutically acceptable salt ofeither. They have selective and potent CETP inhibitory activity and are henceusable as, e.g., a therapeutic or preventive drug for hyperlipemia,arteriosclerosis, etc.
The invention relates to a pharmaceutical formulation which is characterised bydelayed release of the active ingredient. Said formulation contains 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol or one of its pharmaceutically acceptable salts in amatrix with delayed release of the active ingredient. Said matrix contains between 1and 80 wt. % of at least one hydrophilic or hydrophobic polymer as a pharmaceuticallyacceptable matrix forming agent and exhibits, in vitro, the following dissolution speed:between 3 and 35 wt. % (in relation to 100 wt. % of active ingredient) of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after half an hour, between 5and 50 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released afterone hour, between 10 and 75 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after two hours, between 15 and 82 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after three hours, between30 and 97 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released aftersix hours, more than 50 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol isreleased after twelve hours, more than 70 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after eighteen hours, and more than 80 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after twenty-four hours.
]57[
December–ע"התש בכסלו'ז 24, 2009417
__________
161643]21][11[
בעל חלוןCDMAמעריך פרמטרי למקלטו או מיקום/חיפוש עם גודל
PARAMETER ESTIMATOR FOR ACDMA RECEIVER WITH ASEARCH WINDOW OF VARIABLESIZE AND/OR PLACEMENT
A parameter estimator for estimating one or more parameter(s) from a correlationfunction derived from a signal using a dynamically variable search window is described.The parameter estimator may be employed in a subscriber station to estimate the timeof arrival of one or more base station pilot signals in a wireless communication system.This information may be utilized in an overall advanced forward link trilateration (AFLT)process for estimating the location of the subscriber station.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 418
161654]21][11[
–שיטה לייצור נתבים מיקרוגנטיים המבוססים על אלקטרומ
CMOSמצעתואם
METHOD OF FABRICATINGMICRO-ELECTROMECHANICALSWITCHES ON CMOSCOMPATIBLE SUBSTRATES
,מעבדות יבמ מחלקת קנין רוחני חיפה, אוניברסיטת חיפה הר הכרמל
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
A method of fabricating micro-electromechanical switches (MEMS) using a processstarting with a copper damascene interconnect layer, made of metal conductors inlaidin a dielectric (150). All, or portions, of the interconnects are recessed to a degreesufficient to provide a capacitive air gap when the switch is in the closed state, as wellas provide space for a protective layer of, for example, Ta/TaN. The metal structuresdefined within the area specified for the switch act as actuator electrodes to pull downthe movable beam (160) and provide one or more paths for the switched signal totraverse. The advantage of an air gap is that air is not subject to charge storage ortrapping that can cause reliability and voltage drift problems. Instead of recessing theelectrodes to provide a gap, one may just add dielectric on or around the electrode.The next layer is another dielectric layer which is deposited to the desired thickness ofthe gap formed between the moveable beam (160) that forms the switching device.Vias are fabricated through this dielectric to provide connections between the metalinterconnect layer and the next metal layer which will also contain the switchable beam.The via layer is then patterned and etched to provide a cavity area which contains thelower activation electrodes as well as the signal paths. The cavity is then back-filledwith a sacrificial release material.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009419
161872]21][11[
RA1יצור –ILהמומרץ על ידי נוגדן ANTIBODY STIMULATING IL-1RA PRODUCTION
LABORATOIRE FRANCAIS DUFRACTIONNEMENT ET DESBIOTECHNOLOGIES, FRANCE
]71[
WO/2003/040188]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention concerns natural antibodies eventually monoclonalcapable of inducing a high production of IL-1Ra with monocytes ormacrophages and the use of said antibodies for treating inflammatory orautoimmune diseases.
]57[
__________
161876]21][11[
BLOCK גוש בינייני מגורים הצף על פני הים OF RESIDENTIALBUILDINGS FLOATING ON THESEA SURFACE
A block of residential buildings floating on the sea surface; the residential buildings 6-11 are each interlinked only to the two nearest buildings around the periphery of theblock by rigid connections (16) to form a block; the rigid connection interlink both thelower and upper of the residential buildings; the residential buildings are connected asstraight hexahedron prisms; center gravity of each residential building is situated on itsaxis symmetry.
]57[
December–ע"התש בכסלו'ז 24, 2009 420
__________
161898]21][11[
ייצור מילחי אמוניום של חומצות קרבוכסיליות ארומטיות
PRODUCTION OF AMMONIUMSALTS OF AROMATICCARBOXYLIC ACIDS
]54[
03.12.2002]22[DE]33[04.12.2001]32[10159420.8]31[
Int. Cl.(2009.01) C07C 63//04, 63//08]51[BASF SE, GERMANY]71[WO/2003/048099]87[
,ריינהולד כהן ושותפיו רמת החייל',א26רחוב הברזל
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method for the production of ammonium salts of aromatic carboxylic acidsby reaction of an aromatic carboxylic acid with ammonia in an aprotic solventis disclosed. Said reaction is carried out in a closed vessel and a solution ofthe aromatic carboxylic acid in an aprotic solvent and gaseous ammonia arecontinuously introduced into the vessel, such that a partial pressure ofammonia of 0.1 to 3 bars is maintained in the gas chamber of the vessel and asuspension of the ammonium salt separates out in the aprotic solvent. Themethod permits the production of ammonium salts with defined crystal sizeand a narrow size distribution.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009421
161984]21][11[
מערכת ושיטה להפסקת פעילות ערוץ תנועה בתצורת שקע תקשורת אלחוטי
SYSTEM AND METHOD FORTRAFFIC CHANNEL DORMANCYIN WIRELESS COMMUNICATIONSOCKET MODE
In a wireless communication system such as a CDMA system, a traffic channelsupporting two applications running in socket mode on a mobile station is allowed to godormant and is released when respective idle periods associated with each socketexpire, i.e., when there is no transmission over the traffic channel for the longer of twopotentially unequal idle periods.
]57[
__________
162035]21][11[
–Nתולדותהטרוארילניקוטינאמידותכשירים קוטלי
מזיקים המכילים אותן
N-HETEROARYLNICOTINAMIDEDERIVATIVES AND PESTICIDALCOMPOSITIONS CONTAININGTHE SAME
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
December–ע"התש בכסלו'ז 24, 2009 422
N−Heteroaryl−4−(trifluoromethyl)nicotinamide derivatives represented by the generalformula (‖) or salts thereof; pesticides containing the same as the activeingredient; a process for the production thereof; and intermediatestherefor: (‖) wherein R is C1−6 haloalkyl; R1 is hydrogen, optionallysubstituted C1−6 alkyl, C2−6 alkenyl, or acyl; X is C−R2 or nitrogen; and R2
and R3 are each independently hydrogen, halogeno, optionally substituted C1−6 alkyl,C3−7 cycloalkyl, C2−6 alkenyl, C3−7 cycloalkenyl, formyl, CH=NOR4, cyano, optionallysubstituted phenyl, a heterocyclic group which may be substituted, optionallysubstituted C1−6 alkoxy, C1−6 alkylthio, or optionally substituted phenoxy.
]57[
__________
162092]21][11[
שיטה והתקן לקריאה למסוף אלחוטי ברשת תקשורת אלחוטי
METHOD OF AND APPARATUSFOR PAGING A WIRELESSTERMINAL IN A WIRELESSTELECOMMUNICATIONSSYSTEM
Int. Cl.(2008.04) H04J 13/00, H04Q 7/20]51[DIVISION FROM 133157]62[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/1998/054919]87[ט ',קולב ושות. סנפורד
, 2273.ד.ת, מרמורק,4שער הגיא רחובות
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A method of and apparatus for paging a wireless terminal in a wirelesstelecommunications system reduce standby mode power consumption. A minimallyencoded quick paging channel is established over which short, quick page messages(30) are transmitted during one of a set of quick paging slots. The quick page messageindicates that a communications request has been received, and that the receivingcommunication terminals should process a highly encoded full paging channel overwhich more detailed, full page messages (32) are transmitted during the next fullpaging slot. A terminal monitors full paging channel only after a quick page messagehas been received on the quick paging channel.
]57[
December–ע"התש בכסלו'ז 24, 2009423
__________
162492]21][11[
שימוש באלקילפוספוכולינים להכנתלטיפול מניעתי במחלות הנגרמות תרופה
תאיים–מיצורים חד
USE OFALKYLPHOSPHOCHOLINES FORPRODUCING A MEDICAMENTFOR THE PREVENTATIVETREATMENT OF PROTOZOANDISEASES
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to pharmaceutical compositions containingalkylphosphocholines, especially hexadecylphosphocholine oroctadecyl-(1, 1-dimethyl-piperidinio-4-yl)-phosphate for thepreventative treatment of protozoan diseases, especially leishmaniasis.The invention also relates to a dosing scheme of said compositions forthe preventative treatment of said illnesses.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 424
162513]21][11[
שיטה וערכה לגילוי ספינגומיאלינז אלקלי
METHOD AND KIT FORDETECTING ALKALINESPHINGOMYELINASE
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An analytical fluorometric method and a kit for use in such method aredisclosed for assessing the presence of alkaline sphingomyelinase(SMase) in the stools of a patient in need of such an assessment sincealkaline SMase is a marker of serious pathological states, such as coloncancer.
]57[
__________
162522]21][11[
שיטה לשידור נתונים עבור מערכתנקודות–שידור נתונים דיגיטליים רב
משתמשים–נקודות לרב–לרב
PROCESS FOR THETRANSMISSION OF DATA BY AMULTI-USER, POINT TO MULTI-POINT DIGITAL DATATRANSMISSION SYSTEM
The invention relates to a data transmission method for a multi-user, multipoint-to-multipoint digital data transmission system involving a plurality of pieces of userequipment (1) which are bidirectionally connected via a physical means (6). Theinventive method can be used to establish various communications from a piece ofuser equipment (1a) to different pieces of destination user equipment (1b-1d) at
]57[
December–ע"התש בכסלו'ז 24, 2009425
different speeds, while maintaining the bandwidth and maximum latency valuesrequired by each of the pieces of destination user equipment (1b-1d). Said methodconsists in sending multiple information frames (4) from a piece of equipment (1a) to amultitude of pieces of destination user equipment (1b-1d) at different speeds.Moreover, using the percentage reserve of the frame, the invention provides a qualityof service based on that required by the piece of user equipment and supplies acriterion for dynamically assigning the packets which are sent to each piece of userequipment in the frame, grouping or dividing the packets to be sent.
The invention relates to new imidazolidine-type compounds of formula (I) in which R1to R7 have the meanings disclosed in the claims. Said compounds represent potentinhibitors of sodium/hydrogen exchanger (NHE), particularly NHE. These novelcompounds are used to produce a drug for the therapy or prophylaxis of the centralnervous system, lipometabolism, infestations by ectoparasites, dysfunctions of the galland for improving respiratory drive. The inventive compounds are therefore used for thetherapy of respiratory conditions in the following clinical states and diseases:malfunctioning central respiratory drive (e.g. sleep apnoea, sudden infant death,postoperative hypoxia), muscle-related breathing disturbances, breathing disturbancesfollowing long-term respiration, breathing disturbances when adapting to high mountainareas, obstructive sleep apnoea and a mixed type of sleep apnoea, acute and chronic
]57[
December–ע"התש בכסלו'ז 24, 2009 426
lung diseases with hypoxia and hypercapnia. Said compounds also increase themuscle tone in the upper respiratory tract so as to suppress snoring.
__________
162567]21][11[
הסרת הפרעה עצמית באמצעות פיצוי ממיר
במערכת תקשורת ממסרית
SELF-INTERFERENCE REMOVALUSING CONVERTERCOMPENSATION IN A RELAYEDCOMMUNICATION SYSTEM
Self-interference cancellation (10) in two-way relayed communication is improved bycreating models of upconverter and downconverter imperfections and thencompensating for those imperfections before self interference cancellation processing(36). The model includes compensation for phase offset, for amplitude imbalance andfor leakage in the mixers.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009427
162592]21][11[
CYSTINE-KNOT ציסטין–חלבון מקופל בצורת קשר FOLD PROTEIN]54[
באר שבע, 5352.ד.ת, עומר,הגן תעשייLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
This invention relates to a novel protein (INSP002), herein identified as a secretedprotein that is a member of the Dan family of the cystine-knot fold cytokine superfamilyand to the use of this protein and nucleic acid sequences from the encoding genes inthe diagnosis, prevention and treatment of disease.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 428
162676]21][11[
תהליך לייצור מוצרים של בור קרבידי צפיפות גבוהה בעל
PROCESS FORMANUFACTURING HIGHDENSITY BORON CARBIDEARTICLES
]54[
22.06.2004]22[Int. Cl.(2008.04) C04B 355/63]51[
,מ"רפאל מערכות לחימה מתקדמות בע חיפה
RAFAEL ADVANCED DEFENSESYSTEMS LTD.
]71[
זהר, יהושע חכמו, דוד גורני, זיו-שמשון ברצבי, יוסף פריי, איתמר גוטמן, אופיר
ניסנהולץ
SHIMSHON BAR-ZIV, DAVIDGORNI, YEHOSHUA HACHAMO,ZOHAR OPHIR, ITAMARGUTMAN, JOSEPH FREY, ZVINISENHOLZ
]72[
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A process for manufacturing boron carbide objects comprising the steps of:(a) pre-washing a raw boron carbide powder;(b) mixing the washed boron carbide powder with a carbon precursor;(c) drying the mixture;(d) granulating the dried mixture;(e) compacting the granulated dried mixture to form a shaped object by applying apressure thereto;(f) carbonizing the shaped body in an inert atmosphere, by holding at a hightemperature for a predetermined period of time;(g) sintering the carbonized shaped body at a temperature between about 2,290oC andabout 2,350oC in an inert atmosphere for a time period of not less than about 30 min.
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention provides substituted 2-aminopyridines useful in treating cellproliferative disorders. The novel compounds of the present invention are potentinhibitors of cyclin-dependent kinases 4 ( cdk4 ).
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
198243,The applications for divisionfrom this application havenot yet been published
An apparatus (100) for aiding in donning a sock comprising:(a) a base (101) having proximate and distal ends;(b) an elongated caddy (113) having a U-shaped cross-section, a first end of saidcaddy being connected to said base at a location close to said distal end and a second
]57[
December–ע"התש בכסלו'ז 24, 2009 430
end of said caddy over which a sock can be draped being displaceable with respect tosaid base;(c) a connecting pivot (110) for pivotally connecting said first end of the elongated U-shaped caddy with said base at a location close to the base distal end, allowing rotationof said elongated caddy about said pivot; and(d) counter weight means (103) by which said base is coupled to a fixed or heavyarticle, such as a furniture article, wherein said caddy is upwardly pivotable from aninitial substantially horizontal disposition, upon insertion of a foot within a sock drapedover the second end of said caddy, until a disposition at which said sock is releasedfrom said caddy after being fully donned on said foot and wherein said connectingmeans comprise a ribbon which is affixed to the base close to its proximate end.
Techniques are disclosed for compensating for second-order distortion in a wirelesscommunication device. In a zero-intermediate frequency (IF) or low-IF architecture, IM2distortion generated by the mixer (20) results in undesirable distortion levels in thebaseband output signal. A compensation circuit (104) provides a measure of the IM2distortion current independent of the radio frequency (RF) pathway to generate an IM2calibration current. The IM2 calibration current is combined with the baseband outputsignal to thereby eliminate the IM2 currents generated within the RF pathway. In oneembodiment, the calibration is provided at the factory during final testing. In alternativeembodiment, additional circuitry (156, 158) may be added to the wirelesscommunication device to provide a pathway between the transmitter (150) and the
]57[
December–ע"התש בכסלו'ז 24, 2009431
receiver (146). The transmitter signal is provided to the receiver to permit automaticcalibration of the unit. An internal signal source (162) may be used in place of thetransmitter (150). The auto-calibration may be performed to eliminate IM2 distortion orpermit optimization of the circuit to minimize other forms of distortion or interference.
The invention relates to a pyrimidone derivative represented by formula (I) or a saltthereof wherein: (I) X represents two hydrogen atoms, a sulphur atom, an oxygen atomor a C1-2 alkyl group and a hydrogen atom; Y represents a bond, an ethenylene group,an ethynylene group or a methylene group optionally substituted; R1 represents a 2, 3or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring optionally substituted; R2 represents aheterocyclic bicyclic rings, having 1-4 heteroatoms selected from an oxygen atom, asulfur atom and a nitrogen atom and having 5-9 carbon atoms, of formula (II) R3represents a hydrogen atom, a C1-6 alkyl group, a hydroxy group, a C1-4 alkoxy group ora halogen atom; R4 represents a hydrogen atom, a C1-6 alkyl group, a C1-4 alkoxy groupor a halogen atom. The invention relates also to a medicament comprising the saidderivative or a salt thereof as an active ingredient which is used for preventive and/ortherapeutic treatment of a neurodegenerative disease caused by abnormal activity ofGSK3&bgr; or GSK3&bgr; and cdk5/p25, such as Alzheimer disease.
The invention relates to a imidazo[1,2-a]pyrimidone derivative represented by formula(I) or a salt thereof: R1 wherein X represents a bond, an ethenylene group, anethenylene group, a methylene group optionally substituted; a carbonyl group, anoxygen atom, a sulfur atom, a sulfonyl group, a sulfoxide group or a nitrogen atombeing optionally substituted; R1 represents a 2, 4 or 5-pyrimidinyl optionally substituted;R2 represents a C1-6 alkyl group, a C1-2 perhalogenated alkyl group, a C1-3 halogenatedalkyl group, a benzyl group, a benzene ring, a naphthalene ring, 5,6,7,8-tetrahydronaphthalene ring, a pyridine ring, an indole ring, a pyrrole ring, a thiophenering, a furan ring or an imidazole ring, the benzyl group and the rings being optionallysubstituted; and n represents 0 to 3. The invention relates also to a medicamentcomprising the said derivative or a salt thereof as an active ingredient which is used forpreventive and/or therapeutic treatment of a neurodegenerative disease caused byabnormal activity of GSK3ß, such as Alzheimer disease.
There is provided a decoppering agent that is incorporated into thepropellant to remove copper from the rifling of the internal bore of agun barrel. The decoppering agent consists essentially of a lead-freepulverized additive mixed together with the other propellantcompounds. We have found that a mixture of tin and bismuth is a verygood decoppering agent. Especially in the ratio 42% Sn/58%Bi, themelting point for this combination is 138 degree C. Much lower thaneach of the components. It can be all kinds of suitable tin and bismuthcompounds. The bismuth and tin either vaporizes or liquefies when thepropellant is ignited and either embrittles or dissolves the copperdeposits facilitating removal.
]57[
__________
163450]21][11[
GUIDED טיל מונחה עם מנגנון הנחיה מבוזר MISSILE WITHDISTRIBUTED GUIDANCEMECHANISM
A weapons system comprising:(a) a guided missile including:(i) a seeker for producing signals indicative of a position of a target, and(ii) a steering mechanism for steering said guided missile; and(b) a guidance mechanism, separate from said guided missile, for controlling saidsteering mechanism, based on said signals, so as to steer said guided missile tworadssaid target; wherein said guided missile is too small to carry an on-board guidancemechanism that activates said steering mechanism to guide said guided missileautonomously to said target in response to said signals.
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Shaped tampons having varying perimeters are provided. Tampons disclosed comprisea mass of absorbent material formed into a self-sustaining shape comprising aninsertion end, a withdrawal end, and a center region. The center region has at least oneperimeter which is less than a largest insertion end perimeter and is less than awithdrawal end perimeter. The shaped tampons may also have varying average fiberdensity regions. The shaped tampons may be wrapped in tightly conforming wrapperswhich optionally aid in maintaining the self-sustaining shape prior to use. Optionally, theshaped tampons may utilize tampon applicators which enable a user to visually see theshape of the tampon prior to use.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009435
163738]21][11[
די DISCסקמנעול למסובב TUMBLER LOCK]54[
14.03.2003]22[FI]33[27.03.2002]32[20020587]31[
Int. Cl.(2008.04) E05B 21/00]51[BJORKBODA LAS OY AB,FINLAND
]71[
WO/2003/080969]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A disc tumbler lock, which comprises a lock case (1), which includes a bolt (3)displaceable with a key of the lock and a number of locking discs (13) provided withlocking channels (17) and which are displaceable with the key of the lock against theforce of a spring (14) to open the lock and for guiding the movements of which the lockcase is provided with stationary guiding members (8,9), and a locking pin (12)dependent on the movements of the bolt and which is arranged to cooperate with thelocking channels (17) of the locking discs. At least one of the locking discs (13) isequipped with gripping means (18), which, when the bolt (3) is pressed inwards to thelock case are arranged to cooperate with counter means (19) arranged in the lock casefor preventing the displacement of the said at least one locking disc (13). Further, thesaid at least one locking disc (13) is spring-loaded to turn the locking disc around a firstguiding member (8) against a second guiding members (9) so that the said secondguiding member (9) guides the said at least one locking disc (13) substantially towardsthe head of the bolt (3) to be protruded out from the lock case.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 436
163921]21][11[
וי ולסינתזה של תרכובות שיטה לזיה כימיות
METHOD FOR THEIDENTIFICATION ANDSYNTHESIS OF CHEMICALCOMPOUNDS
A preferred embodiment of the present invention comprises method forplanning the synthesis of one or more chemical compounds withspecified chemical properties, comprising the steps of: (a) representinga space of synthesis plans, wherein each synthesis plan in the space ofsynthesis plans represents one or more vitual reaction schemas appliedto one or more classes of virtual input reactants; (b) representing a spaceof virtual compounds, wherein each compound in the space of virtualcompounds is a product of one or more of said synthesis plans; (c)constructing a first mapping from the space of virtual compounds torange space representing the desirability of a compound, wherein thefirst mapping is determined by one or more compound properties beingmeasured; and (d) searching the space of synthesis plans for desirablecompounds as represented in the range space.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009437
164037]21][11[
מערכת סינכורוניזציה לכל רשתותטבעתיות דינמציות בעלי חריצים
אופטיים
SYNCHRONIZATION SYSTEMFOR ALL OPTICAL SLOTTEDRING DYNAMIC NETWORKS
A method for communicating data over a network having a plurality of nodes (0-3)thereupon is discussed. A time slot clock signal is transmitted from one node (0-3) ofthe plurality of nodes (0-3) to other nodes of the plurality of nodes. After each of theother nodes of the plurality of nodes receives the time slot clock signal, the time slotclock signal is recalculated to achieve an integer number of slots on the network. Therecalculated time slot clock signal is transmitted from the one node of the plurality ofnodes (0-3) to the other nodes of the plurality of nodes.
]57[
__________
164066]21][11[
שדה בנוי על בסיס–טרנזיסטור תוצאננוצינוריות עם יכולת להתיישר בצורה
עצמית ושיטת ייצורו
SELF-ALIGNED NANOTUBEFIELD EFFECT TRANSISTORAND METHOD OF FABRICATINGSAME
,מעבדות יבמ מחלקת קנין רוחני חיפה, אוניברסיטת חיפה הר הכרמל
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
December–ע"התש בכסלו'ז 24, 2009 438
A self-aligned carbon-nanotube field effect transistor semiconductor device comprisesa carbon-nanotube [104] deposited on a substrate [102], a source and a drain [106-107] formed at a first end and a second end of the carbon-nanotube [104], respectively,and a gate [112] formed substantially over a portion of the carbon-nanotube [104],separated from 10 the carbon-nanotube by a dielectric film [111].
]57[
__________
164199]21][11[
אחרי עם היסטרסיס–בקר מערכת עקוב ועם שיטת בקרה תואמת
A control system (102) operates within a dynamic range, and a follow-up system (104)is commanded to reduce a positional error between the follow-up system and thecontrol system when the dynamic range is exceeded. A linear follow-up command maybe initially provided once a dead band value (208) is exceeded. The follow-up system(104) is driven relative to its base mount (103) in a direction to reduce the positionalerror to within a null value range (214). The follow-up command may also implement adecay function to control the follow-up system (104). A control variable transfer functionmay also be utilized to gradually subtract the dead band value from the follow-upsystem position error command as a function of time. The decaying function mayinclude linear as well as non-linear decaying functions. In one embodiment, a figureeight-type hysteresis control function may be implemented to control the inertialposition of an inertial element. The various embodiments of the present invention maybe suitable for space-based laser designating and targeting systems, space-basedcamera-positioning systems, space-based telescopes, and radar antenna positioningsystems.
]57[
December–ע"התש בכסלו'ז 24, 2009439
__________
164271]21][11[
יהול זכויות של תוכן מקודד שיטה לנ המאוחסן ברשם סיפרתי אישי
METHOD FOR MANAGING THERIGHTS OF AN ENCRYPTEDCONTENT STORED ON APERSONAL DIGITAL RECORDER
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The aim of the invention is to provide a method for storing an event which is encryptedby control words (CW) guaranteeing access to said event at any moment, even ifcertain modifications occur in the designation of the identifiers of said events betweenthe moment of storage and the moment of visualization.This is achieved by means of amethod for storing such an event in a receiving and decrypting unit (STB) connected toa security unit (SC), said control words (CW) and the required rights being contained incontrol messages (ECM). The inventive method is characterized in that it comprises thefollowing steps: the encrypted event is stored, along with the control messages (ECM),on the storage unit; the control messages (ECM) are transmitted to the security unit(SC); verification occurs as to whether the access rights to said event are contained inthe security unit (SC), if this is the case, a receipt (Q) is provided for all or part of thecontrol message (ECM) by means of a secret key (K) which is contained in the securityunit (SC) and is proper to each security unit; said receipt (Q) is stored on the storageunit.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 440
164696]21][11[
על אזמל ניתוחים עם גשש צף לבקרה עומק החדירה
LANCING DEVICE WITH AFLOATING PROBE FORCONTROL OF PENETRATIONDEPTH
A lancing device comprising: a lancing mechanism having: a lancet carriage (614); alancet holder (676) slidably connected to the lancet carriage; a lancet (618) attached tothe lancet holder; and a lock-stop assembly; a floating probe (608); and a pressure tip(664) for engaging a target site and creating a target site bulge; wherein the floatingprobe is adapted to floatably rest upon said target site bulge as said target site bulge iscreated by the pressure tip and is configured to operatively interact with the lancetcarriage to control a penetration depth of the lancet into the target site bulge, andfurther configured to engage the lock-stop assembly to prevent movement of thefloating probe during penetration of the lancet into the target site bulge.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009441
164709]21][11[
מלא חיתוך ורקון, התקן אוטומטי להרמת של שקים
APPARATUS FORAUTMATICALY LIFTINGSLITTING, SITTING AND FULLYEPTYING BAGS
An apparatus for emptying bags comprising a gripper having a plurality of pointedhooks for gripping at least one of said bags; a bag slitting and empting device, whereinsaid bag slitting and emptying device comprises at least two parallel blades for slittingsaid at least one bag, and at least two rods aligned in a row respectively with saidblades.
הרשות למחקר,בגוריון בנג-אוניברסיטת בן שבע-באר, ופיתוח
BEN GURION UNIVERSITY OFTHE NEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
]71[
RAZ רז ילינק JELINEK]72[,פ"פיירניק רוטמן עו
, 10012.ד.ת,91הרצל'רח, בית עציון באר שבע
PYERNIK RUTMAN,BEIT ETSION,
91 HERZL ST.,P.O.B. 10012,BEER SHEVA
]74[
A construct comprising functional membrane fragments and one or more perturbation-detecting polymers associated therewith, wherein said construct responds toperturbations of said membrane fragments by means of a detectable change in one ormore physical or chemical properties associated with said construct.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 442
164944]21][11[
ARTIFICIAL שריר מלאכותי MUSCLE]54[
04.05.2003]22[US]33[03.05.2002]32[10/137,387]31[
Int. Cl.(2008.04) F01B 19/00]51[ZALMAN זיםכור, זלמן פלס PELES]71[
WO/2003/093647]87[עו' דר ,פ"אייל ברסלר
גן-רמת,11תובלDR. EYAL BRESSLER,11 TUVAL ST.,
RAMAT GAN 52522
]74[
A hydraulic actuated artificial muscle is use with orthetic devices, prosthetic devices oras an actuator for other applications in medical or robotic devices. Working fluid ispumped between two expandable fluid-containing cells (2,10), which arecomplimentary active elements of the artificial muscle. This eliminates the need for astorage reservoir, thereby providing a self-contained, and force efficient device. Each ofthe preferred embodiments described has one or more expandable fluid-containingcells (2,10) that are defined by at least one flexible wall (4). The flexible walls (4,12) areconfigured so as to have elastic properties that are limited to predefined directions ofexpansion and contraction.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009443
164961]21][11[
תערובות של אסטרים טטרהלופתאלאטוחומרים מונעי בעירה המכילים זרחן
ךשימוש בהרכבי פוליאורתאן
BLENDS OFTETRAHALOPHTHALATEESTERS AND PHOSPHORUS-CONTAINING FLAMERETARDANTS FORPOLYURETHANECOMPOSITIONS
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Flame retardant flexible polyurethane foam compositions, methods of flame retardingflexible polyurethane foam compositions, articles made therefrom and flame retardantsthat comprise blends of tetrahalophthalate esters and phosphorus containing flameretardant having at least about 5 wt.% phosphorus additives. The combined weight ofthe tetrahalophthalate ester and the phosphorus-containing flame retardant comprisesabout 5 to about 20% by weight of the flexible polyurethane foam compositions orreaction mixtures. The ratio of the tetrahalophthalate ester to the phosphorus-containing flame retardant is from about 80:20 to about 20:80 percent by weight andpreferably from about 60:40 to about 40:60 percent by weight.
]57[
__________
164972]21][11[
EVENT תזמון אירועים למערכות גילוי SYNCHRONIZATION FORDETECTOR SYSTEMS
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An event synchronizing apparatus E for an image intensification camera system C forgathering image data includes an image intensifier (348) for amplifying received light(312). A relay optic assembly (316) is coupled between the image intensifier (348) and
]57[
December–ע"התש בכסלו'ז 24, 2009 444
a digital image sensor (350), such as a CMOS or CCD device. Digital logic (352) isused to process or output an image or related data (334). An event detector (340)digitizes an input signal (342) from an illumination source (338) and generates anelectrical output synchronization signal (346) in response to the input optical signal(342). The image intensifier camera C derives imaging and control information for thesynchronization signal.
__________
165027]21][11[
צבים על בסיס שמן תכשירי רוקחות מיושמן קיק מטוהר שעבר
פוליאוקסיאתילציה ושיטה לייצורם
STABILIZED PHARMACEUTICALCOMPOSITIONS BASED ONPURIFIEDPOLYOXYETHYLATED CASTOROIL AND METHODS FORMANUFACTURING THE SAME
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The invention relates to a stabilised pharmaceutical composition comprising apharmaceutically active substance poorly soluble in water, a solubilising agentwith a low content of both basic and acidic compounds and a polar organicsolvent, in particular a stabilised injection concentrate, methods for preparingsuch stabilised pharmaceutical compositions and the use of a solubilisingagent with a low content of both basic and acidic compounds to stabilisepharmaceutical compositions for pharmaceutically active substances.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009445
165162]21][11[
של התקן פשוט להפעלה מגנטית תריסים בתוך תא סגור בזכוכית
SIMPLIFIED DEVICE FORMAGNETICALLY OPERATINGBLINDS WITHIN A GLASS-ENCLOSED CHAMBER
A system for operating a blind (18) in a glass-enclosed chamber (10), comprising twopanes of glass, (17, 18) and a frame (20) having an upper section (25) a lower section(86) and two lateral sections (27) joined together by four corner pieces (30) the systemcomprising an upper fixed box (40) which is fixed to the upper section of the frame andholds one end of the blind; a movable box (60) which holds another end of the blindand is elongated; a pulling device (85, 86) extending through a pane and operating saidmovable box; and a guiding device for translating said movable box parallel to adirection of elongation of said movable box when the blind is being opened or closed,wherein said device for pulling said movable box includes a first means (150) and asecond means for generating reciprocal magnetic attraction, said first means beingfixed to said movable box, said second means having a free knob (170) so that,through one pane of the glass-enclosed chamber, said knob cooperates with said firstmeans fixed to said movable box to open or close the blind, wherein said first meansfixed to said movable box include a parallelepiped box inserted in a center of saidmovable box, a small box housing, a cage (155) permanent magnets (152, 153) placedside-by-side between two sets of free rollers (160) longitudinal pins (161) passingthrough an external surface of said permanent magnets and from a fron of said box toassist said first means to slide over a glass pane.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 446
165439]21][11[
VOICE התקן ומערכת להעברת קול TRANSMISSION DEVICEAND VOICE TRANSMISSIONSYSTEM
]54[
04.04.2003]22[Int. Cl.(2009.01) H04M 03//00]51[MITSUBISHI DENKI KABUSHIKIKAISHA, JAPAN
]71[
WO/2004/091183]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A speech transmitter having a tandem pass through function in an STM, ATM and IPnetwork. A noise canceller (21) is provided at the succeeding stage of an echocanceller (12) in an encoding section. If not a tandem connection state, noise isremoved to carry out high-efficiency encoding; if the relay is in a tandem connectionstate, switching is carried out so that the operation of the noise canceller (21) isstopped so as to prevent degradation of speech quality due to excessive decoding andencoding. As a result, even if a portable telephone has no noise canceling function,high-quality speech transmission is realized in both normal and tandem pass throughmodes. By thus removing the noise component, the soundless portions in speech dataincrease, and the portions to be encoded decrease, thereby reducing the amount ofdata transmitted through the circuit.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009447
165520]21][11[
אן –דהידרו–2,3–אוקסו–3((–נגזרות) אצטיל,)איל–1–איזואינדול–הידרוגן
תכשיריםNHE–1גואנידין כמעכבותתהליך להכנתן, רפואיים המכילים אותן
ושימוש שלהן
N-((3-OXO-2, 3-DIHYDRO-1H-ISOINDOL-1-YL), ACETYL)GUANIDINE DERIVATIVES ASNHE - 1 - INHIBITORS,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM, PROCESS FOR THEIRPREPARATION AND USESTHEREOF
Isoindolone derivatives, preparation process and intermediates of this process, theiruse as medicaments, and pharmaceutical compositions comprising them. The presentinvention relates to the novel isoindolone derivatives of the Formula (I), in which R1 toR6 have the meanings stated in the claims. The inventive compounds are suitable asantiarrhythmic medicaments with a cardioprotective component for infarctionprophylaxis and infarction treatment and for the treatment of angina pectoris. They alsoinhibit in a preventive manner the pathophysiological processes associated with thedevelopment of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias and of heart failure.
The present invention provides a method of preparing a 5H-dibenz[b,f]azepine-5-carboxamide of formula (1) wherein R1, R2, R3, and R4 are independently selectedfrom the group consisting of hydrogen, halogen, nitro, cyano, carboxyl, A, -CO(A), -OCO(A), -O(A), -N(A)2, -CON(A)2, and -COO(A), wherein A is selected from the groupconsisting of C-1-C10 alkyl, C3-C10 cycloalkyl, C-2-C10 alkenyl, C-5-C10 cycloalkenyl,C-2-C10 alkynyl, and C-6-C20 aryl, wherein the two A groups of -N(A)2 and -CON(A)2can be the same or different, and wherein R2 and R3 can together form a bond;comprising reacting a 5H-dibenz[b,f]azepine of formula (2) with a) a cyanate saltselected from the group consisting of alkali metal cyanate salts and alkaline-earth metalcyanate salts, and b) a salt of an amino compound having no N-H bonds, wherein thesalt has a Ka (25° C) of at least about 10 x 10-11.
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
198455,The applications for divisionfrom this application havenot yet been published
2-UREIDO-6-HETEROARYL-3H-BENZIMIDAZOLE-4-CARBOXYLIC ACIDDERIVATIVES,PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME AND METHODS FORTHE PREPARATION THEREOF
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The present invention relates to compounds of formula I, wherein X, Q, W, R1, R2 andR3 are as defined in the claims, which inhibit bacterial gyrase and/or Topo IV andpharmaceutically acceptable compositions comprising said compounds. Thesecompounds, and composition thereof, are useful in treating bacterial infection.Accordingly, the present invention also relates to methods for treating bacterialinfections in, mammals. The present invention also relates to a method for preparingthese compounds.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 450
165782]21][11[
ת להגדלת איזור קריאה שיטת כח פוליסי של קורא המזהה תדר רדיו
PULSED POWER METHOD FORINCREASED READ RANGE FOR ARADIO FREQUENCYIDENTIFICATION READER
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method to power a radio frequency identification (RFID) reader to increase multitagreading capability and increase the reading range of a passive tag without maximizingthe continuous transmitted power level is provided. The RFID reader transmits a pulsedinterrogation signal until an RFID tag response is received, and then switches to acontinuous and pulsed power scheme. The continuous power emitted maintains thepower supplied to the RFID tags so the tags will not reset due to loss of power. Thepulsed signal permits reading the tags at longer ranges, especially when there is aplurality of tags in the area.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009451
165925]21][11[
, תהליכים להכנתם, פניל בנזאמידים תכשירים המכילים אותם ושימושיהם
PHENYL BENZAMIDES,PROCESSES FOR THEIRPREPARATION, COMPOSITIONSCOMPRISING THEM AND USESTHEREOF
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to novel phenyl benzamides of formula (I), in which R1 representstrifluoromethyl, chlorine, bromium or iodine and R2 represents hydrogen, methyl orethyl. The invention also relates to a method for producing said substances and to theiruse for controlling undesired micro-organisms, in addition to novel intermediateproducts and the production thereof.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 452
165965]21][11[
חומר מרכיב לאלקטרודה שלילית עבור ום משני ושיטה לייצורומצבר ליתי
LITHIUM SECONDARYBATTERY NEGATIVEELECTRODE COMPONENTMATERIAL AND METHOD OFITS MANUFACTURE
]54[
01.04.2004]22[Int. Cl.(2009.01) H01M 04//02, 04//40, 04//48]51[SUMITOMO ELECTRICINDUSTRIES, LTD., JAPAN
It is intended to provide a secondary lithium battery in which short circuitcaused by the formation of dendrite from the metallic lithium negativeelectrode is regulated and which has a high energy density, a high stabilitywith excellent charge-discharge cycle properties and a high safety. A negativeelectrode member for a secondary lithium battery comprising a metallic lithiumfilm and an inorganic solid electrolyte film which are layered on a basematerial, characterized in that the inorganic solid electrolyte contains lithium,phosphorus, sulfur and oxygen, and is represented by the followingcompositional formula: aLi·bP·cS·dO (Li: lithium, P: phosphorus, S: sulfur, O:oxygen) and the contents of the elements respectively fall within the followingranges: 0.20≤a≤0.45 0.10≤b≤0.20 0.35≤c≤0.60 0.03≤d≤0.13 (a+b+c+d=1).
]57[
__________
166014]21][11[
CULTURE מצע לגידול ומערכת של כור ביולוגי DISH ANDBIOREACTOR SYSTEM
]54[
26.06.2003]22[US]33[02.07.2002]32[189300]31[
Int. Cl.(2008.04) C12M 1/12, 1/34, 3/06]51[ORGANOGENESIS INC., U.S.A.]71[WO/2004/005453]87[A bioreactor has a base for defining a well, a dish with a membrane suspended in thebase, and a lid with gas permeable membranes and self-sealing ports.
]57[
December–ע"התש בכסלו'ז 24, 2009453
__________
166354]21][11[
ASSEMBLY מיכלל ושיטה לכיול בסיס תצוגה עלית AND METHOD FORHEAD-UP DISPLAY (HUD) TRAYHARMONIZATION
]54[
18.01.2005]22[Int. Cl.(2009.01) G02B 27//01]51[
אופטיקה אלאופ-אלביט מערכות אלקטרו רחובות,מ"בע
ELBIT SYSTEMS ELECTRO-OPTICAL ELOP LTD.
]71[
MICHAEL יעקב יושע, מיכאל ברודסקי BRODSKY, JACOBYOSHA
]72[
,ברגמן וגולר, וולף ירושלים, 1352.ד.ת,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A head-up display (HUD) tray harmonization assembly, comprising: a mount alignmentjig (MAJ) (20) having a first end and a second end, said first end being connectable toan adjustable tray (18) affixed in an aircraft cabin (16) having a pilot's seat, located in afront end (6) of an aircraft, at a spaced-apart relationship to a front window (8) having alower edge (12) located adjacent the front end of said aircraft; a telescope (22)connected to the MAJ at, or adjacent, its second end oriented for viewing through saidwindow; an optical collimator holder (24) having a first portion (26) connectable to anoutside wall of said front end of the aircraft and a second portion (28) extendingtowards and terminating at least at least lower edge of said window, and an opticalcollimator (32) coupled to the second portion of said holder to form a line of sight withsaid telescope.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 454
166439]21][11[
אנדיאנדרית כמעכביHנגזרות חומצהC–MAFהכנתן, לשימוש נגד אסתמה
ותכשירים רוקחיים המכילים אותן
ENDIANDRIC ACID HDERIVATIVES AS C-MAFINHIBITORS FOR USINGAGAINST ASTHMA, THEIRPREPARATION ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM
whereR1 and R2 are, independently of one another,1, 0 H or2.0 a –O-C1-C6-alkyl, -O-C2-C6-alkenyl, -O-C2-C6-alkynyl or –O-C6-C10-aryl group, inwhich alkyl, alkenyl and alkynyl are straight-chain or branched, and in which thealkyl, alkenyl and alkynyl groups are optionally mono- or disubstituted by:2.1 –OH,2.2 =O,2.3 –O-C1-C6-alkyl in which alkyl is straight-chain or branched,2.4 –O-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.5 C6-C10-aryl,2.6 –NH-C1-C6-alkyl in which alkyl is straight-chain or branched,2.7 –NH-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.8 –NH2 or2.9 halogen,and in which the aryl group is optionally mono-or disubstituted by substituent 2.1 or
]57[
December–ע"התש בכסלו'ז 24, 2009455
2.3 to 2.9, in which the substituents 2.3, 2.4, 2.6 and 2.7 may be further substituted by–CN, -amide or –oxime functions, and 2.5 may be further substituted by –CN or amidefunctions, or R1 and R2 together form a group –O-[(C1-C6)-alkylene]-O-, R3 is 1.0 H or2.0 a C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl or C2-C10-aryl group, in which alkyl,alkenyl and alkynyl are straight-chain or branched, and in which the alkyl, alkenyl andalkynyl groups are optionally mono- or disubstituted by:2.1 –OH,2.2 =O,2.3 –O-C1-C6-alkyl in which alkyl is straight-chain or branched,2.4 –O-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.5 –C6-C10 aryl,2.6 –NH-C1-C6-alkyl in which alkyl is straight-chain or branched,2.7 –NH-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.8 –NH2 or2.9 halogen,and in which the aryl group is optionally mono-or disubstituted by substituent 2.1 or2.3 to 2.9, in which the substituents 2.3, 2.4, 2.6 and 2.7 may be further substituted by–CN, -amide or –oxime functions, and 2.5 may be further substituted by –CN or amidefunctions, and R4 is CO2R3, CO2NHR3, CHO, CH2OR3, CH2OSi(R3)3, CH2CN, whereR3 is as defined above, or a stereoisomeric form of the compound of the formula (l) ora physiologically tolerated salt of the formula (l) or a salt of a stereoisomeric form ofthe compound of the formula (l).
An Echinacea angustifolia extract and a process for the preparation thereofare herein described. The extract is characterized by an alkylamides contentlower than 0.1 %, an echinacoside content ranging from 1 to 10% andcontaining from 1 to 15% of a polysaccharide characteristic of Echinaceaangustifolia. The extract can be used for the treatment of pathologicalconditions in which it is desirable to strengthen the immune defenses.
__________
]57[
December–ע"התש בכסלו'ז 24, 2009 456
166746]21][11[
מערכת ושיטה לביטול הפרעה בחישוב חוטית–מיקום לשימוש במערכת מיקום אל
SYSTEM AND METHOD FORINTERFERENCECANCELLATION IN ALOCATION CALCULATIONFOR USE IN A WIRELESSLOCATION SYSTEM
In a Wireless Location System, reception and demodulation of signals is oftenperformed at many sites. A collision may occur, e.g., in a TDMA, AMPS, GSM, GPRS,EDGE, CDMA, CDMA 2000, or WCDMA system, when a signal of interest (atransmission from a mobile transmitter to be located) and an interfering signal arereceived at the same time and at the same site. In the event such a collision occurs,the interfering signal may have been demodulated by a receiver system, or SCS, atanother site, and the demodulated data be known by the TLP. This interferer can bereconstructed and subtracted from the raw data representing the combined signal ofinterest and interferer at the site where the collision occurred. This technique canprovide significant (e.g., approximately 10 - 15 dB) interference rejection, with littledegradation to the signal of interest.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009457
166769]21][11[
CATALYST בתהליך אוסוולדN2Oזרזים לפירוק FOR THEDECOMPOSITION OF N2O IN THEOSTWALD PROCESS
Use of a composition comprising:(A) a carrier material, wherein the carrier material is alpha-Al2O3 or ZrO2 or CeO2 ormixtures thereof,(B) a coating made of rhodium or rhodium oxide or a Pd-Rh alloy for the preparation ofa catalyst for the decomposition of N2O under the conditions of the Ostwald process at750oC to 1000oC and 0.9 to 15 bar.
]57[
__________
166897]21][11[
SINGLE יהלום מגביש יחיד CRYSTAL DIAMOND]54[
15.02.2005]22[Int. Cl.(2009.01) C30B 25//02, 28//04, 33//00]51[ELEMENT SIX LIMITED, UNITEDKINGDOM
]71[
WO/2004/027123]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method of producing a large area plate of single crystal diamond from CVD diamondgrown on a substrate substantially free of surface defects by chemical vapourdeposition (CVD). The homoepitaxial CVD grown diamond and the substrate aresevered transverse to the surface of the substrate on which diamond growth took placeto produce the large area plate of single crystal CVD diamond
]57[
December–ע"התש בכסלו'ז 24, 2009 458
__________
167005]21][11[
CLOSED סגור-מעגל-כינון ארטילריה על יד משוב LOOP-FEEDBACKARTILLERY FIRE CONTROL
]54[
21.02.2005]22[Int. Cl.(2009.01) F41G 05//06]51[
בעל מערכות לחימה מתק"רפא ,מ"דמות חיפה
RAFAEL ADVANCED DEFENSESYSTEMS LTD.
]71[
MENACHEM מנחם דביר DVIR]72[בע"ד ,מ"ר מרק פרידמן
ז,54.ק, מגדל משה אביב ,7בוטינסקי'רחגן-רמת
DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54TH
FLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520
]74[
A method of directing fire of a gun at a target, comprising:(a) aiming the gun at the target in accordance with geographic coordinates of thetarget;(b) firing a shell at the target from the gun; and(c) if the shell misses the target:(i) acquiring an image of a region including an indication of an impact of the shell;(ii) inferring geographic coordinates of said indication from said image; and(iii)correcting an aim of the gun in accordance with said geographic coordinates of thetarget and said inferred geographic coordinates of said indication.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009459
167081]21][11[
קו –מערכת ושיטה לביצוע סיומת שלתמסורת באמצעות ביטול אות וישומים
שלהן
SYSTEM AND METHOD FORTRANSMISSION-LINETERMINATION BY SIGNALCANCELLATION ANDAPPLICATIONS THEREOF
A method for signal termination with a device having terminating and transmittingstates, said method comprising: connecting the device to a connection point of a two-conductor transmission line; providing a termination circuit constructed for terminating asignal propagated over the two-conductor transmission line; providing a first driveroperative to conduct a signal over the two-conductor transmission line, the first driverhaving an input port selectively couplable to a signal source doe coupling the signalsource to the transmission line, and an output port; and placing the device in a selectedone of: a terminating state in which said termination circuit is coupled to the connectionpoint; and a transmitting state in which the first driver output port is coupled to theconnection point.
]57[
בקשות חלוקה מבקשה זו.שטר� פורסמו
199120,The applications fordivision from thisapplication have not yetbeen published
An electrochromic or electrodeposition display comprising a plurality of cells, each ofsaid cells comprises surrounding partition walls, an electrochromic or electrolytic fluidfilled therein, and a polymeric sealing layer which encloses said fluid within each celland sealingly adheres to the surface of the partition walls. Microcups are formed byembossing or imagewise exposure.
]57[
__________
167624]21][11[
CELL תכשירים ושיטות להפרדת תאים SEPARATIONCOMPOSITIONS AND METHODS
The invention provides compositions and methods for cell separation. Thesereagents and techniques specially agglutinate cells via surface recognition andcan be used to recover even rare cell types in high yield.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009461
167673]21][11[
HIGH מראה דיוק גבוה ושיטה לעשותה PRECISION MIRROR ANDA METHOD OF MAKING IT
A mirror includes: a substrate having a surface; and a thin-film finishlayer provided over the surface of the substrate and having aon a sidethereof opposite from the substrate a surface with a polished finish.According to a different aspect of the invention, a method of making amirror includes: providing a substrate having a surface thereon; forminga thin-film finish layer over the surface of the substrate using thin-filmtechniques, the finish layer having a surface on a side thereof oppositefrom the substrate; and polishing the surface of the finish layer.
Int. Cl.(2008.04) H01L 213/065]51[LAM RESEARCH CORPORATION,U.S.A.
]71[
LUMIN LI, ZHISONG HUANG,REZA SADJADI
]72[
WO/2004/034445]87[בי'ג בע, יי אמ ,מ"פקטור אנד קו
, 45087.ד.ת, הר חוצבים, רחוב המרפא ירושלים
JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,JERUSALEM 91450
]74[
A method for etching a feature in a layer through an etching mask is provided. Aprotective layer is formed on exposed surfaces of the etching mask and verticalsidewalls of the feature with a passivation gas mixture. The feature is etched through
]57[
December–ע"התש בכסלו'ז 24, 2009 462
the etching mask with reactive etching mixtures containing at least one etchingchemical and at least one passivation chemical.
בקשות חלוקה מבקשה זו.שטר� פורסמו
190716,The applications for divisionfrom this application havenot yet been published
__________
168014]21][11[
שיטה ליצור גליל חומר ארוג ומכונת גלילה המיישמת את השיטה
METHOD FOR PRODUCING LOGSOF WEB MATERIAL ANDREWINDING MACHINEIMPLEMENTING SAID METHOD
method for producing logs (Ll, L2) of web material (N) wound around tubular coreswherein the tubular core (Al-A4) is equipped with glue to secure the initial end of theweb material and allow winding. Part of the glue applied to the tubular core istransferred to the web material (N) before it is severed upon termination of winding thelog, to seal the final free end of the formed log.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009463
168041]21][11[
METHOD שיטה לטיפול בבוצת שפכים גולמית OF TREATING RAWSEWAGE SLURRY
BAR-EDAN קרית מלאכי,מ"בר עידן יצור ופיתוח בע MANUFACTURINGAND DEVELOPMENT LTD.
]71[
AHIAM אחיעם בן יעקב BEN YAACOV]72[,לוצאטו את לוצאטו
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A method of treating a raw preconcentrated sewage slurry comprising(i) providing a preconcentrated sewage slurry having from about 10 to about 40% dryweight (%dw);(ii) irradiating said slurry with an electron dose of from 2.5 kGy to 20 kGy;(iii) mixing the irradiated slurry from the previous step with a base that is added in anamount of from about 20 to about 200 kg per 1 ton of dry weight of said irradiatedslurry, thereby obtaining an essentially homogeneous mixture; and(iv) allowing said base and said irradiated sludge to react in said mixture at a pH of atleast 11.5;thereby obtaining essentially disinfected and stabilized sludge.
Int. Cl.(2008.04) C12N 1/14, 15/57, 9/60]51[DIVISION FROM 111482]62[NOVARTIS AG, SWITZERLAND]71[
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A isolated DNA molecule comprising a DNA sequence encoding an Aspergillus nigeraspartic protease having the amino acid sequence shown in SEQ ID NO.2.
]57[
December–ע"התש בכסלו'ז 24, 2009 464
168608]21][11[
ראש מדפסת תרמי להזרקת דיו בעליעילות גבוהה ושיטה להזרקת טיפה של
נוזל מוזרק מראש המדפסת
HIGH EFFICIENCY THERMALINK JET PRINTHEAD AND AMETHOD FOR EJECTING ADROP OF AN EJECTABLELIQUID FROM THE PRINTHEAD
]54[
17.11.2003]22[US]33[23.11.2002]32[10/302669]31[
Int. Cl.(2008.04) B41J 2/05]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA
]71[
WO/2004/048108]87[,לוצאטו את לוצאטו
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
There is disclosed an ink jet printhead which comprises a plurality of nozzles (3) andone or more heater elements (10) corresponding to each nozzle (3). Each heaterelement is configured to heat a bubble forming liquid in the printhead to a temperatureabove its boiling point to form a gas bubble (12) therein. The generation of the bubblecauses the ejection of a drop of an ejectable liquid (such as ink) through the respectivecorresponding nozzle, to effect printing. Each heater element is configured such that anactuation energy of less than 500 nanojoules (nJ) is required to be applied to thatelement to heat it sufficiently to form such a bubble (12) in the bubble forming liquid(which liquid can also be the ink). This configuration thus provides for a high efficiencyprinthead.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009465
168700]21][11[
מערכת, ראש מדפסת להזרקת דיומדפסת המכילה אותו ושיטה להזרקת
טפה של בועה בצורת נוזל ממנו
INK JET PRINTHEAD, PRINTERSYSTEM COMPRISING IT ANDMETHOD OF EJECTING A DROPOF A BUBBLE FORMING FLUIDFROM IT
]54[
17.11.2003]22[US]33[23.11.2002]32[10/302297]31[
Int. Cl.(2008.04) B41J 2/05]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA
]71[
WO/2004/048104]87[,לוצאטו את לוצאטו
באר שבע, 5352.ד.ת, עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
There is disclosed an ink jet printhead which comprises a plurality of nozzles (3) andone or more heater elements (10) corresponding to each nozzle (3). Each heaterelement is configured to heat a bubble forming liquid in the printhead to a temperatureabove its boiling point to form a gas bubble (12) therein. The generation of the bubblecauses the ejection of a drop of an ejectable liquid (such as ink) through the respectivecorresponding nozzle, to effect printing. Each heater element is substantially coveredby a conformal protective coating (77) which has been applied to all sides of the heaterelement (10) simultaneously so that the coating is seamless.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 466
168770]21][11[
שיטות לבקרת מזיקים תוך שימוש בחלקיקים מתכתיים
METHODS FOR CONTROLLINGPESTS USING METALLICPARTICLES
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
There is disclosed a method of controlling pests which comprises exposing asurface of the pest to a particulate composition containing particles of aninitially unmagnetized material, which is capable of becoming magneticallypolarized when subjected to an electric or magnetic field, the said particlesbeing associated with at least one pesticide or behaviour modifying chemical.
]57[
__________
168793]21][11[
STREPTOCOCCUS מולקולה דביקה של יובריס סטרפטוקוקוס UBERISADHESION MOLECULE
]54[
22.10.2003]22[US]33[26.11.2002]32[60/429499]31[
Int. Cl.(2009.01) A61K 39//09, C07K 14//315]51[UNIVERSITY OF TENNESSEERESEARCH FOUNDATION, U.S.A.
]71[
WO/2004/048515]87[,ר יצחק הס ושותפיו"ד
תל אביב, 6451.ד.ת, 279רחוב הירקוןDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
A polypeptide, designated as “Streptococcus uberis Adhesion Molecule” (SUAM), andfragments of SUAM, prevent internalization and adherence of Streptococcus uberis andother streptococcal pathogens to cells. The SUAN polypeptide and fragments may beused diagnostically and therapeutically. Nucleic acid sequences encoding the SUAMpolypeptide and fragments are included in the invention.
]57[
December–ע"התש בכסלו'ז 24, 2009467
__________
168977]21][11[
CROSS שיתוף חוצה מחיצות של מידע על מצב PARTITION SHARING OFSTATE INFORMATION
,מעבדות יבמ מחלקת קנין רוחני חיפה, אוניברסיטת חיפה הר הכרמל
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
A method and system are disclosed for managing saved process states in a memory ofa data processing system that has multiple partitions executing independent operatingsystems. A hypervisor manager affords access to any processor in the data processingsystem for the purpose of storing process states for that processor the memory,independent of the operating system running on the processor.
A flow control valve (22) such as for a catheter (10) allows discharge of urine from abladder (12) by manual actuation. The valve (22) may be a double−duckbill valve (22)with a single slit (62) at one apex (60a) thereof. An elastomeric band (66) is positionedin a groove (68) of the valve member (22). An isolation member such as a stem (72)spaces the valve (22) from the walls (34, 36) of the valve housing (32). Crush limitingstructure, such as a tube (76) or blade (82), is provided within valve member (22), orstop elements (86 or 92) are positioned external to valve member (22).
]57[
__________
169463]21][11[
פזור רגיש אור עם צמיגות הניתנתלויסות עבור הפקדה של מתכת על גבי
מצע מבדד והשימוש בו
PHOTOSENSITIVE DISPERSIONWITH ADJUSTABLE VISCOSITYFOR METAL DEPOSITION ON ANINSULATING SUBSTRATE ANDUSE OF SAME
,פרל כהן צדק לצר, 12704.ד.ת,5שנקר'רח,1ים-מרכז גב הרצליה
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
December–ע"התש בכסלו'ז 24, 2009469
The invention relates to a photosensitive dispersion with adjustable viscosityfor metal deposition on an insulating substrate, which combines the following:a pigment providing oxidation-reduction properties under light irradiation, ametallic salt, a complex-forming agent for the metallic salt, a liquid film-formingpolymer formulation, a basic compound, an organic solvent and water. Theinvention also relates to the use of said dispersion.
]57[
__________
169515]21][11[
שימוש בפירטרויד או פירטרין ביחד עם אגוניסט ניקוטיני לדיחוי ארטרופדים
USE OF A PYRETHROID ORPYRETHRIN IN COMBINATIONWITH A NICOTINIC AGONISTFOR REPELLING ARTHROPODS
]54[
05.01.2004]22[DE]33[17.01.2003]32[10301906.5]31[
Int. Cl.(2008.04) A01N 37/34, 53/00]51[BAYER ANIMAL HEALTH GMBH,GERMANY
]71[
WO/2004/064522]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to the use of an arthropod-repelling constituent of thepyrethroid/pyrethrin class combined with an agonist of the nicotine-producingacetylcholine receptors of arthropods, for efficiently repelling arthropods,preferably on animals, for a long time.
]57[
__________
169612]21][11[
FREIGHT מערכת השגחת מיכל מטען CONTAINERMONITORING SYSTEM
A system for monitoring a freight container comprising: means for monitoring the freightcontainer including means for generating a resonant spectrum representative of aninitial condition of internal surfaces and contents of the freight container; and means forsaving said resonant spectrum representative of an initial condition of internal surfaces
]57[
December–ע"התש בכסלו'ז 24, 2009 470
and contents of the freight container; and means for saving said resonant spectrum forfuture comparison purposes.
A method for improving flux in a membrane bioreactor of which the influent has aconcentration of salts or inorganic oxides sufficient to cause scaling or inorganic foulingconditions comprising adding an effective amount of one or more cationic, amphoteric,or zwitterionic polymers, or a combination thereof to said membrane bioreactor,wherein a membrane bioreactor system comprises said membrane bioreactor, whereinsaid membrane bioreactor comprises an aerobic reactor wherein said membranebioreactor system further comprises a reactor selected from the group consisting ofanaerobic reactors and anoxic reactors and wherein said effective amount of cationicpolymer is about 10 to about 2,000 ppm as active based on the total membranebioreactor volume.
]57[
__________
170046]21][11[
SINGLE-BLOW הלם יחיד-מכשיר מחולל גל SHOCKWAVEGENERATION DEVICE
]54[
30.01.2004]22[FR]33[14.02.2003]32[03/01793]31[
Int. Cl.(2008.04) A61B 17/22]51[DULIVER INTERNATIONAL LTD.,BRITISH VIRGIN ISLANDS
]71[
WO/2004/078048]87[,פרל כהן צדק לצר
, 12704.ד.ת,5שנקר'רח,1ים-מרכז גב ליההרצ
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to a single-blow mechanical shockwave generation device usedin urological surgery for disintegration of urinary duct stones (1), comprising strikingmeans (2) which strike shock wave generation means (3) at high speed. The shock
]57[
December–ע"התש בכסלו'ז 24, 2009471
waves are transmitted by shock wave transfer means (4) to an object for destructionwith which said shock wave transfer means are in direct or indirect contact. The strikingmeans (2) are displaced by means of the expansion of a high-pressure gas introducedprior to each shock wave generation into accumulation means (5) supplied with highpressure gas from independent gas stores (7) and with supply and sealing meanswhereby the stored gas is released by the manual manipulation of control means (8)which connect the accumulation means (5) to the striking means (2).
A valve unit (26) comprising: a valve body (48) presenting an inlet (58) adapted forcoupling with a source of pressurized gas (24) and an outlet (60) adapted for couplingwith a gas receiver (30); a shiftable valve member (56) located within said bodybetween said inlet and said outlet and shiftable between a closed, gas flow-blockingposition and an open position permitting flow of gas from said source to said receiver; aspring (186) operably coupled with said valve member and biasing the member towardthe open position thereof; first and second operating surfaces (S1, S2) forming a part ofsaid member, said first surface exposed to said pressurized gas from said source andsaid member being normally maintained in said closed position against the bias of saidspring, there being a modulation chamber (182) formed between at least a part of saidsecond operating surface and adjacent portions of said valve body, and a passageway(168) communicating said source with said modulation chamber; and an actuator (50)operable upon actuation thereof to cause flow of pressurized gas from said source intoand out of said modulation chamber, said passageway presenting a gas flow restriction(169) operable to limit the flow rate of gas between said source and said modulationchamber, said operating surface, modulation chamber, and spring being correlated sothat when said member is shifted to the open position thereof, gas from said source isdelivered to said receiver at a pressure of between 1MPa to 10MPa (10 to 100 bar)over a substantial part of the time gas flows from the source to the receiver by flow ofsaid gas into and out of said modulation chamber.
]57[
December–ע"התש בכסלו'ז 24, 2009 472
__________
170324]21][11[
מזרק ללא מחט המכיל כלי קיבול יעיל למזרק
NEEDLELESS SYRINGECOMPRISING AN OPTIMIZEDINJECTOR-RECEPTACLE
The invention relates to the realm of needleless syringes used for injecting liquid activesubstances. Said syringe comprises a reservoir that is enclosed by means ofdisplaceable plugs which trap the liquid. The reservoir is initially isolated from aninjector-receptacle (37) which is provided with at least two peripheral injection conduits(38) that are arranged outside the receptacle (37). Said receptacle (37) encompasses apocket bore (31) which accommodates the plug located downstream such that theoptimized inlets (39) of the conduits are unobstructed. The face of the receptacle (37),which is located upstream, comprises a multilobed sealing joint (34) which is disposedparallel to and as close as possible to the edges of the bore (31) and the inlets (39).The aim of the invention is to create an injector-receptacle (37) that is optimizedregarding discharging and the resistance thereof to the injection pressure.
]57[
December–ע"התש בכסלו'ז 24, 2009473
__________
170728]21][11[
OPTICALLY תרכובת לזירוז נחושת אופטית פעילה ACTIVE COPPERCATALYST COMPOSITION
]54[
25.03.2004]22[JP]33[31.03.2003]32[2003-093750]31[
Int. Cl.(2008.04) B01J 31/18, 31/28]51[SUMITOMO CHEMICALCOMPANY, LIMITED., JAPAN
]71[
WO/2004/087317]87[,ר יצחק הס ושותפיו"ד
תל אביב, 6451.ד.ת, 279רחוב הירקוןDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
An optically active copper catalyst composition comprising (a) an optically activesalicylideneamino alcohol represented by the general formula (1): (1) [wherein R1 andR2 are each independently substituted or unsubstituted lower alkyl, substituted orunsubstituted aralkyl, or substituted or unsubstituted aryl; X1 and X2 are eachindependently hydrogen, lower alkoxy, nitro, lower alkoxy- carbonyl, cyano, orhalogeno; and * represents an asymmetric center, with the proviso that both of X1 andX2 are not hydrogen], (b) a mono- or di-valent copper compound, and (c-1) a lithiumcompound or (c-2) a compound selected from among aluminum compounds havingLewis acidity, titanium compounds having Lewis acidity, boron compounds havingLewis acidity, zirconium compounds having Lewis acidity, and hafnium compoundshaving Lewis acidity; and a process for the production of optically activecyclopropanecarboxylic acids with the composition.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 474
170901]21][11[
DEAD טכנולוגית דיסק המשמידה את תוכנו ON DEMAND DISKTECHNOLOGY
]54[
18.03.2004]22[US]33[18.03.2003]32[60/455501]31[
Int. Cl.(2008.04) G06F 1/00, G11B 23/28]51[ENSCONCE DATA TECHNOLOGY,U.S.A.
]71[
WO/2004/084470]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A system for rendering data stored on a data storage device (14) unrecoverable uponthe occurrence of a certain event, the system comprising: a reactant reservoir (18)including at least one chamber for holding a reactant chemical, the reactant reservoir influid communication with at least an area proximate at least one surface of said datastorage device; an activation device (44) coupled to said reactant reservoir andresponsive to at least one event, for causing at least a portion of the reactant chemicalto flow from the reactant reservoir into the at least an area proximate at least onesurface of said data storage device, thereby destroying the stored data, the at least oneevent being selected from the group consisting of removal of the data storage devicefrom a host computer, removal of data storage device from a primary power circuit (22),detected movement of the data storage device from its resting point, a certain numberof detected unsuccessful login attempts, an infrared signal sent from an infraredcontroller, a remote transmitter signal sent from a remote transmitter, a cellular signalsent from a cellular telephone, a wireless transmitter signal sent by a wirelesstransmitter, a keyboard signal sent from a wired controller, detected physical tamperingwith the data storage device, detected loss of power from the primary power circuit andbackup batteries, a command sent through an Internet, a key command sequenceentered from the keyboard, a voice command through a voice recognition system, abiometric signal, an incorrect biometric signal, and detected temperature outside arange of temperatures; and an event interface (42), coupled to said activation device,for establishing selected predetermined criteria for said at least one event, wherein theselected predetermined criteria include a countdown time before the reactant chemicalflows from the reactant reservoir.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009475
171104]21][11[
COMPACT מעגל משולב OPTIC SENSOR]54[
23.02.1999]22[Int. Cl.(2008.04) G01B 9/00, G01N 21/01]51[DIVISION FROM 128659]62[CONMED CORPORATION, U.S.A.]71[
,לוצאטו את לוצאטו באר שבע, 5352.ד.ת, עומר, גן תעשייה
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An integrated circuit (16) for the use in a compact optical sensor comprising a packageof at least two light sources (38, 40) concentrically surrounded by at least two waveguides (20, 22) being ring-like in cross-section, the integrated circuit comprises a pair ofsubstantially ring-like areas of photodiodes (26, 28) having different diameters andpositioned concentrically one inside the other; said integrated circuit being alsoprovided with a plurality of printed contact areas (30) and electric conductors (32),respectively intended for mounting thereon said light sources, controlling said lightsources, and for transmitting electric signals produced by said photodiodes areas tofurther processing.
A lock (10) that includes a wedge (12) and spool (14) are used to releasably secureseparable components of an assembly together. The wedge (12) and spool (14) arethreadedly coupled together to drive the wedge into and out of an opening in theassembly without hammering or prying. The direct coupling of the wedge (12) andspool eliminates the need for bolts, washers, nuts and other hardware so as tominimize the number of parts. As a result, the lock is inexpensive to make, easy to use,and unlikely to become inoperative because of lost or broken parts or due to fines orother difficulties encountered in harsh digging environments. Further, the wedge (12)can be driven into the assembly to provide the degree of tightness necessary for theintended operation and/or to re-tighten the assembly after incurring wear during use. Alatch assembly (56) is preferably provided to securely hold the wedge (12) in place andavoid and undesired loss of parts during use.
]57[
__________
171508]21][11[
DAMAGED לולב פגום והתקנים להסרת בורג BOLT AND SCREWREMOVING DEVICES
ירושלים, 1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A bit for removing a broken fastener comprises a tip from which extend two or morenotches separated by scraping surfaces formed from two-sided frusto-conically-shapedregions. The scraping surfaces are bounded on one side by a cutting edge and on theother side by a non-cutting edge and are configured to cut into the fastener when thebit is rotated in a direction opposite to the fastener's direction of engagement. Specificembodiments include configurations where the cutting edges extend at different angles
]57[
December–ע"התש בכסלו'ז 24, 2009477
with respect to the bit axis and where the scraping surfaces comprise a plurality ofserrations.
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a pallet container (10) comprising: a thin-walled inner container(12) made of thermoplastic material for storing and transporting liquid or free-flowingproducts; a lattice tube frame (14), which closely surrounds the plastic container (12) inthe form of a supporting cage and which consists of vertical and horizontal tubular rods(20, 22) that are welded to one another, and; a base pallet (16) upon which the plasticcontainer (12) rests and to which the lattice tube frame (14) is joined in a fixed manner.Prior art pallet containers have shortcomings with regard to strength (tubular rod fatiguefailure) that are considerable in the event of longer lasting shaking during transport thatinvolves dynamic cyclic stresses. In order to improve the lattice tube frame durabilitywhile maintaining sufficient stacking load-bearing capacity, the invention achieves anadapted optimal elasticity for dynamic alternating loads. This is realized by virtue of thefact that the tubular rods (20, 22) with a closed tubular profile have a varying tubularprofile height, which is discontinuously higher in the intersection areas and continuouslylower between the intersection areas.
]57[
December–ע"התש בכסלו'ז 24, 2009 478
__________
171585]21][11[
מכשיר לחיתוך חומר באמצעים של קרן לייזר
DEVICE FOR CUTTINGMATERIAL BY MEANS OF ALASER BEAM
Device for cutting material by means of a laser beam, which device (1) comprises alaser source (2) for generating a laser beam (3) with an optical axis (10) and a focusinglens (8) for focusing said beam, characterized in that, between said laser source andsaid focusing lens are provided a first and a second retardation plate (4, 5) and arefraction element in between them, which is provided rotatable and tiltable withrespect to said optical axis of the incoming light beam.
A wideband, constant-gain voltage amplifier. An input transistor has atransconductance that is a function of temperature and fabrication process. Atransimpedance amplifier is connected to the input transistor. The transimpedanceamplifier has a transimpedance that is a function of temperature and process that issubstantially the inverse of the function of temperature and fabrication process of thetransconductance of the input transistor.
]57[
__________
171860]21][11[
FOOD אריזת מזון PACKAGING]54[
18.06.2004]22[GB]33[18.06.2003]32[0314189.2]31[
Int. Cl.(2009.01) B32B 27//32]51[TOMMEN GRAM HOLDING AS,NORWAYBOREALIS AG, AUSTRIA
]71[
WO/2004/113072]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
December–ע"התש בכסלו'ז 24, 2009 480
The use of a polyolefin film comprising a polypropylene polymer and apolyethylene polymer for the packaging of fresh produce.
]57[
__________
171947]21][11[
תותבת לירך המסופקת עם מוט המוחדר לתוך עצם הירך
HIP PROSTHESIS PROVIDEDWITH A SHAFT INSERTED INTOTHE FEMUR
]54[
16.06.2004]22[EP]33[16.07.2003]32[03016157.4]31[
Int. Cl.(2008.04) A61F 2/36]51[WALDEMAR LINK GMBH & CO.KG, GERMANY
]71[
WO/2005/007039]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a hip prosthesis provided with a shaft (1) which can be insertedinto a hole in the femur without using cement. The proximal section of the shaft is madeup of a base body and the form thereof corresponds to the complementary form of thehole which is to be formed in the bone by means of a corresponding tool. A cuneus rib(12) is raised on the dorsal or ventral side of the base body and the width in the centrethereof is at least three times greater than the height thereof. The rear surface thereof(13) has rough and abrasive properties.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009481
171955]21][11[
שילוב של מחלק ומיכל עבור שתיה מוגזת
COMBINATION OF A DISPENSERAND CONTAINER FORCARBONATED DRINK
]54[
14.05.2004]22[NL]33[14.05.2003]32[1023429]31[
Int. Cl.(2008.04) B67D 1/04, 1/08]51[HEINEKEN TECHNICAL SERVICESB.V., THE NETHERLANDS
Combination of a dispenser (1) and container (7) for carbonated drink, the containerbeing provided at the top with an outflow channel (10), extending in the directio of thecentral axis of the container, and a dispensing valve (11), closed under spring tension,for dispensing carbonated drink via a dispensing line (12, 13) connected to the outflowchannel (10), the dispenser (1) being provided with a chill chamber (4) foraccommodating the container (7) and with a dispensing head (15) with a handle (17)whereby the handle (17) is connected to an operating member (18, 20) that, duringuse, engages on the dispensing valve (11).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 482
172437]21][11[
טה ליצור מסילה מסילה עם צדודית ושי עם צדודית
PROFILED RAIL AND METHODFOR PRODUCING A PROFILEDRAIL
The invention relates to a profiled rail for supporting plate-shaped elements, particularlyfor inlay mounting of ceiling plates for louvered ceilings. The profiled rail comprises abase body, which is provided, at least in areas with a T-profile and which has alongitudinally extended web as well as a lower flange. The lower flange is placed alonga longitudinal edge of the web and comprises two lower flange sections each extendingfrom the web essentially in opposite directions. The lower flange is formed by bendingthe web, and the side of the lower flange, which is oriented away from the web, isprovided with a facing board. A multitude of openings are provided in the web, wherebyat least one of the lower flange sections is formed by material sections of the web thatare folded out from the openings, and the web is provided as a single layer essentiallyover its entire surface. The invention also relates to a method for producing a profiledrail of this type.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009483
172670]21][11[
מתקן שיטה ומערכת לזיהוי פריט באופן מפורש
APPARATUS, METHOD ANDSYSTEM FOR POSITIVELYIDENTIFYING AN ITEM
,מעבדות יבמ מחלקת קנין רוחני חיפה, אוניברסיטת חיפה הר הכרמל
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
checkout station, for positively identifying items includes a reader that reads codedan item. The system further includes a capture module, such as a camera. The capture
sual characteristic of the item to be identified, such as the color, size, shape, or texture ofcharacteristic of the item is compared with visual characteristics of candidate items storedmultiple items within the database are associated with the item to be identified, theate items may be displayed to a user. The user may then select the candidate item thattem to be identified. The coded information of the item being identified is then compared
on of the selected item within the database. If the coded information of both itemsm is positively identified and is accepted for purchase by a consumer.
]57[
__________
172839]21][11[
עצוב תרחיף מימי של קוטל חיידקים ליישום עם עלים
AQUEOUS SUSPENSIONFORMULATION OF ABACTERICIDE FOR FOLIARAPPLICATION
It is intended to provide an aqueous suspension preparation of (RS)-N-[2-(1,3-dimethylbutyl)thiophen-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide showing stable residual effectiveness whilelittle affected by rainfall. An aqueous suspension preparation for foliageapplication, which is characterized by containing a bactericidalcomponent (RS)-N-[2-(1,3-dimethylbutyl)thiophen-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide together with apolyoxyalkyelne rosin acid ester or liquid paraffin, shows an improvedrain resistance on foliage and excellent residual effectiveness.
]57[
__________
173158]21][11[
פוליפפטידים בעלי פעילות ציטוזין דאמינאז משופרת
POLYPEPTIDE HAVING ANIMPROVED CYTOSINEDEAMINASE ACTIVITY
The present invention relates to a polypeptide possessing a CDase activity,characterized in that it is derived from a native CDase by addition of an amino acidsequence with the proviso that said polypeptide has no UPRtase or Thymidine Kinaseactivity.
]57[
ה זו בקשות חלוקה מבקש.שטר� פורסמו
198433,The applications for divisionfrom this application havenot yet been published
A machining apparatus, comprising: a mounting member (6) to be rotationally driven; atool support member (28) mounted on the mounting member; and a fixing member(30), fixed to the mounting member, for fixing the tool support member to the mountingmember, the mounting member having a mounting outer peripheral surface (24) of agenerally cylindrical shape, a cylindrical mounting hole (32) as a through-hole beingformed in the tool support member, and the tool support member being mounted on themounting member by fitting the mounting hole of the tool support member onto themounting outer peripheral surface of the mounting member, and wherein the mountingouter peripheral surface of the mounting member has a guide region, a support region,and a relief region arranged sequentially in a central axial direction, the support regionis of a cylindrical shape having an outer diameter D1, an outer diameter D2 of the guideregion increases up to D1 toward the support region, an outer diameter D3 of the reliefregion decreases from D1 with increasing distance from the support region, themounting hole of the tool support member has an inner diameter D4, D4 is larger thanD1 (D4>D1), a length in the central axial direction of the support region of the mountingouter peripheral surface is Wl, andWl is √ D42-Dl2 or smaller (Wl ≤ √ D42-D12).
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 486
173681]21][11[
גל OSCILLATOR שטח אקוסטי–מתנד בעל מהוד WITH ACOUSTICSURFACE WAVE RESONATOR
The invention relates to an oscillator or a sensor comprising a unit consisting of twofrequency determining elements each of which comprises at least one interdigitalconverter (24, 34) for acoustic surface waves and a back-coupling circuit comprising anamplifier, wherein the frequency determining elements (2, 3) are distinguished by atemperature dependence of a synchronous frequency. Said invention is characterisedin that a) the frequency determining elements are embodied in the form of acousticsurface wave resonators, b) the temperature coefficients of n-th order of thesynchronous frequency of the two acoustic surface wave resonators have differentsings if they are not equal to zero and the temperature coefficients of (n+1st) order ofthe synchronous frequency of the two acoustic surface wave resonators have the samesign and the temperature coefficients from the first order to (n-1st) order of thesynchronous frequency of the two acoustic surface wave resonators are equal to zero ifn is greater than 1, wherein n being equal to or greater than 1, c) the ratio between theconverter openings and the ratio between the lengths in the direction perpendicular tothe edge teeth of the converter and to strips of the object reflectors having differentfrequency determining elements which are assembled in one unit are selected in sucha way that the oscillator frequency variation is minimum within the range of giventemperatures.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009487
175109]21][11[
BEAK טיפול במקור עם הגנה ללשון TREATMENT WITHTONGUE PROTECTION
The present invention provides apparatus and methods for treating the beaks of poultryto prevent further growth by non-contact heating while protecting the birds' tongues.The birds' tongues are protected by providing pressure on underside of the lower beakof the bird, proximate the base of the lower beak.
]57[
__________
175191]21][11[
מוצר תוכנה עבור הדמיה קרדיאליתמימדית המשתמשת–תלת
ברקונסטרוקצית מתאר אולטרסונית
SOFTWARE PRODUCT FORTHREE-DIMENSIONAL CARDIACIMAGING USING ULTRASOUNDCONTOUR RECONSTRUCTION
',ר שלמה כהן ושות"ד תל אביב, 11490.ד.ת, 124אבן גבירול
DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
A computer software product for modeling of an anatomical structure, the productcomprising a computer-readable medium, in which program instructions are stored,which instructions, when read by the computer, cause the computer to acquire aplurality of ultrasonic images of the anatomical structure using an ultrasonic sensor, ata respective plurality of spatial positions of the ultrasonic sensor, to measure location
]57[
December–ע"התש בכסלו'ז 24, 2009 488
and orientation coordinates of the ultrasonic sensor at each of the plurality of spatialpositions, to receive a manual input marking contours-of-interest that refer to featuresof the anatomical structure in one or more of the ultrasonic images and to construct a3-D model of the anatomical structure based on the contours-of-interest and on themeasured location and orientation coordinates.
A system for transferring gas from a gas supply vessel (2) to a delivery point of usewhich comprises: a vessel containing a gas source; a pigtail conduit (8) having an initialend and a terminal end adapted for delivery of gas to a point of use; a surge chamber(22) having a first end, a body section and a second end, said first end incommunication with the initial end of said pigtail conduit, said body section of saidsurge chamber having a cross-section larger than the cross-section of said pigtailconduit and a second end in communication with said vessel containing said gassource; a purge gas source for delivery of a purge gas in the direction from the terminalend toward the vessel containing a gas source within said pigtail conduit during analternating cycle of pressurization of said pigtail conduit with said purge gas; and adepressurization source within said pigtail conduit allowing for removal of impuritygases retained within said pigtail conduit.
The present invention relates to topical compositions containing: a) Ginkgo bilobaterpenes; b) floroglucinols pure or in mixture thereof, extracted from Humulus lupulus,Hypericum sp and Mirtus sp; c) Zanthoxylum bungeanum or Echinacea angustifolialipophilic extract; for the treatment of atopic dermatitis, skin allergic conditions andacne.
]57[
__________
176518]21][11[
BALLISTIC-RESISTANT עצם עמיד בליסטיתARTICLE
]54[
01.01.2004]22[Int. Cl.(2008.04) F41H 5/04]51[DSM IP ASSETS B.V., THENETHERLANDS
]71[
WO/2005/066577]87[,לוצאטו את לוצאטו
באר שבע, 5352.ד.ת, עומר,גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The invention relates to a preformed sheet comprising at least two mono-layers, eachmono-layer containing unidirectionally oriented fibers having a tensile strength of atleast about 1.2 GPa and a tensile modulus of at least 40 GPa, and a binder, with a fibredirection in each mono-layer being rotated with respect to the fibre direction in anadjacent mono-layer, and a separating film on both outer surfaces, characterized in thatthe separating film has a porosity of between 40 and 90 %. With this preformed sheetassemblies and articles offering a substantially higher ballistic protection level at acertain weight can be obtained. The invention further relates to an assembly of at leasttwo such sheets and to a flexible ballistic-resistant article comprising said assembly.
]57[
December–ע"התש בכסלו'ז 24, 2009 490
__________
176731]21][11[
שיטה ליצור קו תאים סובלני לשכפולHCVוקו תאים המיוצר בשיטה זו
METHOD FOR PRODUCING ACELL LINE PERMISSIVE FORHCV REPLICATION AND A CELLLINE PRODUCED BY SAIDMETHOD
]54[
23.05.2001]22[US]33[23.05.2000]32[09/576989]31[
Int. Cl.(2008.04) A61K 39/29, C12Q 1/70]51[DIVISION FROM 152671]62[WASHINGTON UNIVERSITY,U.S.A.
]71[
WO/2001/089364]87[,ריינהולד כהן ושותפיו
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfectionefficiency and ability to survive subpassage greater than HCV that have wild-typepolyprotein coding regions. Expression vectors comprising the above polynucleotidesand HCV variants are also described, as are the provision of cells and host cellscomprising the expression vectors. Methods for identifying a cell line that is permissivefor infection with HCV are also provided, as are vaccines comprising the abovepolynucleotides in a pharmaceutically acceptable carrier. Additionally, methods forinducing immunoprotection to HCV in a primate are described, as are methods fortesting a compound for inhibiting HCV replication.
–פניל]מתוקסי]קינזולינילדיאון בצורה–4,2–תיאדיאזולידין]מתיל אבקה או כמוסה ותהליך להכנתו, טבלית
PHARMACEUTICALCOMPOSITION COMPRISING 5 -[[4-[3 - METHYL- 4- OXO - 3,4 -DIHYDRO - 2 -QUINAZOLINYL]METHOXY]PHENYL-METHYL]THIADIAZOLIDINE-2,4-DIONE IN THE FORM OF ATABLET, A POWDER OR ACAPSULE AND PROCESS FORITS PREPARATION
רמת החייל',א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention provides a new stable pharmaceutical composition containing 5-[[4-[ 3-Methyl-4- oxo-3,4- dihydro-2- quinazolinyl] methoxy]phenyl -methyl]thiadiazolidine -2,4-dione as active ingredient.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009 492
180304]21][11[
התוית פגמי מסה עבור קביעת רצפי וליגומריםא
MASS DEFECT LABELING FORTHE DETERMINATION OFOLIGOMER SEQUENCES
Mass tagging methods are provided that lead to mass spectrometer detectionsensitivities and molecular discriminations that are improved over other methods. Inparticular the methods are useful for discriminating tagged molecules and fragments ofmolecules from chemical noise in the mass spectrum. These mass tagging methodsare useful for oligomer sequencing, determining the relative abundances of moleculesfrom different samples, and identifying individual molecules or chemical processingsteps in combinatorial chemical libraries. The methods provided are useful for thesimultaneous analysis of multiple molecules and reaction mixtures by massspectrometric methods.
]57[
__________
184004]21][11[
התקן למדידת וכיוונון פרמטרים רכב–גיאומטריים של תושבת כלי
APPARATUS FOR MEASURINGAND ADJUSTING CHASSISGEOMETRY OF A MOTORVEHICLE
]54[
18.06.2007]22[Int. Cl.(2009.01) G01M 17//06]51[
MYKHAYLO חיפה, מיכאלו לוקשין LOKSHYN]71[,שימעון גוזמן
חיפה, 13/3אהבה' רחSHIMON GOYZMAN,13/3 AHAVA ST.,
HAIFA 35418
]74[
December–ע"התש בכסלו'ז 24, 2009493
An apparatus for measuring and adjusting chassis geometry of a motor vehicle,comprising a pair of optically matched tools (1, 2), one of which includes device (7) witha laser emitter (20) and other tool (2) – device (8) with a plane target (22) deflecting alaser beam, each tool having a mounting support (3) adapted to mount the tool on aninternal side of a circular element of a wheel and an X-direction orienting level (6) whichperpendicular to the laser beam and parallel to the plane target, wherein the devicesand the mounting supports are pivotally connected to each other through a pivot pin (9,10) disposed parallel to abscissa axis of the X-direction orienting level, wherein themounting supports are designed as a bracket having faces formed mostly by a pair ofright dihedral angles (internal and external), said bracket having edges parallel to theabscissa axis of the X-direction orienting level; wherein the internal bracket faces (B, C)are equipped with a fixing means (4, 5) intended for holding the bracket on the internalside of the circular element of the wheel, and a first external bracket face (D) comprisesthe rigidly fixed X-direction orienting level, and a second external bracket face (E) bearssaid device as well as a Y-direction orienting level (17) (18) disposed mainlyperpendicular to the abscissa axis of the X-direction orienting level on the plane parallelto the said abscissa axis.
]57[
לתקנות35פירוט זה נבחן בהתאם לתקנה 1968–ח"תשכ, הפטנטים
This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968
__________
December–ע"התש בכסלו'ז 24, 2009 494
187551]21][11[
תכשירי, תרכובות אנטימיקרוביותרוקחות המכילים אותן ותהליכים
להכנתן
ANTIMICROBIALCAPURAMYCIN DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
Pharmacologically acceptable esters, ethers and carbamoyl N-alkylates derived fromcompounds represented by general formula (Ia), and pharmacologically acceptablesalts of the same, which exhibit an excellent antibacterial activity and are useful in thetreatment or prevention of infectious diseases, wherein R?1¿ is hydrogen or methyl;R?2¿¿a? is hydrogen, a hydroxyl-protecting group or methyl; R?3¿ is hydrogen or ahydroxyl-protecting group; R?4¿¿a? is hydrogen or optionally protected hydroxyl; R?5¿is hydrogen or a hydroxyl-protecting group; and X is methylene or sulfur.
]57[
__________
December–ע"התש בכסלו'ז 24, 2009495
188086]21][11[
שיטות וציוד לעשות חלקיקים בשימושבמייבש בתרסיס ובמטחנת סילון בתוך
הקו
METHOD AND APPARATUS FORMAKING PARTICLES USINGSPRAY DRYER AND IN-LINE JETMILL
Methods and apparatus are provided for making particles comprising: (a) spraying anemulsion, solution, or suspension, which comprises a solvent and a bulk material (e.g.,a pharmaceutical agent), through an atomizer (14) and into a primary drying chamber(12), having a drying gas flowing therethrough, to form droplets comprising the solventand bulk material dispersed in the drying gas; (b) evaporating, in the primary dryingchamber (12), at least a portion of the solvent into the drying gas to solidify the dropletsand form particles dispersed in drying gas; and (c) flowing the particles and at least aportion of the drying gas through a jet mill (24) to deagglomerate or grind the particles.By coupling spray drying with 'in-line' jet milling, a single step process is created fromtwo separate unit operations, and an additional collection step is advantageouslyeliminated. The one-step, in-line process has further advantages in time and cost ofprocessing.
פטנטים שחודשו לעשרים שנהPATENTS RENEWED FOR 20 YEARS
113776
December–ע"התש בכסלו'ז 24, 2009501
צווי הארכה שחודשוEXTENSION ORDERS RENEWED
88363 84601 84497
December–ע"התש בכסלו'ז 24, 2009 502
NOTICEהודעהלחוק60לפי סעיף 1967-ז"תשכ, הפטנטים
Under section 60 of thePatent Law, 5727-1967
חזר תוקפו הוגשה בקשה לה, של הפטנט המפורט מטהשתוקפו פקע מחמת אי
תשלום אגרות החידוש :הקבועות
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 137745 הפטנט' מס of PatentAcceptance 3/2005:'קיבול פורסם ביומן מס published in
journal no::Proprietors:שם בעל הפטנט
MOTOROLA, INC.Title:שם האמצאה of invention:
חוטית-שיטה ומערכת להערכת מיקום של מנוי באזור שירות ברשת תקשורת אלMETHOD AND SYSTEM FOR ESTIMATING A SUBSCRIBER'S LOCATION IN A
WIRELESSCOMMUNICATION SYSTEM SERVICE AREAכל אדם רשאי להתנגדלבקשה האמורה תוך
שלושה חודשים מתאריך כפי שנקבע, יומן פטנטים זה
92לחוק ובתקנה61בסעיף -ח"תשכ, לתקנות הפטנטים
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
December–ע"התש בכסלו'ז 24, 2009503
NOTICEהודעהלחוק60לפי סעיף 1967-ז"תשכ, הפטנטים
Under section 60 of thePatent Law, 5727-1967
הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטהשתוקפו פקע מחמת אי
תשלום אגרות החידוש :הקבועות
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 138303 הפטנט' מס of PatentAcceptance 6/2005:'קיבול פורסם ביומן מס published in
journal no::Proprietors:שם בעל הפטנט
TELEFONAKTIEBOLAGET LM ERICSSONTitle:שם האמצאה of invention:
שיטה והתקן לבקרה על זרימת מידעMETHOD AND DEVICE FOR DATA FLOW CONTROL
אדם רשאי להתנגד כללבקשה האמורה תוך
שלושה חודשים מתאריך כפי שנקבע, יומן פטנטים זה
92לחוק ובתקנה61בסעיף -ח"תשכ, לתקנות הפטנטים
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
December–ע"התש בכסלו'ז 24, 2009 504
NOTICEהודעהלחוק60לפי סעיף 1967-ז"תשכ, הפטנטים
Under section 60 of thePatent Law, 5727-1967
הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטהשתוקפו פקע מחמת אי
שלום אגרות החידושת:הקבועות
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 138324 הפטנט' מס of PatentAcceptance 5/2005:'קיבול פורסם ביומן מס published in
journal no::Proprietors:שם בעל הפטנט
ERICSSON, INC.Title:שם האמצאה of invention:
מערכת ושיטה לידע רשת על יכולות שיטת מיקום מבוסס מסוףSYSTEM AND METHOD FOR INFORMING NETWORK OF TERMINAL BASED
POSITIONING METHOD CAPABILITIESל התנגד כל אדם רשאי
לבקשה האמורה תוך שלושה חודשים מתאריך
כפי שנקבע, יומן פטנטים זה92לחוק ובתקנה61בסעיף
-ח"תשכ, לתקנות הפטנטים1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
December–ע"התש בכסלו'ז 24, 2009505
NOTICEהודעהלחוק60לפי סעיף 1967-ז"תשכ, הפטנטים
Under section 60 of thePatent Law, 5727-1967
הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטהשתוקפו פקע מחמת אי
תשלום אגרות החידוש :תהקבועו
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 165945 הפטנט' מס of PatentAcceptance 11/2005:'קיבול פורסם ביומן מס published in
journal no::Proprietors:ל הפטנטשם בע
שלמה זילברמןSHLOMO ZILBERMAN
Title:שם האמצאה of invention: מערכת לגלילת ספרי תורה
APPARATUS FOR ROLLING A SEFER TORAHכל אדם רשאי להתנגדלבקשה האמורה תוך
שלושה חודשים מתאריך כפי שנקבע, יומן פטנטים זה
92לחוק ובתקנה61בסעיף -ח"תשכ, לתקנות הפטנטים
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
December–ע"התש בכסלו'ז 24, 2009 506
NOTICEהודעהלחוק60 לפי סעיף 1967-ז"תשכ, הפטנטים
Under section 60 of thePatent Law, 5727-1967
הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטהשתוקפו פקע מחמת אי
תשלום אגרות החידוש :הקבועות
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 169950 הפטנט' מס of PatentAcceptance 3/2006:'קיבול פורסם ביומן מס published in
journal no::Proprietors:שם בעל הפטנט
שמעון זילברמןSHLOMO ZILBERMAN
Title:שם האמצאה of invention:ר תורה בעל מיסביםספ
SEFER TORAH WITH BEARINGSכל אדם רשאי להתנגדלבקשה האמורה תוך
שלושה חודשים מתאריך כפי שנקבע, יומן פטנטים זה
92לחוק ובתקנה61בסעיף -ח"תשכ, לתקנות הפטנטים
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
December–ע"התש בכסלו'ז 24, 2009507
תיקון טעותCORRIGENDUM
11/2008יומן
P. 4868 Patent application No 166919 166919'בקשת פטנט מס4868'עCorrect divisional application to- ל 153028-תקן בקשת חלוקה
3/2009יומן
P. 394 Patent application No 168609 168609'בקשת פטנט מס394'עCorrect date of priority to- ל 23.11.2002-תקן תאריך דין קדימה
December–ע"התש בכסלו'ז 24, 2009 508
קודים למדינת המופיעים ביומןCOUNTRY CODES APPEARING IN THIS JOURNAL
Code Country or OrganizationAR ArgentinaAT AustriaAU AustraliaBA HerzegovinaBE BelgiumBR BrazilCA CanadaCH SwitzerlandCN ChinaCU CubaCZ Czech RepublicDE GermanyDK DenmarkEC EcuadorEP European Patent OfficeES SpainFI FinlandFR FranceGB United KingdomGE GeorgiaGR GreeceGT GuatemalaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV LatviaMX Mexico
MY Malaysia
December–ע"התש בכסלו'ז 24, 2009509
NL The NetherlandsNO NorwayNZ New ZealandPL PolandPT PortugalRU Russian FederationSE SwedenSG SingaporeSI SloveniaSK SlovakiaTH ThailandTR TurkeyTW TaiwanUA UkraineUS United States of AmericaUY UruguayUZ UzbekistanWO World Intellectual Property Organization (W.I.P.O.)ZA South Africa
December–ע"התש בכסלו'ז 24, 2009 510
DESIGNS מדגמים מדגמים שנרשמו
DESIGNS REGISTERED
44267, 44268, 44269, 44270Class 8(08) סוג
3. 6.2007XI MODULAR DESIGN LTD. מ"קסאי עיצוב מודולארי בעProfile פרופיל
